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Protecting groups play a key role in the synthesis of complex natural products.1 
This holds especially true for the synthesis of oligosaccharides,2 of which the monomeric 
carbohydrate building blocks usually contain up to five different hydroxyl functions. The 
discrimination of these hydroxyl functions requires a careful protecting group strategy and 
typically involves multistep protocols. Although protecting groups primarily function to 
mask a given functionality on the carbohydrate core, they also have a profound effect on 
the overall reactivity of a carbohydrate building block3 and can control the stereochemical 
outcome of a glycosylation reaction.4 Furthermore protecting groups can be used to 
introduce extra functionality on the carbohydrate core, such as visualization and/or 
1 
CHAPTER 
General Introduction: Novel 





purification handles.5 This chapter describes selected examples of novel protecting groups 
and protection strategies in carbohydrate chemistry from the beginning of the 21st century 
and highlights how protecting group chemistry has evolved from a necessary time 
consuming burden to a sophisticated synthetic tool for the efficient and stereoselective 
assembly of oligosaccharides.6  
 
Advances in the regioselective protection of carbohydrates: 
 
The regioselective manipulation of the different hydroxyl groups on a 
carbohydrate monomer is key to any protecting group strategy. Although all hydroxyl 
groups are of comparable reactivity they can be discriminated by exploiting their subtle 
reactivity differences and their relative orientation. The nucleophilicity of the different 
hydroxyls under neutral or acidic conditions increases from the anomeric to the secondary 
to the primary alcohol function.  The anomeric hydroxyl  group is most acidic and therefore 
selective protection of the hemiacetal -OH can be achieved in the presence of other 
secondary hydroxyls using basic reaction conditions.  The general reactivity difference 
between an axially and an equatorially oriented hydroxyl group can often be exploited to 
attain a regioselective protection step. Commonly, the use of cyclic protecting groups 
presents a more robust way to discriminate between the different functionalities on a 
carbohydrate ring.  For example, benzylidene type acetals are widely used to selectively 
mask the C-4 and C-6 alcohols,7 whereas isopropylidene ketals are used to block two 
neighboring cis hydroxyls,8 and butane 2,3-bisacetals to protect vicinal diequatorial diols.9 
 
Recently several sequential procedures have been developed to streamline the 
regioselective protection of carbohydrates. Hung and co-workers disclosed that 
anomerically protected per-silylated carbohydrate monomers can be transformed into a 
wide array of differentially protected building blocks using a one-pot protocol, which 
combines up to five reaction steps (Scheme 1).10 Because all steps are consecutively 
executed in the same reaction vessel the intermediate work-up and purification steps are 
omitted making this process highly efficient. The strategy builds on the trimethylsilyltriflate 




Scheme 1: One-pot regioselective protection of glucosides.  
c1a: X = -OMe

















2a-7a: R1= Ph, R2 = Ph (91%),
4-OMePh (94%), 3,4-DiOMePh
(81%), 2-naphthyl (71%), 4-ClPh
(73%) or 4-BrPh (76%).
8a-13a: R1= 4-NO2Ph, R2 = Ph (70%),
2-naphthyl (68%), 3,4-DiOMePh
(81%), 4-ClPh (73%), 4-BrPh (64%)
or 4-OMePh (71%).
14a-16a: R1= 2-naphthyl, R2 = Ph (85%),
2-naphthyl (72%) or 4-OMePh (75%).
17a-19a: R1= 4-ClPh, R2 = Ph (74%),
4-OMePh (70%) or 4-ClPh (70%).
2b-5b: R1= Ph, R2 = Ph (82%), 4-OMePh
(76%), 2-naphthyl (72%)
or Crotyl (58%).
20a-21a: R1 = CH3, R
2 = Ph, R3 = Ph (60%)
or 2-naphthyl (60%).
22a-23a: R1 = CH3, R
2 = 2-naphthyl, R3 = Ph (60%)
or 2-naphthyl (63%).
24a-25a: R1, R2 = Ph, R3 = Ph (65%)
or 2-naphthyl (62%).
26a-27a: R1= Ph, R2 = 2-naphthyl, R3 = Ph (61%)
or 2-naphthyl (65%).
20b-21b: R1 = CH3, R
3 = Ph, R2 = Ph (53%)
or 2-naphthyl (61%).
22b-23b: R1, R3 = Ph, R2 = Ph (62%)
or 2-naphthyl (50%).
52a-53a: R1= CH3, R
2 = Ph, R3 = Ph
(50%) or 2-naphthyl (51%).
54a-55a: R1= Ph, R2 = R3 = Ph (51%)
orR2 = R3 = 2-naphthyl (50%).
52b-53b: R1= CH3, R
3 = Ph, R2 = Ph
(70%) or 2-naphthyl (67%).
54b-55b: R1= Ph, R3 = Ph, R2 = Ph
(57%) or 2-naphthyl (53%).
56a-60a: R2 = Ph, R1= Ac (81%), Bz,
(61%), Bn (60%), 4-BrBn (60%)
or All (73%).
61a-62a: R2 = 4-ClPh, R1= Ac (79%)
or Bz (60%)
.63a-64a: R2 = 4-BrPh, R1= Ac (75%)
or Bz (71%).






28a-31a: R1 = Ac, R3 = Ph, R2 = Ph (94%), 4-ClPh
(88%), 4-BrPh (71%) or 2-naphthyl (70%).
32a-35a: R1 = Ac, R3 = 4-NO2Ph, R
2 = Ph (70%),
4-ClPh (72%), 4-BrPh (79%) or
2-naphthyl (68%).
36a-37a: R1 = Ac, R3 = 2-naphthyl, R2 = Ph (79%)
or 2-naphthyl (72%).
38a-39a: R1 = Ac, R3 = 4-ClPh, R2 = Ph (86%) or
4-ClPh (91%).
40a-43a: R1 = Bz, R3 = Ph, R2 = Ph (67%), 4-ClPh,
(62%), 4-BrPh (55%) or 2-naphthyl (67%).
44a-47a: R1 = Bz, R3 = 4-NO2Ph, R
2 = Ph (61%),
4-ClPh (57%), 4-BrPh (64%) or
2-naphthyl (62%).
48a-49a: R1 = Bz, R3 = 2-naphthyl, R2 = Ph (63%)
or 2-naphthyl (57%).
50a-51a: R1 = Bz, R3 = 4-ClPh, R2 = Ph (75%) or
4-ClPh (73%).
28b-29b: R1 = Ac, R3 = Ph, R2 = Ph (78%) or
2-naphthyl (70%).















Reagents and conditions; a) i- TMSOTf (cat), R1CHO, DCM, 3Å MS, -86 ºC; ii- R2CHO, Et3SiH, -86 ºC; iii- 
TBAF (1 M); b) i- TMSOTf (cat), R3CHO, DCM, 3Å MS, -86 ºC; ii- R2CHO, Et3SiH, -86 ºC; iii- (R1CO)2O; 
iv- BH3/THF c) i- TMSOTf (cat), R
3CHO, DCM, 3Å MS, -86 ºC; ii- R2CHO, Et3SiH, -86 ºC; iii- TBAF (1 M); 
iv- base, electrophile; d) i- TMSOTf (cat), R3CHO, DCM, 3Å MS, -86 ºC; ii- R2CHO, Et3SiH, -86 ºC; iii- 
(R1CO)2O; iv- HCl(g), NaCNBH3; e) i- TMSOTf (cat), R
2CHO, DCM, 3Å MS, -86 ºC; ii- 4-OMePhCHO, 
Et3SiH, -86 ºC; iii- TBAF; iv- electrophlie; v- DDQ; f) i- TMSOTf (cat), R
2CHO, DCM, 3Å MS, -86 ºC; ii- 2-






regioselective formation of a benzyl type ether at O-3. Next, the C-2-OH can be acylated 
and the arylidene opened to liberate either the C-4-OH or C-6-OH. Alternatively the C-3-
benyl ether is removed to expose the C-3-alcohol. Instead of the introduction of a O-2 acyl 
functionality also the incorporation of various ethers was described. Using the one-pot 
protocol, Hung and co-workers reported the synthesis of a large panel of differentially 
protected glucosides, two galactosides, a mannoside and one glucosamine building block.  
 
Simultaneously, Beau and co-workers reported a closely related procedure in 
which per-silylated glucosides were functionalized with a O-4, O-6 benzylidene acetal and 
a O-3 benzyl ether using benzaldehyde using Cu(OTf)2 catalysis (Scheme 2).
11 They also 
demonstrated the possibility to extend the one-pot reaction sequence with an acylation step 
or a reductive opening of the benzylidene acetal.   
 
Scheme 2: Cu(OTf)2 catalyzed one-pot regioselective protection of glucosides.  
Reagents and conditions; g) i- PhCHO, Et3SiH, Cu(OTf)2, DCM/ACN (4:1), RT (X = -OMe) or 0 ºC (X = -
SPh), 10 min; ii- Ac2O, DCM, RT, 1 h or Bz2O, DCM, reflux, 24 h or Piv2O, DCM, reflux, 24 h; h) i- PhCHO, 
Et3SiH, Cu(OTf)2, DCM/ACN (4:1), RT (X = -OMe) or 0 ºC (X = -SPh), 10 min; ii- BH3, THF, Cu(OTf)2, RT, 
3 h; i) i- PhCHO, Et3SiH, Cu(OTf)2 (10 mol%), DCM/ACN (4:1), RT (X = -OMe) or 0 ºC (X = -SPh), 10 min; 





  Stannyl ethers and dialkylstannylene acetals have found wide application in the 
regioselective protection of carbohydrates ever since their introduction in 1974. Onomura 
and co-workers recently described the use of a catalytic amount of dimethyltin dichloride 
(Me2SnCl2) for the regioselective protection of various monosaccharides.
12 The 
regioselectivity in the Me2SnCl2 benzoylation was shown to depend on the relative 
stereochemistry of the hydroxyl functions present. A fully protected -O-methyl 
glucopyranose was obtained as depicted in Scheme 3. Thus, benzoylation of glucoside 70 
provided the C-2 acylated compound 71 in 82% yield. The subsequent tosylation occurred 
selectively at the C-6 hydroxyl to give diol 72 in 88%. Next a tert-butyl carbonate was 
introduced at the C3-OH and phosphorylation of the remaining alcohol provided the fully 
functionalized glucoside 74.  
 
Scheme 3: Dimethyltin dichloride catalyzed regioselective protection of glucose.  
 
 
Reagents and conditions; j) Me2SnCl2, BzCl, DIPEA, THF, RT, 82%; k) Me2SnCl2, TsCl, DIPEA, THF, RT, 88%; 
l) Me2SnCl2, Boc2O, DIPEA, DMAP, THF, RT, 93%; m) ClP(O)(OPh)2, pyr, DMAP, DCM, RT, 95%. 
 
Protecting groups in the stereoselective construction of glycosidic bonds: 
 
Although the primary purpose of a protecting group is to prevent a given hydroxyl 
from reacting, it is now well established that the nature of the protecting group has a major 
effect on the reactivity of glycosyl building blocks and the stereoselectivity and yield of a 
glycosylation reaction. This is of course best demonstrated considering a C-2 acyl 
protecting group in a donor glycoside, which not only deactivates this donor species as 
compared to its C-2 ether counterpart, but also reliably provides anchimeric assistance in 




Scheme 4: Protecting groups providing anchimeric assistance during glycosylation. 
a- Acyl at C-2: Classical neighboring group participation by C-2 ester leading to 1,2-trans 
glycosides.
 




























107: R = Ac































































109: R = Ac (76%)
















111: R = Ac







113: R= Ac, R1 = 104, 85%, = 49/1
114: R= Ac, R1 = 93, 44%, = 49/1
115: R= Bn, R1 = 104, 89%, = 49/1
116: R= Ac, R1 = 93, 72%, = 49/1
117: R= Bn, R1 = 103, 66%, = 49/1
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f- Demchenko’s picolyl ether protecting group 
 
Reagents and conditions; n) BF3·OEt2, AcOH, DCM, 0 ºC, 10 min, 74%; o) Pd(Ph3P)4, AcOH, RT, 24 h, 90%; p) 
DBU, trichloroacetonitril, DCM, 0 ºC, 1 h, 93%; q) TMSOTf, DCM; ; r) TMSOTf, PhSEt, DCM; s) i- thiourea, 
BF3·OEt2, ACN; ii- 92, Et3N, 64%; t) NaOMe, MeOH, 99%; u) i- TsOH, MeOH; ii- Ac2O, pyr or BnBr, NaH, 
DMF iii- m-CPBA; v) Tf2O; w) 1,3,5-trimethoxybenzene, DIPEA, -30 ºC; x) DIPEA, R
1OH, -10 ºC-50 ºC, 18h. 
 
becoming more and more clear that protecting groups at other positions than the C2-OH 
can have a powerful stereodirecting effect. For example, Kim and co-workers recently 
demonstrated that the installment of an acyl function on the C-3 hydroxyl of a mannosyl 
donor leads to the stereoselective formation of -mannosides (Scheme 4b) through 
neighboring group participation.13 
 
The stereoselective formation of 1,2-cis glycosidic bonds has been a long standing 
problem in carbohydrate synthesis. In 2005 the group of Boons developed two C-2 OH 
protecting groups that were capable of promoting the formation of 1,2-cis glycosidic bonds 
by neigbouring group participation.14 As depicted in Scheme 4C, the (1S)-phenyl-2-
(phenylsulfanyl)ethyl ether can be introduced at the C2 hydroxyl of glucoside 84 with (1S)-
phenyl-2-(phenylsulfanyl)ethyl acetate 85 in the presence of BF3·OEt2. The configuration 
of the chiral center of the newly introduced ether is retained in this reaction because of the 
intermediate formation of an episulfonium ion, which is displaced at the benzylic position. 
Using standard protecting group manipulations, glucoside 86 was transformed into 
trichloroacetimidate 88. This donor could be (pre)-activated with TMSOTf to provide a 




phenyl substituent of the C-2 chiral auxiliary occupies an equatorial position. The 
alternative cis-decalin system is not formed because this would place the phenyl group in 
an unfavorable axial orientation. Nucleophilic displacement of the intermediate sulfonium 
ion then provides the 1,2-cis products. The influence of the C2-chiral auxiliary was 
compared to the effects of an external sulfide, a non-chiral internal sulfide and the effect of 
the same auxiliary of opposite chirality. As can be seen in Scheme 4c, the best 
stereoselectivity was obtained with the (1S)-phenyl-2-(phenylsulfanyl)ethyl donor. Along 
the same line, the Boons laboratory developed the ethoxycarbonylbenzyl ether for the 
stereoselective construction of -glucosyl and -galactosyl linkages. It should be noted that 
the best selectivities were obtained with electron withdrawing protecting groups on the C-3 
OH.15 
 
To circumvent the extra synthetic effort that is required to introduce the Boons 
auxiliary in a suitable donor, Turnbull introduced oxathiane type donors as depicted in 
Scheme 4d.16 This type of donor can be activated by transformation into the corresponding 
sulfoxide which can then be treated with triflic anhydride to provide a glycosylating 
species. Because the activated leaving group remains attached to the molecule upon 
glycosylation and thus ends up in the final product, the resulting sulfenyl triflate was 
transformed into arylsulfonium ion 111 and 112 by treatment with trimethoxybenzene. This 
species can be displaced with the acceptor alcohol (Scheme 4d). Because of the stability of 
the intermediate trimethylphenyl sulfonium ion relatively high temperatures are required 
for this substitution and best results were obtained with primary alcohols. Notably the 
stereoselectivity of the glycosylations did not depend on the nature of the other protecting 
groups on the donor glycoside. 
 
The 2-O-(thiophen-2-yl)methyl group was introduced by Fairbanks to provide a 
similar kind of anchimeric assistance as Boons’ phenyl-2-(phenylsulfanyl)ethyl ether.17 
Good to excellent -selectivities were reported for otherwise benzylated donors. No 






The trans-directing effect of the 2-picolyl ether described by Demchenko and co-
workers stands in contrast to the -directing effect of the sulfur-based participating groups 
(scheme 4f).18,19 The C-2 picolyl ether was introduced as a “non-disarming” alternative for 
the participating C-2 acyl function. It was demonstrated that C-2 picolyl S-thiazolinyl donor 
123 was transformed into a mixture of two bicyclic products, in which the -oriented 
pyridinium ion 125 prevailed (20 : 1 at room temperature, 5 : 1 at 50 oC). The predominant 
formation of the 1,2-cis bicycle obviously differs from the generation of the -sulfonium 
ions described above. Possibly, active participation of the picolyl ether in the expulsion of 
the S-thiazolyl under the mild activation conditions (Cu(OTf)2) is at the basis of this 
contrasting behavior. The -pyridinium intermediate could be displaced by a glycosyl 
nucleophile at elevated temperature (50 oC) to provide the 1,2-trans products. The -
pyridinium ion proved to be inert under these conditions and was isolated after the reaction.     
 
Besides the conceptually novel participating groups described above, several new 
acyl type protecting functions have recently been reported. For example, the 4-acetoxy-2,2-
dimethylbutanoate was introduced as a pivaloyl analogue, which can be removed under 
relatively mild conditions (Scheme 5a).20 The 3-(2’-benzyloxyphenyl)-3,3-
dimethylpropanoate ester has been developed as a participating group that can be removed 
by catalytic hydrogenolysis in concert with regularly used benzyl ethers (Scheme 5b).21 
Iadonisi and co-workers introduced alkoxycarbonates as participating functionalities to 
circumvent orthoester formation, which is a common side reaction when C-2-O-acyl 
protected donors are used in combination with mild activating conditions (Scheme 5c).22 
 
Chapter 2 of this thesis describes that the methylsulfonylethoxycarbonyl group is 
an orthogonal protecting group for hydroxyl functions in oligosaccharide synthesis that 
provides anchimeric assistance and excludes orthoester formation, when placed on the C2-
OH of a glycosyl donors.23 The group of Yamago showed that dialkylphosphate esters at 
the C-2-OH position are stereodirecting protecting groups for the synthesis of 1,2-trans-
glycosides. 
 















































































b- Crich’s 3-(2’-benzyloxyphenyl)-3,3-dimethylpropanoate ester. 
 
c- Iadonisi’s alkoxycarbonate. 
 Reagents and conditions; q) TMSOTf, DCM; y) i- BocNH-L-Glu-O-t-Bu, NIS, TfOH, DCM, -40 ºC, 90%; ii-
Pd/C, 3 atm H2, RT, 86%; z) Yb(OTf)2, tol., 50 ºC, 2h, 82%. 
 
Protecting group size can have a major effect on the stereochemical outcome of a 
glycosylation reaction. For example, the large C-6 trityl ether has been shown to enhance 
the -selectivity of glucosylations, presumably by steric shielding of the -face. Crich and 
co-workers have reported on steric buttressing of large protecting groups at the C-3 
hydroxyl in 2-O-benzyl-4,6-benzylidene mannosyl donors, which typically react in a highly 
-selective fashion.24 Placement of a large tert-butyldimethylsilyl (TBDMS) group at the 
C-3 hydroxyl caused erosion of this selectivity because the large silyl group pushes the C-2 




nucleophilic attack on the -face of the molecule. To overcome the poor selectivities of 
mannosyl donors with bulky C-3 substituents, Crich and co-workers introduced various 
propargyl ethers as minimally intrusive hydroxyl protecting groups. Firstly, the use of an 
unsubstituted propargyl ether was reported, which efficiently restored the -selectivity of 
mannosyl donor 138 as depicted in Scheme 6a.25 Because the removal of the propargyl 
ether required a two step sequence, namely base induced isomerisation followed by 
oxidative cleavage of the intermediate allene ether by catalytic OsO4, substituted propargyl 
ethers were developed next (Scheme 6b). The 1-naphthylpropargyl can be cleaved in a 
single step using DDQ in wet DCM, but proved to be incompatible with the commonly 
used sulfonium activator systems BSP/Tf2O and Ph2SO/Tf2O.
26 Furthermore, when placed 
at the C-2 hydroxyl, it engages in nucleophilic attack of the activated anomeric center. 
Therefore the 4-trifluoromethylbenzyl propargyl ether group was introduced.27 This ether 
was shown to be sterically minimally demanding and compatible with electrophilic 
activators, while it could be cleaved using lithium naphtalenide (Scheme 6c).  
 
The C-2 propargyl ether was exploited by Fairbanks and co-workers in an 
intramolecular aglycon delivery (IAD) strategy towards -mannosides.28 As depicted in 
Scheme 6d, the propargyl ether in 144 was isomerised to the allenyl ether, which provided 
the mixed acetal 147 upon treatment with an glycosyl alcohol and iodonium ions. 
Dimethyldisulfide-Tf2O mediated intramolecular glycosylation led to the completely 
stereoselective formation of the disaccharide 148.     
 
Scheme 6: Propargyl ethers in carbohydrate chemistry. 










c- 4-Trifluoromethylbenzylpropargyl protective group the synthesis of -mannosides. 
 
d- Intramolecular aglycon delivery (IAD).  
 Reagents and conditions; aa) i- BSP, TTBP, Tf2O, DCM; ii- R
1OH; iii- t-BuOK, OsO4, NMNO; ab) i- 1-octene, 
TTBP, Tf2O, DCM; ii- ROH; iii- DDQ, DCM; ac) i- BSP, TTBP, Tf2O, DCM; ii- ROH; iii- lithium naphthalenide; 
ad) t-BuOK, Et2O, 66%; ae) I2, AgOTf, DTBMP, DMC, -78 °C-RT, 88%; af) Me2S, Tf2O, DTBMP, DCM, 0 °C-
RT, 81%. 
 
Seeberger and co-workers described another solution to overcome the steric 
buttressing of the large TBDMS ether described above. They showed that the tri-iso-
propylsilyloxymethyl (TOM) group, in which the oxymethylene moiety moves the bulk to 
the silyl group away from the mannosyl core, could be used to install the -mannosidic 
linkage.29 The C-3-O-TOM mannosyl donors were used in the automated solid phase 
synthesis of -mannosides (Scheme 7a). 
 
Chapter 4 of this thesis describes the methylsulfonylethoxymethyl (Msem) group 
as a new hydroxyl protecting group in oligosaccharide synthesis.30 The Msem group is 






 The 4-(tert-butyldipehenylsiloxy)-3-fluorobenzyl group was developed as a 
fluorine labile benzyl ether, attuned to the synthesis of -mannosides.31 The fluorine in this 
p-siloxybenzyl type ether was introduced to enhance its stability under acidic and oxidative 
conditions. The 4-(tert-butyldiphenylsiloxy)-3-fluorobenzyl group was introduced using the 
corresponding benzyl bromide, which was synthesized in three steps from commercially 
available 3-fluoro-4-hydroxybenzoic acid, and cleaved with tetrabutyl ammonium fluoride 
(TBAF) at elevated temperatures under microwave irradiation (Scheme 7b). Lower 
temperatures only led to removal of the silyl group.  
 
Scheme 7: Sterically minimally intrusive silyl based protecting groups in the construction of -
mannosides.  
a- TOM protective group. 
 
b- Silyl substituted benzyl ether. 
 
Reagents and conditions; ag) TMSOTf, tol., DCM, 15 min, repeat; ah) NaOMe, MeOH, DCM, repeat; ai) Tf2O, 
DTBMP, DCM, -30 °C, 2 h, repeat; aj) TBAF, THF, 20 min, repeat; ak) the Grubbs catalyst 1st generation, DCM, 
ethylene atmosphere, overnight; al) DDQ, DCM/H2O, RT, 80-84%; am) TBAF, THF, 90 °C, microwave, 74-78%. 
 
The 4,6-di-tert-butylsilylene (DTBS) group was introduced in carbohydrate 




and acetal functions, such as the isopropylidene and benzylidene groups.32 Dinkelaar et al. 
employed this group for the protection of glucosamine synthons in the assembly of a set of 
hyaluronan oligosaccharides, where the benzylidene group proved to be insufficiently 
stable towards the slightly acidic coupling conditions used.33 Besides its acid stability the 
4,6-DTBS has attracted considerable attention because of the -directing effect it has when 
mounted on a galactosyl donor.34 Although the reasons for this stereodirecting effect are not 
completely clear yet, it has been hypothesized based on a crystal structure of a DTBS-
protected thiogalactoside (Figure 1) that the near half chair conformation of the silylene 
group places one of the tert-butyl groups over the -face of the galactosyl donor during 
glycosylation (Scheme 8). Notably the -directing effect is so strong that it can override 
neighboring group participation by C-2 acyl functions, such as the C-2-O-benzoyl, C-2-N-




Reagents and conditions; an) NIS, TfOH, DCM, MS 4Å, 0 °C. 
The DTBS has also been applied in the stereoselective synthesis of -
arabinofuranosides.35 As depicted in Scheme 9, it was proposed that the 3,5-DTBS group 
Scheme 8: Stereoselective -galactosylation using 
4,6-silylidene galactosides. 
Figure 1: Crystal structure of DTBS 




locks the arabinosyl oxacarbenium ion in the E3 conformation, which is attacked from the 
-face in order to avoid eclipsing interaction on the -face, to provide the 1,2-cis 
arabinosides.  
 
Scheme 9: Stereoselective arabinofuranosylation using a 3,5-DTBS group. 
 
Reagents and conditions; ao) NIS, AgOTf, DCM, -30 °C. 
 
Protecting groups for the amino group in glycosamines: 
 
Several new protecting groups for the glucosamine nitrogen function have also 
been reported recently. Schmidt and co-workers investigated several C2-symmetric N,N-
diacyl groups, such as the dimethylmaloyl (DMM), diphenylmaloyl (DPM), 
dimethylglutaryl (DMG), diglycolyl (DG) and thiodiglycolyl (TDG) group (Figure 2).36 Of 
these the DG group proved to perform best in terms of ease of introduction, removal and 
compatibility in glycosylation reactions. Yang and Yu introduced the N-
dimethylphosphoryl (DMP) group for the protection of the glucosamine nitrogen. The 
DMP-group was used in the synthesis of several -glucosamines, and shown to be stable to 
certain basic and acidic reaction conditions and could be readily removed using NaOH or 
hydrazine. Alternatively the N-DMP could be transformed into N-acyl derivatives using an 
acyl chloride in refluxing pyridine.37  
 
Figure 2: The dimethylmaloyl (DMM), diphenylmaloyl (DPM), dimethylglutaryl (DMG), diglycolyl 


























While there is a plethora of trans-directing nitrogen protecting groups, very few 
groups are available to mask the glycosyl amino function with a non-participating group. In 
fact the azide group has almost exclusively been used for the installation of 1,2-cis 
glycosylamine linkages. In 2001 Kerns and co-workers introduced the oxazolidinone group 
for the protection of 2-aminoglycosides and it was shown that oxazolidinone protected 
glucosamine donors stereoselectively provided 1,2-cis linked products.38 Mechanistic 
studies revealed that the stereochemical outcome of condensations of these donors depends 
strongly on the nature of the activator and acceptor nucleophile used (Scheme 10c and 
10e).39,40 Kerns and co-workers described that 2,3-oxazolidinone-N-acetyl protected 
glucosamine donor 171 can be activated with benzenesulfinylpiperidine (BSP) and triflic 
anhydride (Tf2O) in the presence of tri-tert-butylpyrimidine (TTBP), to mainly provide an 
-anomeric triflate intermediate. Relatively reactive nucleophiles stereoselectively 
provided -linked products, whereas the use of stererically hindered, less reactive 
nucleophiles led to the predominant formation of the -products (Scheme 10a). These 
results were interpreted by assuming that the reactive nucleophiles can displace the -
triflate, but that less reactive nucleophiles can only substitute the more reactive -triflate, or 
intermediate oxacarbenium ion. In subsequent studies the groups of Oscarson, Ye and Ito 
showed that the stereochemical outcome of 2,3-oxazolidinone-N-acetyl and 2,3-




(Lewis)-acidity of the employed activator systems.40 Less acidic conditions mainly led to 
the isolation of -linked products, where a more acidic milieu favored the formation of -
isomeric products. Convincing evidence has been forwarded that the glucosamine donors 
initially provide the -linked products, which rapidly anomerise to the more stable -
isomers under acidic conditions through an endo-cyclic ring opening pathway (Scheme 10b 
and 10d).  
 
It is also of interest to note the beneficial effect of the 2,3-oxazolidinone-N group 
on the nucleophilicity of the C-4 hydroxyl in N-acetyl glucosamines. The reason for this 
enhanced reactivity probably originates from the tied back nature of the oxazolidinone 
group.41 
 
Scheme 10: Stereoselective condensations of 2,3-oxazolidinone protected glucosamine donors. 
a- Synthesis of a deprotected disaccharide using a 2,3-oxazolidinone protected glucosamine. 
 
b- Conversion of the stereochemistry under Lewis acid conditions. 
  
 

































































































































184 185 186 187
188
Reagents and conditions; ap) PST, DCM, -78 °C, 75%; aq) NaOH, H2O/THF, 80%; ar) NIS, AgOTf (0.1 eq) , 
DCM, RT; as) AgOTf (0.4 eq), 82%; at) PhSCl, AgOTf, DTBMP, DCM, RT; au) N-(phenylthio)-e-caprolactam, 
Tf2O, DCM, RT; av) PhSCl, AgOTf, DTBMP, tol/1,4-dioxane (3:1), 0 °C- RT. 
 
Finally, the application of the 4,5-oxazolidinone group in the synthesis of -
sialosides deserves mentioning. Various groups have reported on the excellent 
stereoselectivity achieved with sialic acid donors bearing a 4,5-oxazolidinone group, 





Scheme 11: Stereoselective sialylations of 4,5-oxazolidinone protected N-acetyl sialic acids. 
 
Reagents and conditions; aw) NIS, TfOH, DCM/ACN (2:1), -78 °C, 64%,  = 15:1. 
 
Removal of the oxazolidinone moiety can be accomplished using a variety of 
nucleophiles (NaOMe in MeOH, LiOH/LiCl in THF/H2O) but the selective removal of the 
oxazolidinone in N-acyl oxazolidinones has been shown to be difficult in many 
cases.39,41a,42b,43  
 
Protecting groups as visualization tags: 
 
Besides the primary role of masking a functional group on a carbohydrate, 
protecting groups can be used to introduce extra functionality in a carbohydrate building 
block. The UV-active 9-fluorenylmethoxycarbonyl (Fmoc) group has been extensively used 
as an amine protecting group in automated solid phase peptide chemistry to monitor the 
efficiency of the coupling steps.44 This group has also found application as a hydroxyl 
protecting group in the automated synthesis of oligosaccharides.45 Because the Fmoc is 
rather base labile when mounted on an alcohol, Pohl and co-workers set out to develop an 
alternative UV-active hydroxyl protecting group. They introduced the 
nitrophthalimidobutyric (NPB) ester, which can be introduced on a given hydroxyl function 
using the corresponding acid.46 Cleavage of the NPB ester can be accomplished with 
hydrazine acetate in DMF at elevated temperature (50 oC) to provide the orange 3-
nitrophthalhydrazide 197, which can be used in the colorimetric monitoring of reaction 
cycles. To illustrate its applicability Pohl and co-workers described the solid phase 
synthesis of a resin bound glucosamine dimer 198 as displayed in Scheme 12. 
Aminomethylated polystyrene, functionalized with an allyl carbonate linker 194, was 
glycosylated with trichloroacetimidate donor 193 using a double glycosylation cycle. 




simultaneously allowed the colorimetric monitoring of the coupling efficiency, which was 
determined to be 98%. The second coupling/deprotection cycle proceeded in 96% yield. 
The dimer was not cleaved form the resin.  
 























































194: solid phase and linker
Reagents and conditions; ax) i- TMSOTf, DCM, 15 min; ii- rinse; iii- repeat i and ii; ay) i- H2NNH2·AcOH, DMF, 
15 min; ii- rinse.  
 
The Seeberger laboratory introduced the UV-active 2-[dimethyl(2-
naphtylmethyl)silyl]ethoxycarbonyl (NSEC) as a novel group to mask carbohydrate 
hydroxyl functions.47 The NSEC group was shown to be compatible with various reactions 
commonly employed in carbohydrate synthesis and could be selectively cleaved with 
tetrabutylammonium fluoride (TBAF) (Scheme 13). The NSEC group was developed to 
allow UV-monitoring of glycosylation efficiency during automated synthesis but no such 











Scheme 13: The NSEC group.  
 
Reagents and conditions; az) i- DMDO, DCM, 30 min; ii- HOP(O)(OBu)2, DCM, -78 °C, 30 min; iii- BzCl, 
DMAP, 0 °C, 3h, 47%; ba) TMSOTf, DCM, -78 °C to -30 °C, 3h ; bb) TBAF, THF, 0 °C, 50 min, 96%. 
 
Several recent reports have described the use of azulene derived protecting groups. 
Azulene is a bicyclic hydrocarbon having a fused 7- and 5-membered ring and a 10-
electron -system, and an intense blue color. Lindhorst and Aumüller used guajazulene 
derived acid 206 for the protection of mannosyl alcohol 208.48 After deprotection of the 
BDA-acetal, the mannoside was used in the synthesis of mixtures of acylated products. The 
blue color of the products allowed the visualization of the products during silica gel column 
chromatography (Scheme 14a). Timmer et al. introduced the azulen-1-yl-dicarbonyl (Az) 
group 221, which was used to protect a variety of carbohydrate alcohols.49 It was 
introduced from the corresponding acid chloride, and could be removed using catalytic 
NaOMe in methanol or diaminobenzene and acetic acid in refluxing ethanol. The latter 
deprotection conditions allowed the selective removal of the Az-ester in the presence of 
acetyl groups, providing the colored benzopyrazine 225 as a side product (Scheme 14b). 
The Az-group was shown to be compatible with glycosylation conditions involving 
trichloroacetimidate donors (catalytic TMSOTf), but NIS-TfOH mediated activation of an 
Az-protected thiophenyl galactoside led to thiophenylation of the Az-group. The color of 
the Az-group aided in the monitoring of reactions by TLC analysis and purification via 





Scheme 14: Azulene based protecting groups in carbohydrate chemistry. 
a- The gaujazulene (G) protective group. 
 
b- The Az protective group. 
 Reagents and conditions; bc) CDI, DMF, RT, 1h; bd) DBU, DMF, 0 °C, overnight, 46% over two steps; be) 
DMP, H[BF4], DCM, RT, 2 h, 78%; bf) PMe3, (RCO)2O, THF, RT, overnight; bg) toluene; bh) DCM, pyr., 89-








Protecting groups as purification handles: 
 
Fluorous chemistry has been applied in various chemistry areas,50 including 
catalysis,51 combinatorial and parallel synthesis,52 and selective tagging of biomolecules.53 
The properties of fluorous tags, being both hydrophobic and lipophobic, have been widely 
used in protecting group chemistry. Both “heavy” and “light” fluorous tags have been 
introduced as purification handles and their use has been extensively reviewed. “Heavy” 
fluorous groups are characterized by the presence of many fluorine atoms (39 or more) on 
multiple alkyl chains, often described as ponytails.54 The high fluorine content of these 
groups renders the molecules to which it is attached soluble in a fluorous solvent but 
insoluble in both organic and aqueous solvents. “Heavy” fluorous compounds can therefore 
be purified from non-fluorous compounds by simple liquid-liquid extractions. “Light” 
fluorous groups contain significantly less fluorine atoms, typically between 9 and 17. 
Because of the lower fluorine content these molecules are often cheaper, easier available 
and much more soluble in organic solvents.55 Purification of “light” fluorous compounds 
can be effected by fluorous solid phase extraction (FSPE) techniques.56 Light fluorous 
versions of the most commonly used carbohydrate protecting groups have been described, 
including fluorous benzyl,57 trityl,58 allyl,59 and pentenyl ethers,60 the fluorous benzylidene 
acetal,61 and various fluorous acyl62,59d and silyl based63 groups.  
 
In analogy to oligosaccharide synthesis on solid or soluble polymeric supports, 
two strategies can be followed in the fluorous supported assembly of oligosaccharides. In a 
“donor-bound” strategy, the growing oligosaccharide chain is build up from the non-
reducing end, with a donor glycoside bearing a fluorous protecting group/tag. The 
“acceptor-bound” strategy on the other hand starts with a fluorous acceptor building block. 
Both strategies have been employed, but the latter has found most applications, because 
most side reactions in a glycosylation reaction take place on the donor glycosides. Liu and 
co-workers described the synthesis and application of fluorous glycosyl donor, in which the 
light fluorous tag was attached to the C-6 hydroxyl via a di-iso-propylsilyl ether.63c As 




propylsilane under the agency of triflic acid (TfOH) and subsequently converted into 
trichloroacetimidate 229. This donor was glycosidated with an excess of primary acceptor 
230 to provide the disaccharide 231 in 93% yield. The S-tolyl disaccharide was transformed 
into a trichloroacetimidate to be coupled to reducing end glucoside 233 in the next step. 
After both glycosylation steps, FSPE was used to purify the products and recover the excess 
acceptor. Purification by silicagel chromatography was required in the transformation of the 
thioglycosides into the corresponding trichloroacetimidates. The fluorous di-iso-propylsilyl 
ether was cleaved at the end of the synthesis using 0.02 M HCl in MeOH/H2O. 
 
Scheme 15: Donor-bound fluorous synthesis of a trisaccharide using a fluorous di-iso-propylsilyl 






























































234: R1 = FTIPS, R2 = Bz (94%)








235: R1 = FTIPS, R2 = H








Reagents and conditions; bj) i- TfOH, 0 °C; ii- 2,6-lutidine, DCM, RT, 99%; bk) i- NBS, TMSOTf, DCM/H2O, 0 
°C-RT; ii- Cl3CCN, DBU, DCM, RT, 76%; bl) i- TMSOTf, DCM, MS 4Å, -40 °C; ii- FSPE; bm) i- NaOMe, 
MeOH/DCM, RT; ii- FSPE, 94%; bn) i- HCl (aq), MeOH, RT; ii- FSPE, 84%.  
 
An example of an “acceptor-bound” oligosaccharide assembly strategy is depicted 
in Scheme 16. In 2007, Seeberger and co-workers introduced the fluorous version of the n-
pentenyl group 237, which was employed in the assembly of a tetrasaccharide.60 A silicon-
glass microreactor was used for the optimization of the glycosylation reactions. It was 
described that -glycosyl phosphate donor 238 could be employed at room temperature 
using reaction times ranging from 20 to 60 seconds (Scheme 16). The first glycosylation 




fluorous pentenyl alcohol in solution. The lipophilic O-6 Fmoc protecting group was 
removed in the quenching step to facilitate purification by FSPE (Scheme 16). After 
oligosaccharide assembly, the fluorous n-pentenyl group could be cleaved using N-
bromosuccinimide or transformed into different functional groups.  
 
Scheme 16: Acceptor-bound fluorous synthesis of a oligosaccharide using the fluorous pentenyl 
group. 
 
 Reagents and conditions; bo) TMSOTf, DCM or TFT, 0 °C or 20 °C; bp) i- piperdine/DMF (1:4), TBAF; ii- 
FSPE . 
 
In chapter 3, the fluorous version of the Msc-group is introduced.50e It was found 
that an ethylene insulator, which is commonly used to spacer a fluorous tail from a 
functional group in a fluorous protecting group, made the FMsc very base labile. Therefore 
the C8F17-moiety was removed from the sulfonyl group by a C3 spacer to provide the 
fluorous propylsulfonylethoxycarbonyl (FPsc) group.23 This sulfonyl carbonate was 
successfully employed in the synthesis of a trisaccharide as depicted in Scheme 17. First the 
FPsc was regioselectively introduced at the primary alcohol of glucoside 247. The resulting 
acceptor was coupled with levulinoyl protected thioglucoside 250 to provide the fluorous 




252 (81% after FSPE), which was elongated with glucosamine 253 to yield the 
trisaccharide 254 in 78% after FSPE.  
 

























































251: R = Lev












Reagents and conditions; bq) pyr., DCM, -40 ºC-RT, 4 h, 94%; br) i- NIS, TMSOTf, DCM, 0 ºC-RT, 1h; ii- FSPE, 
93%; bs) i- H2NNH2.H2O, pyr./HOAc, 5 min; ii- FSPE, 94%; bt) i- TfOH, DCM, -20 ºC-RT, 15 min; ii- FSPE, 
78%. 
 
Besides fluorous supports, large lipophilic moieties and ionic liquids have also 




Protecting groups take up a central role in carbohydrate chemistry and hold a key 
position in controlling the stereoselectivity of glycosylation reactions. Over the years 
several new and ingenious protecting groups have been added to the broad palette of 
carbohydrate protecting groups to allow the stereoselective construction of both 1,2-cis and 
1,2-trans linkages. New protecting groups, with tailor-made properties in terms of chemical 
stability and lability, allow ever more sophisticated glycosylation schemes to be developed, 
while colored or UV-active groups and purification tags continue to increase the efficiency 
of oligosaccharide assembly. Given the growing demand for ever more and complex, pure 




development of new protecting groups and protection/deprotection schemes will continue 
to be a major theme in carbohydrate chemistry.  
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The synthesis of (complex) oligosaccharides is a multi-step process, in which 
protective group manipulations play a central role.2 Protecting groups in the donor and 
acceptor molecules, the reaction partners in a glycosylation event, not only control the 
regioselectivity but also determine the productivity and stereochemistry of glycosylation 
reactions.3 Additionally, elongation of oligosaccharides generally requires the selective 
removal of one of the protecting groups in the growing chain. Therefore, progress in the 
assembly of oligosaccharides can be realized by the development of new protecting groups 
with improved properties, such as ease of introduction and removal and orthogonality 




(Msc) as hydroxyl protecting group 




methylsulfonylethoxycarbonyl group (Msc, 1, Figure 1) as hydroxyl protecting group in 
carbohydrate chemistry.  
Figure 1: The Msc protecting group. 
 
  
The methylsulfonylethoxycarbonyl (Msc) group, developed by Tesser and 
coworkers,5 is well known in peptide chemistry for the protection of amino functions. The 
Msc-group is removed by base-mediated -elimination while it resists catalytic 
hydrogenation and is highly stable in acidic media. The Msc group has also proven to be 
suitable for the protection of the guanidino function in the side chain of arginine during 
solid phase peptide synthesis.6 In addition, methylsulfonylethyl esters have been employed 
to mask carboxylic acids7 and used as protective groups en route to phosphate mono- and 
diesters.8,9 Conversely, the sulfonylethoxycarbonyl groups, related to the Msc group, have 
only scarcely been applied to protect alcohol functions.10,11 In the meantime, the 9-
fluorenylmethyl carbonate (Fmoc) is becoming increasingly popular in carbohydrate 
chemistry for the protection of alcohol functions.12,13 It was envisaged that the Msc group 
could be a promising hydroxyl protecting group as it would be equally stable but sterically 
less demanding and less lipophilic than the Fmoc carbonate. 
  
Results and discussion: 
 
As a first research objective, the optimal conditions for the introduction of the Msc 
group were investigated using glucofuranose 2 as a model compound (Table 1). In the first 
attempt a DCM solution of compound 2 was treated with methylsulfonylethoxycarbonyl 
chloride (Msc-Cl) and 3 equivalents of triethylamine (TEA) (Table 1, Entry 1). The 
reaction did not proceed and the starting material could be recovered. Employment of the 
same solvent and 2,6-lutidine (3 eq.) as a base led to the isolation of 1,2:5,6-di-O-
isopropylidene-3-O-methylsulfonylethoxycarbonyl--D-glucofuranose 3 in moderate yield 
(41%, Table 1, Entry 2). Using pyridine (3 eq.) as base in dioxane (Table 1, Entry 3) the 
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reaction proceeded equally sluggishly, but the yield of 3 was improved to 55%. Returning 
to the use of DCM as a solvent not only reduced the reaction time to 4 hours, but also 
increased the yield of 3 to 99% (Table 1, Entry 4). 
 
Table 1: Installation of the Msc group on carbohydrate hydroxyls. 
         
Entry Conditions Time Yield 
(1) DCM, Et3N (3 eq.), 0 
oC-rt 90h No Conversion 
(2) DCM, Lutidine (3 eq.), 0 oC-rt 90h 41% 
(3) Dioxane, Pyridine (3 eq.), 0 oC-rt 90h 55% 
(4) DCM, Pyridine (3 eq.), 0 oC-rt 4h 99% 
 
 
The applicability of the DCM/pyridine conditions was further evaluated by the 
introduction of the Msc group onto a range of partially protected pyranose building blocks. 
The Msc group was readily introduced on the primary hydroxyl function of ethyl 2,3,4-tri-
O-benzyl-1-thio--D-glucopyranoside to give 4 in 98% yield (Table 2, Entry 1). The 
protection of a variety of secondary hydroxyl functions with the Msc group proceeded 
uneventfully, leading to high yields of the expected products (Table 2, Entry 2-6).14  It is of 
interest to note that migration of the benzoyl group in the starting compound (Table 2, entry 
2) was not observed and that the labile galacturonic acid lactone endured the mild 
conditions (Table 2, Entry 6). Moreover, subjection of ethyl 2,3-di-O-benzyl--D-
glucopyranoside to these conditions, albeit at a lower temperature (-20 oC), led to the 
regioselective introduction of the Msc group at the primary position of the diol starting 




Table 2: Installation of the Msc on carbohydrate hydroxyls.a 
 







0 ºC-RT 3 h 98% 
2 0 ºC-RT 5 h 
5 (R = Bn): 78% 
6 (R =Bz): 76% 
3 0 ºC-RT 4 h 79% 
4 0 ºC-RT 4 h 79% 






0 ºC-RT 3 h 88% 
7 
 
-20 ºC-RT 5 h 90% 
a Msc-Cl (2 eq.), pyridine (3 eq.), DCM (0.2 M). 
 
Next, the most favorable conditions for cleavage of the Msc group were examined 
using 1,2:5,6-di-O-isopropylidene-3-O-methylsulfonylethoxycarbonyl--D-glucofuranose 
3. As summarized in Table 3, the use of a catalytic amount of sodium methoxide (NaOMe, 
0.1 eq.) in methanol required 18 hours to completely remove the Msc group (Table 3, Entry 
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1). The deblocking of the Msc on 3 via a -elimination with the aid of 30 equivalents of 
triethylamine reached completion after 20 hours (Table 3, Entry 2). On the other hand, 
tetrabutylammonium fluoride (TBAF, 0.1 eq.) and 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU, 0.1 eq.) eliminated the Msc group within 30 minutes (Table 3, Entries 3 and 4). The 
removal of the Msc group from 6 went smoothly and left all the benzoyl groups intact, 
thereby illustrating the mildness of the cleavage conditions (Table 3, Entry 5). Analogously, 
cleavage of the Msc group from galacturonic acid lactone 1415 was accomplished without 
compromising the integrity of the labile lactone ring to afford the expected alcohol in 97% 
yield (Table 3, Entry 6). 
 
Table 3: Cleavage of the Msc group. 
 
Entry Substrate Conditions Quantity Time Yield 
1 3 NaOMe, MeOH 0.1 eq 18 h 100% 
2 3 Et3N, DCM 30 eq 20 h 100% 
3 3 TBAF, THF 0.1 eq 30 min. 100% 
4 3 DBU, DMF 0.1 eq 25 min. 100% 
5 6 DBU, DMF 0.1 eq 30 min 98% 
6 14 DBU, DMF 0.1 eq 1 min. 97% 
 
Having established the conditions for both installation and cleavage of the Msc 
group, the stabilities of the Msc group and the 9-fluorenylmethoxycarbonyl (Fmoc) group 
were compared. With 0.1 equivalents DBU the Fmoc group was cleaved from 
glucofuranose 16 within 5 minutes while the removal of the Msc group in the 
corresponding glucofuranose 3 needed 25 minutes (Table 4, Entry 1 and 2). The removal of 
the Fmoc group in 16 required 2 hours when triethylamine (TEA, 30 eq.) was used in DCM 




hours (Table 4, Entry 4). The outcome of these experiments indicates that the Msc group is 
slightly more stable than the Fmoc group.  
 
Table 4: Comparison of the stability of the Msc group and the Fmoc group. 
    
Entry Conditions R Quantity Time Yield 
1 DBU, DMF Fmoc 0.1 eq 5 min 87% 
2  Msc 0.1 eq 25 min. 92% 
3 Et3N, DCM Fmoc 30  eq 2 h 89% 
4  Msc 30 eq 20 h 93% 
 
Protecting groups that can be selectively cleaved en route to a target 
oligosaccharide are of prime importance in synthetic carbohydrate chemistry. As the Msc 
group could be selectively cleaved in the presence of benzoyl esters (vide supra), the 
orthogonality of the Msc group and the levulinoyl (Lev) ester was explored. To this end 
alcohol 15 was levulinoylated to provide fully protected glucopyranoside 17  (Scheme 1).  
  The levulinoyl group of 17 could be cleaved without affecting the Msc carbonate 
at the primary C6-OH position by standard treatment with hydrazine hydrate in a mixture of 
 
Scheme 1:  Orthogonality of the Msc and the Lev. 
Reagents and conditions; b) LevOH, DMAP, EDC.HCl, DCM, 1 h, 89%; c) H2NNH2.H2O, pyridine/HOAc, 5 min, 
96%; d) DBU, DMF, 25 min. 
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pyridine and acetic acid. Alternatively, cleavage of the Msc group at C4-OH in 17 was 
accomplished with catalytic amount of DBU to provide primary alcohol 18 in 95% yield. 
Apart from this, 2% of 6-O-levulinoylated side product was isolated, originating from 
migration of the levulinoyl group from the secondary C4-OH to the primary C6-OH. These 
experiments indicate that the Msc and the Lev protective groups are orthogonal.16 
Next the feasibility of Msc-protected carbohydrates in a set of glycosylation 
reactions was investigated (Scheme 2). In the first example the Msc-protected thioglucoside 
6 was condensed with methyl glucoside 20 under the influence of N-iodosuccinimide (NIS)  
 




















































21 R = MSc



















23 R = MSc












































































Reagents and conditions; e) NIS, TMSOTf, DCM, -40 ºC-RT, 1h;  f) DBU, dioxane, 30  min; g) Ph2SO, Tf2O 




and a catalytic amount of trimethysilyltriflate (TMSOTf) to provide disaccharide 21 in 63% 
yield. The Msc group could be selectively removed from this disaccharide leaving all of the  
benzoyl functionalities untouched to give 22 in excellent yield. The second glycosylation 
employed thioglucose donor 7, having the Msc group located on the C2-OH, acceptor 20 
and the same activator system. The -linked dimer 23 was obtained in 71% yield, showing 
that the methylsulfonylethyl carbonate provided efficient anchimeric assistance in the 
glycosylation reaction. When the same donor (7) and acceptor (20) were condensed, using 
diphenylsulfoxide (Ph2SO) in combination with trifluoromethanesulfonic anhydride 
(Tf2O)
17 and an excess tri-tert-butylpyrimidine (TTBP)18 disaccharide 23 was isolated in 
similar yield (67%). This result indicates that the presence of the Msc carbonate at C2 
excludes the unwanted formation of orthoester, even under non-acidic conditions. 
Treatment of dimer 23 with a catalytic amount of DBU quantitatively liberated the C2’-OH 
to afford 24. Coupling of Msc-protected thiomannoside 13 with methyl mannoside 25 using 
the Ph2SO/Tf2O
19 activator system and an excess of TTBP afforded disaccharide 26 in 78% 
yield as an anomeric mixture ( >10:1), indicating that the Msc group also provides 
anchimeric assistance from the 3-position (for a more detailed discussion, see Chapter 4).20 
The Msc group was also tolerated when present in acceptor building blocks as shown in the 
next glycosylations in which the perbenzoylated S-phenyl glucoside 27 was coupled to both 




 This chapter described the successful application of the 
methylsulfonylethoxycarbonyl (Msc) group as a non-lipophilic protecting group for 
hydroxyl functions in oligosaccharide synthesis. The Msc group can be introduced using 
standard conditions for the formation of carbonates and can be cleaved via -elimination 
using mildly basic conditions to which commonly used ester protecting groups are stable. 
The Msc group is slightly more stable than the Fmoc group and is orthogonal with the 
levulinoyl group. The Msc group is completely stable to acid mediated glycosylation 
conditions, provides anchimeric assistance and excludes orthoester formation, when placed 
on the C2-OH of a glycosyl donor. 





General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic anhydride 
was distilled from P2O5. Traces of water in donor and acceptor glycosides, diphenylsulfoxide and TTBP were 
removed by co-evaporation with toluene. Molecular sieves 3Å were flame dried before use. All other chemicals 
(Acros, Fluka, Merck) were used as received. Column chromatography was performed on Screening Devices silica 
gel 60 (0.040-0.063 mm). Size exclusion chromatography was performed on Sephadex LH20 (eluent MeOH/DCM 
= 1/1). TLC analysis was conducted on DC-alufolien (Merck, kiesel gel 60, F245). Compounds were visualized by 
UV absorption (245 nm), by spraying with 20% H2SO4 in ethanol or by spraying with a solution of 
(NH4)6Mo7O24·4H2O (25g/L) and (NH4)4Ce(SO4)4·2H2O (10g/L) in 10% H2SO4 (aq) followed by charring at 150 
ºC. IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in cm-1. Optical rotations were measured 
on a Propol automatic polarimeter. 1H and 13C NMR spectra were recorded with a Bruker AV 400 (400 MHz and 
100 MHz respectively), AV 500 (500 MHz and 125 MHz respectively). NMR spectra were recorded in CDCl3 
unless stated otherwise. Chemical shift are relative to tetramethylsilane and are given in ppm. Coupling constants 
are given in Hz. All given 13C spectra are proton decoupled. High resolution mass spectra were recorded on a 
LTQ-Orbitrap (thermo electron). 
 
General method for the introduction of the Msc group: A solution of alcohol in DCM (0.2 M) was cooled to 0 
oC before pyridine (3 eq) was added.  Methylsulfonylethoxycarbonyl chloride (Msc-Cal, 10% in DCM, 2 eq) was 
added drop-wise at 0 oC over the span of 30 minutes. The reaction mixture was allowed to warm to room 
temperature. The reaction mixture was quenched with methanol, diluted with DCM, washed with NaHCO3 (aq) and 
brine, dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography. 
 
General method for glycosylations using NIS/TMSOTf: A solution of 1-thio--D-glucopyranoside (donor) and 
acceptor in DCM (0.05 M) was stirred over activated MS3Å for half an hour before N-iodosuccinimide (1.3 eq 
with respect to the donor) was added. The mixture was cooled to -40 oC followed by the addition of trimethylsilyl 
trifluoromethanesulfonate (0.1 eq). The mixture was allowed to warm to room temperature. The reaction mixture 
was quenched with triethylamine (5 eq), filtered, diluted with EtOAc and washed with Na2S2O3 (aq). The aqueous 




(3): Compound 3 was prepared according to the general procedure for the introduction 
of the Msc group from 1,2:5,6-di-O-isopropylidene--D-glucofuranose 2 (1.30 g, 5.0 
mmol) yielding the compound 9 (1.950 g, 4.8 mmol, 95%). TLC (50% n-hexane in 
EtOAc): Rf = 0.45; []D22: -28.6º (c = 1, DCM); IR (neat, cm-1): 731, 1215, 1757; 1H NMR (400 MHz, CDCl3) = 
1.32 (s, 6H, 2xCH3 isopropylidene), 1.41 (s, 3H, CH3 isopropylidene), 1.52 (s, 3H, CH3 isopropylidene), 3.00 (s, 









4.61 (m, 3H, H-2 and  MeSO2CH2CH2-), 5.13 (d, 1H, J = 2.0 Hz, H-3), 5.90 (d, 1H, J = 3.6 Hz, H-1); 
13C NMR 
(100 MHz, CDCl3) = 25.0 (CH3 isopropylidene), 25.9  (CH3 isopropylidene), 26.4  (CH3 isopropylidene), 26.6 
(CH3 isopropylidene), 42.1 (CH3 Msc), 53.3 (MeSO2CH2CH2-), 61.4 (MeSO2CH2CH2-), 66.9 (C-6), 72.0, 79.4 (C-
4 and C-5), 79.9 (C-3), 82.8 (C-2), 104.8 (C-1), 109.2 (Cq isopropylidene), 112.1 (Cq isopropylidene), 153.1 (C=O 
Msc); HRMS [M+H]+ calcd for C16H27O10S 411.13194 was found 411.13201, [M+NH4]
+ calcd for C16H30O10SN 
428.15849  was found 428.15854, [M+Na]+ calcd for C16H26O10SNa 433.11389 was found 433.11364. 
 
 1,2:5,6-di-O-isopropylidene--D-glucofuranose (2) (Cleavage of Msc from 3): 
Method I: To a solution of 3 (80 mg, 200 μmol) in methanol (5 ml, 0.04 M) was added 
sodium methoxide (1% in MeOH, 370 μl, 20 μmol, 0.1 eq) and the reaction mixture was 
stirred for 18 hours. The reaction mixture was neutralized with NH4Cl (aq), diluted with 
EtOAc, washed with NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. The crude 
product was purified by silica gel column chromatography to afford 1,2:5,6-di-O-isopropylidene--D-
glucofuranose 2 (52 mg, 199 μmol, 100%). 
Method II: To a solution of 3 (50 mg, 122 μmol) in DCM (2 ml, 0.06 M) was added triethylamine (500 μl, 360 
μmol, 30 eq) and the reaction mixture was stirred for 20 hours. The reaction mixture was neutralized with NH4Cl 
(aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and concentrated. 
The crude product was purified by silica gel column chromatography to afford 1,2:5,6-di-O-isopropylidene--D-
glucofuranose 2 (32 mg, 122 μmol, 100%). 
Method III: To a solution of 3 (50 mg, 122 μmol) in THF (3 ml, 0.04 M) was added TBAF (1 M in THF, 12.5 μl, 
12 μmol, 0.1 eq) and the reaction mixture was stirred for 30 minutes. The reaction mixture was neutralized with 
NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to afford 1,2:5,6-di-O-
isopropylidene--D-glucofuranose 2 (32 mg, 121 μmol, 100%). 
Method IV: To a solution of 3 (80 mg, 200 μmol) in DMF (5 ml, 0.04 M) was added DBU (0.1 M in DMF, 370 μl, 
20 μmol, 0.1 eq) and the reaction mixture was stirred for 25 minutes. The reaction mixture was neutralized with 
NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to afford 1,2:5,6-di-O-
isopropylidene--D-glucofuranose 2 (52 mg, 199 μmol, 100%). 
 
Ethyl 2,3,4-tri-O-benzyl-6-O-methylsulfonylethoxycarbonyl-1-thio--D-
glucopyranoside (4): Compound 4 was prepared according to the general procedure for 
the introduction of the Msc group from ethyl 2,3,4-tri-O-benzyl-1-thio--D-
glucopyranoside (0.120 g, 0.242 mmol) yielding the compound 4 (0.153 g, 0.237 mmol, 98%). TLC (50% n-
hexane in EtOAc): Rf = 0.5; []D22: 10.0º (c = 0.8, DCM); IR (neat, cm-1): 698, 1733; 1H NMR (500 MHz, CDCl3) 
= 1.31 (t, 3H, J = 8.5 Hz, CH3 Et), 2.68-2.78 (m, 2H, CH2 Et), 2.97 (s, 3H, CH3 Msc), 3.29-3.35 (m, 2H, 
MeSO2CH2CH2-), 3.41 (t, 1H,  J = 9.5 Hz, H-2), 3.50 (m, 2H, H-4 and H-5), 3.70 (t, 1H, J = 8.5 Hz, H-3), 4.23 
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4.53 (m, 2H, MeSO2CH2CH2-), 4.58 (d, 1H, J = 11.0 Hz, CHH Bn), 4.73 (d, 1H, J = 10.5 Hz, CHH Bn), 4.84 (d, 
1H, J = 11.0 Hz, CHH Bn), 4.87 (d, 1H, J = 11.0 Hz, CHH Bn), 4.91 (d, 1H, J = 10.4 Hz, CHH Bn), 4.94 (d, 1H, J 
= 11.0 Hz, CHH Bn), 7.25-7.37 (m, 15H, H arom); 13C NMR (125 MHz, CDCl3) = 15.1 (CH3 Et), 25.1 (CH2 Et), 
42.6 (CH3 Msc), 53.8 (MeSO2CH2CH2-), 61.3 (MeSO2CH2CH2-), 67.2 (C-6), 75.0 (CH2 Bn), 75.5 (CH2 Bn), 75.8 
(CH2 Bn), 76.5 (C-5), 77.3 (C-4), 81.6 (C-2), 85.2 (C-1), 86.5 (C-3), 127.7-129.0 (CH arom), 137.5 (Cq Bn), 137.7 
(Cq Bn), 138.2 (Cq Bn), 154.1 (C=O Msc); HRMS [M+NH4]
+ calcd for C33H44O9S2N 662.24520 was found 
662.24536, [M+Na]+ calcd for C33H40O9S2Na 667.20060 was found 667.20038. 
 
Phenyl 2,3,6-tri-O-benzyl-4-O-methylsulfonylethoxycarbonyl-1-thio--D-
glucopyranoside (5): Compound 5 was prepared according to the general procedure 
for the introduction of the Msc group from phenyl 2,3,6-tri-O-benzyl-1-thio--D-
glucopyranoside (0.154 g, 0.28 mmol) yielding the compound 5 (0.155 g, 0.22 mmol, 78%). TLC (50% n-hexane 
in EtOAc): Rf = 0.6; []D22: -8.0º  (c = 0.25, DCM); IR (neat, cm-1): 694, 732, 1026, 1247, 1755; 1H NMR (500 
MHz, CDCl3) = 2.74 (s, 3H, CH3 Msc), 3.06 (m, 2H, MeSO2CH2CH2-), 3.56 (t, 1H,  J = 9.0 Hz, H-2), 3.62-3.71 
(m, 4H, H-3, H-5 and 2xH-6), 4.35 (m, 2H, MeSO2CH2CH2-), 4.52 (m, 2H, 2xCHH Bn), 4.61-4.71 (m, 3H, H-1 
and 2xCHH Bn), 4.88 (m, 3H, H-4 and 2xCHH Bn), 7.23-7.56 (m, 20H, H arom); 13C NMR (125 MHz, CDCl3) 
= 42.1 (CH3 Msc), 53.4 (MeSO2CH2CH2-), 61.3 (MeSO2CH2CH2-), 69.6 (C-6), 73.5 (CH2 Bn), 75.5 (2xCH2 Bn), 
75.7 (C-4),  76.7 (C-5), 80.5 (C-2), 84.0 (C-3), 87.6 (C-1), 127.3-132.1 (CH arom), 133.2 (Cq SPh), 137.6 (Cq Bn), 
137.9 (Cq Bn), 138.0 (Cq Bn), 153.6 (C=O Msc); HRMS [M+NH4]
+ calcd for C37H44O9S2 N 710.24520 was found  
710.24548, [M+Na]+ calcd for C37H40O9S2Na 715.20060 was found 715.20074.  
 
Phenyl 2,3-di-O-benzoyl-6-O-benzyl-4-O-methylsulfonylethoxycarbonyl-1-thio--
D-glucopyranoside (6): Compound 6 was prepared according to the general procedure 
for the introduction of the Msc group from phenyl 2,3-di-O-benzoyl-6-O-benzyl-1-
thio--D-glucopyranoside (0.160 g, 0.28 mmol) yielding the compound 6 (0.155 g, 0.21 mmol, 76%). TLC (50% 
n-hexane in EtOAc): Rf = 0.5; []D22: +39.4º (c = 1, DCM); IR (neat, cm-1): 1242, 1728; 1H NMR (400 MHz, 
CDCl3) = 2.75 (s, 3H, CH3 Msc), 2.97 (t, 2H, J = 6.0 Hz, MeSO2CH2CH2-), 3.72-3.79 (m, 2H, 2xH-6), 3.92 (m, 
1H, H-5), 4.27 (m, 1H, MeSO2CH2CHH-), 4.36 (m, 1H, MeSO2CH2CHH-), 4.54 (d, 1H, J = 11.6 Hz, CHH Bn), 
4.62 (d, 1H, J = 12.0 Hz, CHH Bn), 4.93 (d, 1H, J = 8.4 Hz, H-1), 5.17 (t, 1H, J = 9.6 Hz, H-4), 5.46 (t, 1H, J = 
9.6 Hz, H-2), 5.70 (t, 1H, J = 9.6 Hz, H-3), 7.12-7.96 (m, 20H, H arom); 13C NMR (100 MHz, CDCl3) = 42.0 
(CH3 Msc), 53.4 (MeSO2CH2CH2-), 61.8 (MeSO2CH2CH2-), 68.7 (C-6), 70.1 (C-2), 73.5 (CH2 Bn), 73.7 (C-4), 
74.5 (C-3), 76.8 (C-5), 86.1 (C-1), 127.5-133.6 (CH arom), 128.9 (Cq Bz), 129.7 (Cq Bz), 131.8 (Cq SPh), 137.7 (Cq 
Bn), 153.2 (C=O Msc), 164.9 (C=O Bz), 165.7 (C=O Bz); HRMS  [M+NH4]
+ calcd for C37H40O11S2 N 738.20373 
was found 738.20386, [M+Na]+ calcd for C37H36O11S2Na 743.15912 was found 743.15897. 
 
Phenyl 2,3-di-O-benzoyl-6-O-benzyl-1-thio--D-glucopyranoside (Cleavage of the 
Msc from 6): To a solution of 6 (82 mg, 161 μmol) in DMF (8 ml, 0.02 M) was added 






















minute. The reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), 
NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by silica gel 




thio--D-glucopyranoside (7): Compound 7 was prepared according to the general 
procedure for the introduction of the Msc group from phenyl 3-O-benzyl-4,6-O-
benzylidene-1-thio--D-glucopyranoside (0.460 g, 1.0 mmol) yielding the compound 7 (0.485 g, 0.81 mmol, 79%). 
TLC (50% n-hexane in EtOAc): Rf = 0.6; []D22: -8.0º  (c = 1, DCM); IR (neat, cm-1): 743, 1265, 1747; 1H NMR 
(400 MHz, CDCl3) =   2.86 (s, 3H, CH3 Msc), 3.19-3.30 (m, 2H, MeSO2CH2CH2-), 3.49 (m, 1H, H-5), 3.71-3.83 
(m, 3H, H-4, H-6 and H-3), 4.38 (dd, 1H, J = 4.8 Hz, J = 10.4 Hz, H-6), 4.54 (m, 1H, MeSO2CH2CHH-), 4.59 (m, 
1H, MeSO2CH2CHH-), 4.65 (d, 1H, J = 12.0 Hz, CHH Bn), 4.73 (d, 1H, J = 10.0 Hz, H-1), 4.80 (t, 1H, J = 8.4 
Hz, H-2), 4.90 (d, 1H, J = 12.0 Hz, CHH Bn), 5.56 (s, 1H, CH benzylidene), 7.24-7.49 (m, 15H, H arom); 13C 
NMR (100 MHz, CDCl3) = 42.3 (CH3 Msc), 53.7 (MeSO2CH2CH2-), 61.7 (CH2 MeSO2CH2CH2-), 68.3 (C-6), 
70.5 (C-5), 74.5 (CH2 Bn), 76.0 (C-2), 79.9 (C-3), 81.0 (C-4), 86.2 (C-1), 101.2 (CH benzylidene), 125.9-132.8 
(CH arom), 131.5 (Cq SPh), 136.9 (Cq CHPh), 137.9 (Cq Bn), 153.4 (C=O Msc); HRMS [M+H]
+ calcd for 
C30H33O9S2 601.15605 was found 601.15636, [M+NH4]
+ calcd for C30H36O9S2 N 618.18260 was found 618.18264, 
[M+Na]+ calcd for C30H32O9S2Na 623.13800 was found 623.13795. 
 
Methyl 2,3-di-O-benzyl-6-O-dimethoxytrityl-4-O-methylsulfonylethoxycarbonyl--
D-glucopyranoside (8): Compound 8 was prepared according to the general procedure 
for the introduction of the Msc group from methyl 2,3-di-O-benzyl-6-O-dimethoxytrityl-
-D-glucopyranoside (0.750 g, 1.11 mmol) yielding the compound 8 (0.770 g, 0.87 mmol, 79%). TLC (33% 
EtOAc in PE): Rf = 0.4; []D22: +26.4º  (c = 0.5, DCM); IR (neat, cm-1): 726, 1247, 1508, 1759; 1H NMR (400 
MHz, CDCl3) = 2.61 (s, 3H, CH3 Msc), 2.98 (t, 2H, J = 6.0 Hz, MeSO2CH2CH2-), 3.14-3.23 (m, 2H, 2xH-6), 
3.43 (s, 3H, CH3 OMe), 3.63 (dd, J = 3.6 Hz, J = 9.6 Hz, 1H, H-2), 3.70 (s, 6H, 2xCH3 DMT ), 3.87 (m, 1H, H-5), 
3.98 (t, 1H, J = 9.2 Hz, H-3), 4.24 (m, 2H, MeSO2CH2CH2-), 4.62 (d, 1H, J = 12.0 Hz, CHH Bn), 4.65 (d, 1H, J = 
12.0 Hz, CHH Bn), 4.72 (d, 1H, J = 3.2 Hz, H-1), 4.76 (d, 1H, J = 11.6 Hz, CHH Bn), 4.86 (t, 1H, J = 10.0 Hz, H-
4), 4.93 (d, 1H, J = 11.6 Hz, CHH Bn), 6.79-7.50 (m, 23 H, H arom); 13C NMR (100 MHz, CDCl3) = 41.6 (CH3 
Msc), 53.1 (MeSO2CH2CH2-), 54.8 (2xCH3 DMT), 54.9 (CH3 OMe), 60.9 (MeSO2CH2CH2-), 62.2 (C-6), 68.1 (C-
5), 73.0 (CH2 Bn), 75.0 (C-4), 75.1 (CH2 Bn), 79.2 (C-3), 79.5 (C-2), 85.7 (Cq DMT), 97.5 (C-1), 112.8 (CH 
DMT)  126.5-129.8 (CH arom), 135.5 (Cq DMT), 137.6 (Cq Bn), 138.2 (Cq Bn), 144.3 (Cq DMT), 153.1 (C=O 
Msc) 158.1 (Cq DMT); HRMS [M+Na]
+ calcd for C46H50O12SNa 849.29152 was found 849.29230. 
 
Phenyl 2-O-benzyl-4,6-O-benzylidene-1-thio--D-mannopyranoside (11): To a 
solution of phenyl 4,6-O-benzylidene-1-thio--D-mannopyranoside (9) (0.355 g, 1.0 
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eq), tetrabutylammonium sulfonate (0.067 g, 0.20 mmol, 0.2 eq) and NaOH (aq) (1M, 5 ml, 5.0 mmol, 5 eq). The 
reaction mixture was refluxed at 40 ºC for 18 hours, after which the reaction was quenched with NH4Cl (aq). The 
mixture was diluted with EtOAc and extracted thrice with EtOAc. The combined organic layers were washed with 
NH4Cl (aq), NaHCO3 (aq), brine, dried over MgSO4, filtered and concentrated. The crude product was purified by 
silica gel chromatography to get 10 (0.071 g, 0.16 mmol, 16%), 11 (0.196 g, 0.44 mmol, 44%) and 12 (0.058 g, 
0.11 mmol, 11%); TLC (33% EtAcO in PE): Rf = 0.8 (12), Rf = 0.6 (10,11); TLC (33% Et2O in PE): Rf = 0.3 (11), 
Rf = 0.2 (10); (compound 10 and 12) analytical data for the compound 10 and 12 was found in accordance to the 
earlier reports. (Compound 11) []D22: 21.2º  (c = 1, DCM); IR (neat, cm-1): 695, 1047; 1H NMR (400 MHz, 
CDCl3) = 2.56 (s, 1H, OH-3), 3.36 (m, 1H, H-5), 3.82-3.90 (m, 2H, H-3 and H-6), 3.97 (t, 1H, J =  9.6 Hz, H-4), 
4.08 (d, 1H, J =  2.4 Hz, H-2), 4.29 (dd, 1H, J =  5.2 Hz, J = 10.8 Hz, H-6), 4.85 (d, 1H, J =  1.2 Hz, H-1), 4.85-
4.97 (m, 2H, 2xCHH Bn), 5.53 (s, 1H, CH benzylidene), 7.24-7.37 (m, 15H, H arom); 13C NMR (100 MHz, 
CDCl3) = 68.3 (C-6), 71.2 (C-5), 72.8 (C-3), 76.6 (CH2 Bn), 78.6 (C-4), 80.5 (C-2), 88.8 (C-1), 102.0 (CH 
benzylidene), 126.1-131.1 (CH arom), 134.7 (Cq SPh), 137.1, 137.8 (Cq CHPh and Cq Bn); CH Gated NMR (100 




thio--D-mannopyranoside (13): Compound 13 was prepared according to the 
general procedure for the introduction of the Msc group from phenyl 2-O-benzyl-
4,6-O-benzylidene-1-thio--D-mannopyranoside (0.140 g, 0.31 mmol) yielding compound 13 (0.182 g, 0.30 mmol, 
97%); TLC (50% EtOAc in PE): Rf = 0.2; []D22: -42.2º  (c = 1, DCM); IR (neat, cm-1): 523, 1267, 1752; 1H NMR 
(400 MHz, CDCl3) = 2.75 (s, 3H, CH3 Msc), 3.15-3.20 (m, 1H, MeSO2CHHCH2-), 3.24-3.31 (m, 1H, 
MeSO2CHHCH2-), 3.48 (m, 1H, H-5), 3.90 (t, 1H, J =  10.4 Hz, H-6), 4.24 (t, 1H, J =  9.6 Hz, H-4), 4.30 (dd, 1H, 
J =  4.8 Hz, J = 10.4 Hz, H-6), 4.36 (d, 1H, J = 2.8 Hz, H-2), 4.48 (t, 2H, J = 6.4 Hz, MeSO2CH2CH2-),  4.79 (d, 
1H, J = 11.2 Hz, CHH Bn),  4.85 (d, 1H, J = 11.2 Hz, CHH Bn),  4.93-4.97 (m, 2H, H-1 and H-3), 5.53 (s, 1H, CH 
benzylidene), 7.24-7.42 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 42.3 (CH3 Msc), 53.4 
(MeSO2CH2CH2-), 61.5 (MeSO2CH2CH2-), 68.2 (C-6), 71.3 (C-5), 75.2 (C-4), 76.4 (CH2 Bn), 77.7 (C-3), 78.1 (C-
2), 88.6 (C-1), 101.7 (CH benzylidene), 126.0-134.0 (CH arom), 134.0 (Cq SPh), 136.9, 137.1  (Cq CHPh and Cq 
Bn), 153.5 (C=O); CH Gated NMR (100 MHz, CDCl3) 88.6 (J = 154 Hz, C-1); HRMS [M+Na]+ calcd for 
C30H32O9S2Na 623.13800 was found 623.13767. 
 
Phenyl 2-O-benzyl-4-O-methylsulfonylethoxycarbonyl-1-thio--D-
galactopyranosidurono-3,6-lactone (14): Compound 14 was prepared according to the 
general procedure for the introduction of the Msc group from phenyl 2-O-benzyl-1-thio--
D-galactopyranosidurono-3,6-lactone (0.414 g, 1.16 mmol) yielding the compound 14 
(0.514 g, 1.01 mmol, 88%); TLC (50% EtOAc in PE): Rf = 0.3; []D22: -232.4º  (c = 1.0, DCM); IR (neat, cm-1): 
734, 1264; 1H NMR (400 MHz, CDCl3) = 2.94 (s, 3H, CH3 Msc), 3.33 (t, 2H,  J = 5.6 Hz, MeSO2CH2CH2-), 
















Bn), 4.99 (d, 1H, J = 4.8 Hz, H-3), 5.41 (s, 1H, H-4), 5.46 (s, 1H, H-1), 7.25-7.43 (m, 10H, H arom); 13C NMR 
(100 MHz, CDCl3) = 42.3 (CH3 Msc), 53.2 (MeSO2CH2CH2-), 61.9 (MeSO2CH2CH2-), 69.8 (C-5), 72.9 (CH2 
Bn), 75.1 (C-4), 78.2 (C-2 and C-3), 85.9 (C-1), 128.0-132.4 (CH arom), 133.0 (Cq SPh), 136.1 (Cq Bn), 152.6 
(C=O Msc), 171.2 (C-6); HRMS [M+Na]+ calcd for C23H24O9S2Na 531.07539 was found 531.07525. 
 
Phenyl 2-O-benzyl-1-thio--D-galactopyranosidurono-3,6-lactone (Cleavage of Msc from 
14): To a solution of 14 (82 mg, 161 μmol) in DMF (8 ml, 0.02 M) was added DBU (1%  in 
DMF, 241 μl, 16 μmol, 0.1 eq) and the reaction mixture was stirred for 1 minute. The 
reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl 
(aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by silica 
gel column chromatography to afford phenyl 2-O-benzyl-1-thio--D-galactopyranosidurono-3,6-lactone (56 mg, 
156 μmol, 97%). 
 
Methyl 2,3-di-O-benzyl-6-O-methylsulfonylethoxycarbonyl--D-glucopyranoside 
(15): Compound 15 was prepared according to the general procedure for the introduction 
of the Msc group from methyl 2,3-di-O-benzyl--D-glucopyranoside (0.214 g, 0.57 
mmol) at -20 oC yielding the compound 15 (0.270 g, 0.52 mmol, 90%). TLC (50% 
EtOAc in PE): Rf = 0.6; []D22: +49.6º (c = 1, DCM); IR (neat, cm-1): 741, 1055, 1265, 1751, 2927; 1H NMR (400 
MHz, CDCl3) = 2.08 (bs, 1H, C4-OH), 2.99 (s, 3H, CH3 Msc), 3.36 (t, 2H, J = 5.6 Hz, MeSO2CH2CH2-), 3.41 (s, 
3H, CH3 OMe), 3.49 (t, 1H, J = 9.6 Hz, H-4), 3.54 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 3.77-3.84 (m, 2H, H-3 
and H-5), 4.43 (m, 2H, 2xH-6), 4.59 (t, 2H, J = 6.0 Hz, MeSO2CH2CH2-), 4.65 (d, 1H, J = 3.2 Hz, H-1), 4.70 (d, 
1H, J = 12.0 Hz, CHH Bn), 4.75 (d, 1H, J = 11.6 Hz, CHH Bn), 4.81 (d, 1H, J = 12.0 Hz, CHH Bn), 5.05 (d, 1H, J 
= 11.2 Hz, CHH Bn), 7.30-7.42 (m, 10H, H arom); 13C NMR (100 MHz, CDCl3) = 42.5 (CH3 Msc), 53.7 
(MeSO2CH2CH2-), 55.3 (CH3 OMe), 61.4 (MeSO2CH2CH2-), 67.2 (C-6), 68.9 (C-5), 69.6 (C-4), 73.1 (CH2 Bn), 
75.4 (CH2 Bn), 79.5 (C-2), 81.0 (C-3), 98.1 (C-1), 128.0-128.6 (CH arom), 137.8 (Cq Bn), 138.5 (Cq Bn), 154.4 
(C=O Msc); HRMS [M+NH4]
+ calcd for C25H36O10S N 542.20544 was found 542.20528, [M+Na]
+ calcd for 
C25H32O10SNa 547.16084 was found 547.16053. 
 
Methyl 2,3-di-O-benzyl-4-O-levulinoyl-6-O-methylsulfonylethoxycarbonyl--D-
glucopyranoside (17): To a solution of the compound 15 (0.196 g, 0.37 mmol) in DCM 
(1.8 ml, 0.2 M) was added LevOH (0.434 g, 3.74 mmol, 10 eq) and the reaction mixture 
was stirred for 30 minutes. A solution of EDC.HCl (0.358 g, 1.87 mmol, 5 eq) and DMAP (2 mg) in DCM (0.5 
ml) was added and stirring was continued for 1 hour. The reaction mixture was diluted with DCM, washed with 
water, NaHCO3 (aq) and brine, dried over MgSO4, filtered, concentrated and purified by silica gel column 
chromatography to afford compound 17 (0.208 g, 3.34 mmol, 89%). TLC (10% Methanol in DCM): Rf = 0.5; 
[]D22: +34.6º (c = 1, DCM); IR (neat, cm-1):  735, 1130, 1251, 1716, 1749; 1H NMR (500 MHz, CDCl3) = 2.15 
(s, 3H, CH3 Lev), 2.24-2.30 (m, 1H, MeCOCH2CHHCOO-), 2.44-2.50 (m, 1H, MeCOCH2CHHCOO-), 2.58 (m, 
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MeSO2CHHCH2-), 3.38 (m, 4H, CH3 OMe and MeSO2CHHCH2-), 3.55 (dd, 1H, J = 3.5 Hz, J = 9.5 Hz, H-2), 
3.86 (m, 1H, H-5), 3.93 (t, 1H, J = 9.5 Hz, H-3), 4.15 (dd, 1H, J = 2.0 Hz, J = 12.0 Hz, H-6), 4.32 (dd, 1H, J = 4.5 
Hz, J = 12.0 Hz, H-6), 4.49 (m, 1H, MeSO2CH2CHH-), 4.58-4.67 (m, 4H, H-1, MeSO2CH2CHH- and 2xCHH Bn), 
4.79 (d, 1H, J = 12.0 Hz, CHH Bn), 4.87 (d, 1H, J = 11.5 Hz, CHH Bn), 4.96 (t, 1H, J = 10.0 Hz, H-4), 7.27-7.35 
(m, 10H, H arom); 13C NMR (125 MHz, CDCl3) = 27.7 (MeCOCH2CH2COO-), 29.7 (CH3 Lev), 37.8 
(MeCOCH2CH2COO-), 42.5 (CH3 Msc), 53.8 (MeSO2CH2CH2-), 55.5 (CH3 OMe), 61.5 (MeSO2CH2CH2-), 66.1 
(C-6), 67.3 (C-3), 69.6 (C-4), 73.5 (CH2 Bn), 75.4 (CH2 Bn), 78.9 (C-2), 79.4 (C-5), 98.2 (C-1), 127.6-128.5 (CH 
arom), 137.8 (Cq Bn), 138.4 (Cq Bn), 154.0 (C=O Msc), 171.7 (C=O (MeCOCH2CH2COO-), 206.3 
(MeCOCH2CH2COO-); HRMS [M+NH4]
+ calcd for C30H42O12S N 640.24222 was found 640.24206, [M+Na]
+ 
calcd for C33H38O12SNa 645.19762 was found 645.19721. 
 
Methyl 2,3,-di-O-benzyl-4-O-levulinoyl-1-thio--D-glucopyranoside (18): To a solution 
of compound 17  (34 mg, 54 μmol) in DMF (1.1 ml, 0.04 M) was added DBU (10% in 
DMF, 81μl, 5.4 μmol, 0.1 eq) and the reaction mixture was stirred for 25 minutes. The 
reaction mixture was quenched with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 (aq) and 
brine, dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to afford the 
compound 17 (23.7mg, 52 μmol, 95%). TLC (66% EtOAc in toluene): Rf = 0.65; []D22: +24.8o (c = 1, DCM); IR 
(neat, cm-1): 738, 1028, 1716, 1739, 2918; 1H NMR (500 MHz, CDCl3) = 2.15 (s, 3H, CH3 Lev), 2.32 (m, 1H, 
MeCOCH2CHHCOO-), 2.48-2.54 (m, 1H, MeCOCH2CHHCOO-), 2.56-2.62 (m, 1H, MeCOCHHCH2COO-), 
2.74-2.80 (m, 1H, MeCOCHHCH2COO-), 3.39 (s, 3H, CH3 OMe), 3.56 (dd, 1H, J = 3.5 Hz, J = 9.5 Hz, H-2), 
3.60-3.66 (m, 3H, H-5 and 2xH-6), 3.99 (t, 1H, J = 9.0 Hz, H-3), 4.61 (d, 1H, J = 4.0 Hz, H-1), 4.64 (d, 1H, J = 
12.5 Hz, CHH Bn), 4.69 (d, 1H, J = 11.5 Hz, CHH Bn), 4.79 (d, 1H, J = 12.0 Hz, CHH Bn), 4.89 (m, 2H, H-4 and 
CHH Bn), 7.26-7.36 (m, 10H, H arom); 13C NMR (125 MHz, CDCl3) = 27.8 (MeCOCH2CH2COO-), 29.7 (CH3 
Lev), 37.8 (MeCOCH2CH2COO-), 55.4 (CH3 OMe), 60.9 (C-6), 69.5 (C-3), 70.9 (C-4), 73.5 (CH2 Bn), 75.4 (CH2 
Bn), 78.9 (C-2), 79.4 (C-5), 98.2 (C-1), 127.6-128.5 (CH arom), 137.9 (Cq Bn), 138.7 (Cq Bn), 173.2 (C=O 
(MeCOCH2CH2COO-), 206.4 (MeCOCH2CH2COO-); HRMS [M+NH4]
+ calcd for C26H36O8N 490.24354 was 
found 490.24324, [M+Na]+ calcd for C26H32O8Na 495.19894 was found 495.19847. 
 
Methyl 2,3,-di-O-benzyl-6-O-levulinoyl-1-thio--D-glucopyranoside (19): Collected as a 
by-product during the synthesis of 18; TLC (66% EtOAc in toluene): Rf = 0.8; []D22: 
+22.6o (c = 0.3, DCM); IR (neat, cm-1): 715, 1026, 1150, 1705; 1H NMR (500 MHz, 
CDCl3) = 2.17 (s, 3H, CH3 Lev), 2.58 (m, 2H, MeCOCH2CH2COO-), 2.74 (t, 2H, J = 6.5 Hz,  
MeCOCH2CH2COO-), 3.38 (s, 3H, CH3 OMe), 3.44 (t, 1H, J = 9.5 Hz, H-4), 3.50 (dd, 1H, J = 3.5 Hz, J = 9.5 Hz, 
H-2), 3.72-3.75 (m, 1H, H-5), 3.79 (t, 1H, J = 9.0 Hz, H-3), 4.22 (dd, 1H, J = 2.0 Hz, J = 12.0 Hz, H-6), 4.42 (dd, 
1H, J = 4.5 Hz, J = 12.0 Hz, H-6), 4.61 (d, 1H, J = 3.5 Hz, H-1), 4.66 (d, 1H, J = 12.0 Hz, CHH Bn), 4.77 (t, 2H, J 
= 11.5 Hz, 2xCHH Bn), 4.99 (d, 1H, J = 11.5 Hz, CHH Bn), 7.26-7.37 (m, 10H, H arom); 13C NMR (125 MHz, 
CDCl3) = 27.8 (MeCOCH2CH2COO-), 29.8 (CH3 Lev), 37.9 (MeCOCH2CH2COO-), 55.2 (CH3 OMe), 63.4 (C-
















arom), 137.9 (Cq Bn), 138.6 (Cq Bn), 173.0 (C=O (MeCOCH2CH2COO-), 206.5 (MeCOCH2CH2COO-); HRMS 




glucopyranoside (21): Disaccharide 21 was prepared form donor 6 
(0.113 g, 0.16 mmol, 1 eq) and acceptor 20 (0.115 g, 0.24 mmol, 1.5 eq) 
according to the general procedure for glycosylations as described above yielding compound 21 (0.109 g, 0.10 
mmol, 63%); TLC (33% EtOAc in Toluene): Rf = 0.45; []D22: +17.6º (c = 0.25, DCM); IR (neat, cm-1): 707, 1247, 
1724; 1H NMR (500 MHz, CDCl3) =   2.70 (s, 3H, CH3 Msc), 2.86 (t, 2H, J = 5.0 Hz, MeSO2CH2CH2-), 3.07 
(dd, 1H, J = 5.0 Hz, J = 10.0 Hz, H-6’), 3.19 (dd, 1H, J = 4.0 Hz, J = 10.0 Hz, H-6’), 3.30 (s, 3H, CH3 OMe), 3.47 
(m, 1H,  H-6), 3.55 (m, 1H,  H-5’), 3.71 (dd, 1H, J = 3.0 Hz, J = 10.5 Hz, H-6), 3.77 (m, 1H, H-5), 4.05-4.10 (m, 
2H, MeSO2CH2CHH- and CHH Bn), 4.12 (d, 1H, J = 12.0, CHH Bn), 4.20-4.26 (m, 2H, H-4 and  
MeSO2CH2CHH-), 4.37 (d, 1H, J = 12.0 Hz, CHH Bn), 4.71 (m, 2H, H-1’ and CHH Bn), 4.91 (t, 1H, J = 9.5 Hz, 
H-4’), 5.10 ( d, 1H, J = 3.5 Hz, H-1), 5.16 (dd, 1H, J = 4.0 Hz, J = 10.5 Hz, H-2), 5.35 (dd, 1H, J = 8.0 Hz, J = 
10.0 Hz, H-2’), 5.46 (t, 1H, J = 9.5 Hz, H-3’), 5.92 (t, 1H, J = 9.5 Hz, H-3), 7.20-8.03 (m, 30H, H arom); 13C 
NMR (125 MHz, CDCl3) = 42.0 (CH3 Msc), 53.5 (MeSO2CH2CH2-), 55.4 (CH3 OMe), 61.4 (MeSO2CH2CH2-), 
67.2 (C-6), 69.4 (C-6’), 69.4 (C-5), 70.7 (C-3), 71.5 (C-2’), 71.5 (C-5’), 72.0 (C-2), 73.1 (CH2 Bn), 73.1 (C-3’), 
73.6 (CH2 Bn), 74.9 (C-4’), 75.5 (C-4), 96.9 (C-1), 100.2 (C-1’), 128.2-133.5 (CH arom), 128.9 (Cq Bz), 129.1 (Cq 
Bz), 130.2 (Cq Bz), 130.4 (Cq Bz), 137.7 (Cq Bn), 137.7 (Cq Bn), 153.1 (C=O Msc), 164.5 (C=O Bz), 165.2 (C=O 
Bz), 165.7 (C=O Bz), 165.9 (C=O Bz); HRMS [M+NH4]
+ calcd for C59H62O19SN 1120.36313 was found 
1120.36426, [M+Na]+ calcd for C59H58O19SNa 1125.31852 was found 1125.31946. 
 
Methyl 2,3-di-O-benzoyl-6-O-benzyl-4-O-(2,3-di-O-benzoyl-6-O-benzyl-
-D-glucopyranosyl)--D-glucopyranoside 22 (Cleavage of Msc from 
21): To a solution of 21 (90 mg, 82 μmol) in dioxane (1.5 ml, 0.05 M) was 
added DBU (5%  in DMF, 23 μl, 8 μmol, 0.1 eq) and the reaction mixture 
was stirred for 30 minutes. The reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with 
NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by 
silica gel column chromatography to afford methyl 2,3-di-O-benzoyl-6-O-benzyl-4-O-(2,3-di-O-benzoyl-6-O-
benzyl--D-glucopyranosyl)--D-glucopyranoside 22 (78 mg, 82 μmol, 100%). TLC (33% EtOAc in Toluene): Rf 
= 0.66; []D22: +31.8º (c = 1.0, DCM); IR (neat, cm-1): 706, 1025, 1068, 1093, 1261, 1451, 1723; 1H NMR (500 
MHz, CDCl3) = 3.00 (dd, 1H, J = 5.0 Hz, J = 9.5 Hz, H-6’), 3.28 (m, 1H, H-6’), 3.30 (s, 3H, CH3 OMe), 3.36 
(m, 1H,  H-5’), 3.46 (dd, 1H, J = 1.5 Hz, J = 10.5 Hz, H-6), 3.70 (m, 2H, H-4’ and H-6), 3.75 (m, 1H, H-5), 4.18 
(t, 1H, J = 9.5 Hz, H-4), 4.21 (m, 2H, 2xCHH Bn), 4.36 (d, 1H, J = 12.0 Hz, CHH Bn), 4.66 (m, 2H, H-1’ and 
CHH Bn), 5.09 ( d, 1H, J = 3.5 Hz, H-1), 5.16 (dd, 1H, J = 4.0 Hz, J = 10.5 Hz, H-2), 5.29 (m, 2H, H-2’ and H-
3’), 5.90 (t, 1H, J = 9.5 Hz, H-3’), 7.19-8.01 (m, 30H, H arom); 13C NMR (125 MHz, CDCl3) =  55.4 (CH3 
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Bn), 73.6 (CH2 Bn), 75.5 (C-4), 75.7 (C-3’), 96.9 (C-1), 100.4 (C-1’), 127.5-133.2 (CH arom), 129.2 (Cq Bz), 
129.2 (2xCq Bz), 130.4 (Cq Bz), 137.2 (Cq Bn), 137.8 (Cq Bn), 164.8 (C=O Bz), 165.1 (C=O Bz), 165.9 (C=O Bz), 
166.5 (C=O Bz); HRMS [M+NH4]
+ calcd for C55H56O15N 970.36445 was found 970.36603, [M+Na]
+ calcd for 




glucopyranosyl)--D-glucopyranoside (23):  
 Method I: Disaccharide 23 was prepared form donor 7 (0.091g, 0.15 
mmol, 1eq) and acceptor 20 (0.109 g, 0.22 mmol, 1.5 eq) according to the general procedure for glycosylations as 
described above yielding the compound 23 (0.103 g, 0.10 mmol, 71%). 
Method II: To a solution of compound 7 (0.127 g, 0.21 mmol, 1q) in DCM (4.2 ml, 0.05 M) was added diphenyl 
sulfoxide (0.556 g, 0.28 mmol, 1.3 eq) and tri-tert-butylpyrimidine (0.157 g, 0.63 mmol, 3 eq) and mixture was 
stirred over molecular sieve 3Å for 30 minutes. After that the mixture was brought to -60ºC and triflic acid 
anhydride (0.046 ml, 0.28 mmol, 1.3 eq) was added and the mixture was stirred for 15 minutes. Next a solution of 
compound 20 (0.156 g, 0.32 mmol, 1.5 eq) in DCM (2.1 ml, 0.15 M) was added and stirring was continued for 10 
minutes. The reaction mixture was quenched with triethylamine (5 eq), diluted with DCM, washed with water and 
extracted with DCM. The combined organic layers were dried over MgSO4, filtered and concentrated. The crude 
product was purified by silica gel column chromatography to yield 23 (0.13 g, 0.14 mmol, 67%). 
TLC (33% Toluene in EtOAc): Rf = 0.45; []D22: +54.4º (c = 0.5, DCM); IR (neat, cm-1): 696, 1093, 1722; 1H 
NMR (500 MHz, CDCl3) =  2.72 (t, 1H, J = 10.5 Hz, H-6’), 2.79 (s, 3H, CH3 Msc), 2.98-3.03 (m, 1H, H-5’), 
3.20 (t, 2H, J = 5.5 Hz, MeSO2CH2CH2-), 3.41 (m, 4H, CH3 OMe and H-4’), 3.49 (t, 1H, J = 9.5 Hz, H-3’), 3.61 
(dd, 1H, J = 5.0 Hz, J = 11.0 Hz, H-6’), 3.73 (d, 1H,  J = 10.0 Hz, H-6), 3.87 (dd, 1H, J = 3.0 Hz, J = 11.0 Hz, H-
6), 3.90 (m, 1H, H-5), 4.13 (t, 1H,  J = 9.5 Hz, H-4), 4.39 (d, 1H, J = 8.0 Hz, H-1’), 4.47-4.57 (m, 4H, 2xCHH Bn 
and MeSO2CH2CH2-), 4.64 (t, 1H, J = 8.5 Hz, H-2’), 4.75 (d, 1H, J = 12.0 Hz, CHH Bn), 4.85 (d, 1H, J = 12.0 Hz, 
CHH Bn), 5.14 (d, 1H, J = 4.0 Hz, H-1), 5.18 (dd, 1H, J = 3.5 Hz, J = 10.0 Hz, H-2), 5.24 (s, 1H, CH 
Benzylidene), 5.88 (t, 1H, J = 10.0 Hz, H-3), 7.22-8.00 (m, 25H, H arom); 13C NMR (125 MHz, CDCl3) = 42.0 
(CH3 Msc), 53.4 (MeSO2CH2CH2-), 55.4 (CH3 OMe), 61.3 (MeSO2CH2CH2-), 65.8 (C-5’), 67.5 (C-6), 67.7 (C-
6’), 69.6 (C-5), 70.6 (C-3), 71.8 (C-2), 73.6 (CH2 Bn), 73.9 (CH2 Bn), 76.0 (C-4), 77.5 (C-2’), 78.5 (C-3’), 80.8 
(C-4’), 96.9 (C-1), 100.6 (C-1’), 100.9 (CH Benzylidene), 125.9-133.2 (CH arom), 129.0 (Cq Bz), 130.2 (Cq Bz), 
136.8 (Cq CHPh), 137.8 (Cq Bn), 138.1 (Cq Bn), 153.3 (C=O Msc), 165.2 (C=O Bz), 165.8 (C=O Bz); HRMS 
[M+H]+ calcd for C52H55O17S 983.31545 was found 983.31689, [M+NH4]
+ calcd for C52H58O17SN 1000.34200 was 




(Cleavage of Msc from 23): To a solution of 23 (94 mg, 96 μmol) in 

























0.1 eq) and the reaction mixture was stirred for 30 minutes. The reaction mixture was neutralized with NH4Cl (aq), 
diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. 
The crude product was purified by silica gel column chromatography to afford methyl 2,3-di-O-benzoyl-6-O-
benzyl-4-O-(3-O-benzyl-4,6-O-benzylidene--D-glucopyranosyl)--D-glucopyranoside 23 (78 mg, 96 μmol, 
100%); TLC (33% Toluene in EtOAc): Rf = 0.6; []D22: +55.2º (c = 1.0, DCM); IR (neat, cm-1): 696, 709, 1026, 
1067, 1277, 1722; 1H NMR (400 MHz, CDCl3) = 2.72 (t, 1H, J = 10.4 Hz, H-6’), 2.94-2.98 (m, 1H, H-5’), 3.41 
(m, 7H, CH3 OMe, H-2’, H-3’, H-4’ and H-6’), 3.79 (dd, 1H, J = 1.60 Hz, J = 10.8 Hz, H-6), 3.9 (m, 1H, H-5), 
3.06 (dd, 1H, J = 2.8 Hz, J = 10.8 Hz, H-6), 4.14 (t, 1H,  J = 9.2 Hz, H-4), 4.32 (d, 1H, J = 7.2 Hz, H-1’), 4.56 (d, 
1H, J = 12.0 Hz, CHH Bn), 4.71 (m, 2H, 2xCHH Bn), 4.88 (d, 1H, J = 12.0 Hz, CHH Bn), 5.16 (m, 2H, H-1 and 
H-2), 5.25 (s, 1H, CH Benzylidene), 5.94 (t, 1H, J = 9.2 Hz, H-3), 7.25-8.00 (m, 25H, H arom); 13C NMR (125 
MHz, CDCl3) = 55.4 (CH3 OMe), 66.1 (C-5’), 67.9 (C-6’), 68.0 (C-6), 69.6 (C-5), 71.1 (C-3), 72.0 (C-2), 73.6 
(CH2 Bn), 74.3 (CH2 Bn), 74.4 (C-2’), 80.2 (C-4’), 80.9 (C-3’), 97.0 (C-1), 100.9 (CH Benzylidene), 103.8 (C-1’), 
125.9-133.2 (CH arom), 129.2 (Cq Bz), 130.3 (Cq Bz), 137.2 (Cq Benzylidene), 137.7 (Cq Bn), 138.4 (Cq Bn), 165.3 




-D-mannopyranoside (26): To a solution of compound 13 (0.160 g, 
0.27 mmol, 1 eq) in DCM (5.3 ml, 0.05 M) was added diphenyl 
sulfoxide (0.070 g, 0.35 mmol, 1.3 eq) and tri-tert-butylpyrimidine (0.199 g, 0.80 mmol, 3 eq) and the mixture was 
stirred over molecular sieve 3Å for 30 minutes. After that the reaction mixture was brought to -78 ºC and triflic 
acid anhydride (58 μl, 0.35 mmol, 1.3 eq) was added and the mixture was stirred for 15 minutes. Next a solution of 
compound 25 (0.148 g, 0.40 mmol, 1.5 eq) in DCM (2.7 ml, 0.15 M) was added and stirring was continued for 18 
hours at -78 ºC. The reaction mixture was quenched with triethylamine (5 eq), diluted with DCM, washed with 
water and extracted with DCM thrice. The combined organic layers were dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to yield 26 (0.178 g, 0.21 
mmol, 78%); TLC (33% Toluene in EtOAc): Rf = 0.6; IR (neat, cm
-1): 697, 734, 1020, 1066, 1108, 1829; 1H NMR 
(500 MHz, CDCl3) = 2.79 (s, 3H, CH3 Msc), 3.18-3.22 (m, 1H, MeSO2CHHCH2-), 3.27-3.33 (m, 1H, 
MeSO2CHHCH2-), 3.38 (s, 3H, CH3 OMe), 3.80-3.90 (m, 5H, H-2, H-5, H-5’, H-6 and H-6’), 4.05 (m, 1H, H-2’), 
4.08-4.16 (m, 2H, H-4’, CHH Bn), 4.20-4.29 (m, 5H, H-3, H-4, H-6, H-6’ and CHH Bn), 4.37 (d, 1H, J = 12.0 Hz, 
CHH Bn), 4.48 (m, 2H, MeSO2CH2 CH2O-), 4.76 (d, 1H, J = 1.5 Hz, H-1), 4.79 (s, 2H, H-1’ and CHH Bn), 5.17 
(dd, 1H, J = 3.5 Hz, J = 10.5  Hz, H-3’), 5.53 (s, 1H, CH Benzylidene), 5.61 (s, 1H, CH Benzylidene), 7.00-7.50 
(m, 20H, H arom); 13C NMR (125 MHz, CDCl3) = 42.4 (CH3 Msc), 53.7 (MeSO2CH2CH2-), 55.0 (CH3 OMe), 
61.4 (MeSO2CH2CH2-), 63.8, 64.4, 77.3 (C-2, C-5 and C-5’), 68.7, 68.9 (C-6 and C-6’), 72.6 (CH2 Bn), 73.5 (CH2 
Bn), 73.8, 79.3 (C-3 and C-4), 75.4 (C-3’), 75.7 (C-2’), 76.0 (C-4’), 99.2, (C-1’), 100.1, (C-1), 101.9 (CH 
Benzylidene), 102.1 (CH Benzylidene), 126.2-129.7 (CH arom), 137.2, 137.3, 137.5 (2xCq Benzylidene and 2xCq 
Bn), 153.5 (C=O Msc); CH Gated NMR (125 MHz, CDCl3) 99.2 (J = 170 Hz, C-1’), 100.1 (J = 182 Hz, C-1). 





















(28): To a solution of 8 (0.240 mg, 0.29 mmol) in DCM (2.9 ml, 0.1 M) was added EtOH 
(1 ml) and acetic acid (7.6 ml) and the mixture was stirred for 18 hours. The reaction 
mixture was neutralized with NaHCO3 (aq), diluted with EtOAc, washed with NaHCO3 (aq) and brine, dried over 
MgSO4, filtered and concentrated. The crude product was purified by silica gel column chromatography to afford 
28 (0.123 g, 0.23 mmol, 81%). TLC (50% EtOAc in PE): Rf = 0.2; []D22: +37.4º  (c = 1.0, DCM); IR (neat, cm-1): 
630, 1262, 1757; 1H NMR (400 MHz, CDCl3) = 2.35 (bs, 1H, C6-OH), 2.83 (s, 3H, CH3 Msc), 3.20-3.27 (m, 
2H, MeSO2CH2CH2-), 3.38 (s, 3H, CH3 OMe), 3.57 (dd, 1H, J = 3.6 Hz,  J = 9.6 Hz, H-2), 3.64 (m, 3H, H-5 and 
2xH-6), 3.98 (t, 1H, J = 9.6 Hz, H-3), 4.42-4.48 (m, 1H, MeSO2CH2CHH-), 4.51-4.56 (m, 1H, MeSO2CH2CHH-), 
4.61 (d, 1H, J = 3.6 Hz, H-1), 4.62-4.66 (m, 2H, 2xCHH Bn), 4.76-4.83 (m, 2H, H-4 and CHH Bn), 4.94 (d, 1H, J 
= 11.6 Hz, CHH Bn), 7.26-7.35 (m, 10H, H arom); 13C NMR (100 MHz, CDCl3) = 42.0 (CH3 Msc), 53.4 
(MeSO2CH2CH2-), 55.4 (CH3 OMe), 60.9 (C-6), 61.3 (MeSO2CH2CH2-), 69.0 (C-5), 73.4 (CH2 Bn), 74.8 (C-4), 
75.3 (CH2 Bn), 78.9 (C-3), 79.3 (C-2), 98.0 (C-1), 127.4-128.4 (CH arom), 137.6 (Cq Bn), 138.4 (Cq Bn), 154.2 




(29): Disaccharide 29 was prepared form acceptor 28 (0.088 g, 0.17 mmol, 
1 eq) and donor 27 (0.168 g, 0.25 mmol, 1.5 eq) according to the general 
procedure for glycosylations as described above yielding compound 29 (0.130 g, 0.12 mmol, 70%). TLC (50% 
EtOAc in PE): Rf = 0.65; []D22: +39.2º (c = 1, DCM); IR (neat, cm-1): 1249, 1725; 1H NMR (400 MHz, CDCl3) 
= 2.78 (s, 3H, CH3 Msc), 3.11-3.20 (m, 5H, CH3 OMe and MeSO2CH2CH2-), 3.37-3.39 (m, 1H, H-2), 3.63 (dd, 
1H, J = 6.4 Hz, J = 11.2 Hz, H-6), 3.81-3.89 (m, 2H, H-3 and H-5), 4.02 (d, 1H, J = 10.8 Hz, H-6), 4.17 (m, 1H, 
H-5’), 4.34 (m, 1H, MeSO2CH2CHH-), 4.40-4.56 (m, 5H, H-1, H-6’, MeSO2CH2CHH- and 2xCHH Bn), 4.67 (m, 
3H, H-4, H-6’ and CHH Bn), 4.87 (d, 1H, J = 11.6 Hz, CHH Bn), 4.92 (d, 1H, J = 8.0 Hz, H-1’), 5.54 (t, 1H, J = 
9.2 Hz, H-2’), 5.69 (t, 1H, J = 9.6 Hz, H-4’), 5.90 (t, 1H, J = 9.6 Hz, H-3’), 7.22-7.96 (m, 30H, H arom); 13C NMR 
(100 MHz, CDCl3) = 42.1 (CH3 Msc), 53.4 (MeSO2CH2CH2-), 55.0 (CH3 OMe), 61.2 (MeSO2CH2CH2-), 63.0 
(C-6’), 68.0 (C-5), 68.4 (C-6), 69.6 (C-3’), 71.8 (C-2’), 72.1 (C-5’), 72.7 (C-4’), 73.2 (CH2 Bn), 75.0 (C-4), 75.2 
(CH2 Bn), 79.0 (C-3), 79.2 (C-2), 97.5 (C-1), 101.4 (C-1’), 127.2-138.5 (CH arom), 128.7 (2xCq Bz), 129.4 (Cq 
Bz), 129.7 (Cq Bz), 137.7 (Cq Bn), 138.5 (Cq Bn), 153.7 (C=O Msc), 165.0 (C=O Bz), 165.1 (C=O Bz), 165.7 

































1 eq) and donor 27 (0.130 g, 0.20 mmol, 1.5 eq) according to the general procedure for glycosylations as described 
above yielding compound 30 (0.92 g, 0.08 mmol, 64%). TLC (50% EtOAc in PE): Rf = 0.7; []D22: +46.6º (c = 1, 
DCM); IR (neat, cm-1): 1250, 1728; 1H NMR (400 MHz, CDCl3) = 2.98 (s, 3H, CH3 Msc), 3.28 (s, 3H, CH3 
OMe), 3.30-3.38 (m, 2H, MeSO2CH2CH2), 3.44 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 3.71 (m, 1H, H-5), 3.81 (t, 
1H, J = 9.2 Hz, H-4), 3.98 (t, 1H, J = 9.2 Hz, H-3), 4.03 (m, 1H,  H-5’), 4.23-4.32 (m, 3H, 2xH-6 and H-6’), 4.39 
(dd, 1H,  J = 3.2 Hz, J = 10.0 Hz, H-6’), 4.45 (m, 1H, MeSO2CH2CHH), 4.50 (d, 1H, J = 3.2, H-1), 4.56-4.62  (m, 
2H, MeSO2CH2CHH and CHH Bn), 4.71 (d, 1H, J = 12.0 Hz, CHH Bn), 4.91 (d, 1H, J = 11.2 Hz, CHH Bn), 5.06 
(d, 1H, J = 11.6 Hz, CHH Bn), 5.10 ( d, 1H, J = 8.0 Hz, H-1’), 5.54 (t, 1H, J = 9.6 Hz, H-2’), 5.66 (t, 1H, J = 9.6 
Hz, H-4’), 5.91 (t, 1H, J = 9.6 Hz, H-3’), 7.16-8.00 (m, 30H, H arom); 13C NMR (100 MHz, CDCl3) = 42.0 (CH3 
Msc), 53.5 (MeSO2CH2CH2), 55.4 (CH3 OMe), 60.9 (MeSO2CH2CH2), 62.8 (C-6’), 66.1 (C-6), 67.7 (C-5), 69.4 
(C-4’), 71.8 (C-5’), 72.4 (C-2’), 73.0 (C-3’), 73.4 (CH2 Bn), 75.0 (CH2 Bn), 78.0 (C-4), 79.1 (C-2), 79.5 (C-3), 
98.0 (C-1), 100.9 (C-1’), 126.9-133.4 (CH arom), 128.7 (Cq Bz), 128.8 (2xCq Bz), 129.5 (Cq Bz), 137.9 (Cq Bn), 
138.9 (Cq Bn), 154.0 (C=O Msc), 164.9 (C=O Bz), 165.0 (C=O Bz), 165.7 (C=O Bz), 165.9 (C=O Bz); HRMS 
[M+H]+ calcd for C59H59O19S 1103.33658 was found 1103.33871,  [M+Na]
+ calcd for C59H58O19SNa 1125.31852 
was found 1125.31962.  
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In 1997, Curran and coworkers reported fluorous solid phase extraction (FSPE) as 
a new purification method in synthetic organic chemistry.2 FSPE involves the 
chromatographic separation of fluorous and non-fluorous components from a mixture by 
the use of a fluorous solid phase in combination with fluorophilic solvents.3  Silica gel 
functionalized with a perfluoroalkyl chain is typically used as a fluorous solid phase in 
combination with methanol, acetonitrile or tetrahedrofuran as fluorophilic solvents and 









(FPsc): a fluorous hydroxyl protecting




Figure 1: The FMsc and the FPsc protecting group. 
 
 
In recent times the application of FSPE in synthetic organic chemistry is greatly 
stimulated by the development of numerous fluorous reagents such as catalysts,6 chiral 
auxiliaries7 and scavengers.8 A variety of fluorous protective groups, serving the dual 
purpose of protective group and purification handle in FSPE, have also been reported. 
Fluorous protecting groups for many relevant functional groups, such as amino9 and 
hydroxyl functions10 have been developed. Generally a fluorous protective group is 
obtained by the appendage of a perfluoroalkyl moiety to the core of a known protective 
group such as the benzyl,11 benzyloxycarbonyl,12 tert-butyl,13 tert-butyloxycarbonyl,14 
trityl15 and benzylidene16 group. Most commonly, an ethylene spacer is incorporated to 
isolate the electron withdrawing effect of the fluorous tail, which can undesirably alter the 
properties of the protecting group.12 
 
A few years ago, the [1H,1H,2H,2H]-perfluorodecylsulfonylethoxycarbonyl 
(FMsc, 1, Figure 1) group was introduced as a fluorous version of the 
methylsulfonylethoxycarbonyl (Msc) protective group for amines.17 The FMsc group was 
used as a purification handle for oligopeptides, assembled by Fmoc-based solid phase 
peptide synthesis (SPPS). The FMsc group could be introduced at the amino terminus of a 
target oligopeptide at the final stage of the SPPS. Cleavage from the solid support and 
purification of the resulting mixture by fluorous HPLC (FHPLC) effected separation of the 
fluorous target oligopeptide and non-fluorous deletion sequences. Removal of the FMsc 
group using mild basic conditions afforded the pure oligopeptide. This result together with 
the successful application of the (Msc) group for the protection of hydroxyl functions, as 
described in chapter 2, was an incentive to explore the use of fluorous Msc-based protective 
groups in carbohydrate chemistry. The outcome of this study, showing the favorable 
properties of the [1H,1H,2H,2H,3H,3H]-perfluoroundecylsulfonylethoxycarbonyl (FPsc) 
group 2 is outlined in the present chapter. 
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Results and discussion: 
 
The assessment of the optimal conditions for the introduction of the 
methylsulfonylethoxycarbonyl (Msc) group is described in chapter 2. It turned out that 
pyridine as base and DCM as solvent were most efficient. Whether these conditions are also 
suitable for the introduction of the FMsc group (1) was checked by the treatment of 1,2:5,6-
di-O-isopropylidene--D-glucofuranose 3 with 2 equivalents of [1H,1H,2H,2H]-
perfluorodecylsulfonylethoxycarbonyl chloride (FMsc-Cl) and 3 equivalents of pyridine in 
DCM (Scheme 1). After 4 hours the reaction was complete and glucofuranose 4 was 
isolated in 95% yield. Next, the FMsc group could be introduced regioselectively at the 
primary C6-OH of diol 5 using the same conditions, albeit at lower temperature (-20 oC), to 
give alcohol 6 in 95% yield. 
The optimal condition for the removal of the Msc group, i.e. 0.1 eq. 1,8- 
diazabicyclo[5.4.0]undec-7-ene (DBU), (see Chapter 2), also proved to be appropriate for 
the cleavage of  the FMsc group, although removal of the latter carbonate proved to be 
significantly faster. Subjection of compound 4 to these conditions for 1 minute gave the 
expected alcohol 3 in 98% yield.  
 




























Reagents and conditions; a) FMS-Cl, pyr, DCM, 0 ºC-RT, 4h, 95%;  b) DBU, dioxane, 1  min, 98%; c) FMS-Cl, 
pyr, DCM, -20 ºC-RT, 4h, 95%. 
 
Next, the feasibility of the FMsc-protective group in N-iodosuccinimide (NIS) and 




first example, the FMsc-protected methyl glucoside 6 was condensed with thioglucoside 7 
to provide disaccharide 8 (Scheme 2). TLC analysis of the crude reaction mixture showed 
the presence of a main product together with side products, probably derived from the 
donor. Purification by FSPE using a gradient of acetonitrile in water (50% to 100%) 
provided disaccharide 8. Although TLC analysis of the combined fractions after FSPE 
showed the presence of one product, subsequent evaporation of the solvents caused the 
formation of an unwanted non-fluorous side product. A second FSPE purification gave the 
same result and ensuing purification by silica gel column chromatography afforded 
disaccharide 8 in 63% overall yield. In the second glycosylation event, FMsc-protected 
methyl glucoside 6 was coupled via the same procedure with perbenzoylated S-phenyl 
glucoside 9 to provide disaccharide 10 (Scheme 2). Disaccharide 10 was purified by FSPE 
to afford the fluorous product 8 in 80% yield. Unfortunately, again a non-fluorous side 
product was generated during the evaporation of the solvents. Homogeneous disaccharide 
10 was obtained by silica gel column chromatography in 60% yield. 
 
Scheme 2: Glycosylation reactions using acceptors containing the FMsc group. 
 
 
 Reagents and conditions; d) i- NIS, TMSOTf, DCM, 0 ºC-RT, 1h; ii- FSPE. 
 
The formation of the non-fluorous products, as described above, indicates that 
simple evaporation of aqueous acetonitrile can lead to partial removal of the FMsc from 
primary OH functions. This undesirable instability of the FMsc can be explained by the 
increased susceptibility of the FMsc for -elimination by the inductive electron 
withdrawing effect of the perfluoroalkyl chain. It was envisaged that the 
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[1H,1H,2H,2H,3H,3H]-perfluoroundecylsulfonylethoxycarbonyl (FPsc, 2, Figure 1) group, 
in which the distance between the sulfonyl functionality and the perfluoro moiety is 
increased by an additional methylene group, should be more stable.  
 The synthesis of [1H,1H,2H,2H,3H,3H]-perfluoroundecylsulfonylethoxycarbonyl 
chloride (FPsc-Cl, 14) started from the commercially available [1H,1H,2H,2H,3H,3H]-
perfluoroundecyl iodide 11 as depicted in Scheme 3.18 The iodide was substituted with 
mercaptoethanol in refluxing tert-butylalcohol to give thioether 12 in 95% yield (Scheme 
3). In the next step, compound 12 was oxidized using peracetic acid in AcOH/H2O. The 
resulting sulfone 13 was isolated in 96% yield. Treatment of primary alcohol 13 with 
phosgene in THF gave chlorocarbonate 14. 
 

















Reagents and conditions; e) mercaptoethanol, t-BuOH, NaOH, Reflux, 4h, 95%; f) AcOOH, AcOH, H2O, EtOAc, 
2h, 96%; g) phosgene, THF, 0 ºC, 16h, 100%. 
 
Next, the usefulness of the FPsc group for oligosaccharide synthesis was assessed 
with the assembly of trisaccharide 19.19 First, the FPsc group was introduced selectively at 
the primary C6-OH of diol 5 by treatment with 1 equivalent FPsc chloride 14 at low 
temperature to give the acceptor glycoside 15 in 94% yield (Scheme 4). NIS/TMSOTf 
mediated condensation of fluorous acceptor 15 with excess of thiodonor 9 (3 equivalents), 
bearing a levulinoyl group at its C4-OH proceeded uneventfully. TLC analysis of the crude 
reaction mixture showed the presence of several products. Subsequent purification by 
FSPE, using a gradient of acetonitrile in water (50% to 100%) provided a single fluorous 
product. FPsc containing dimer 16 was isolated in excellent yield demonstrating the 




of the FPsc was further substantiated by the selective removal of the levulinoyl group in 16 
and ensuing purification by FSPE to afford alcohol 17 in 81% yield. Disaccharide 17 was 
elongated using an excess of (N-phenyl)trifluoro acetimidate 1820 (3 equivalents) and a 
catalytic amount of TfOH at -20 oC. After purification by FSPE, fluorous trimer 19 was 
isolated in 78%.  It is of interest that executing the coupling of dimer 17 with 18 at 0 oC 
instead of -20 oC and purification by FSPE led to the isolation of a mixture of trimer 19 and 
a fluorous side product. After separation by silica gel chromatography, this side product 
was identified as FPsc protected trimer 20, containing dehydroglucosamine. Formation of 
this product can be explained by -elimination of the imidate group of donor 18, followed 
by a Ferrier glycosylation on the resulting glycal.21 
 
Scheme 4: Oligosaccharide synthesis using the FPsc group. 
 
Reagents and conditions; d) i- NIS, TMSOTf, DCM, 0 ºC-RT, 1h; ii- FSPE, 93%; h) FPsc-Cl (14), pyr., DCM, -40 




      In conclusion the FPsc group is a new fluorous hydroxyl-protecting group, suitable 
for implementation in oligosaccharide synthesis. The FPsc group can be introduced under 
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mild conditions and where necessary in a regioselective manner. It is cleaved under mild 
basic conditions, under which commonly used ester protecting groups stay intact. The FPsc 





General: Dichloromethane was refluxed with P2O5 and distilled before use. Traces of water in donor and acceptor 
glycosides were removed by co-evaporation with toluene. Molecular sieves 3Å were flame dried before use. All 
other chemicals (Acros, Fluka, Merck, Fluorous Technologies Inc.) were used as received. Column 
chromatography was performed on Screening Devices silica gel 60 (0.040-0.063 mm). TLC analysis was 
conducted on DC-alufolien (Merck, kiesel gel 60, F245). Compounds were visualized by UV absorption (245 nm), 
by spraying with an aqueous solution of KMnO4 (20%) and K2CO3 (10%), by spraying with 20% H2SO4 in ethanol 
or by spraying with a solution of (NH4)6Mo7O24·4H2O (25g/L) and (NH4)4Ce(SO4)4·2H2O (10g/L) in 10% H2SO4 
(aq) followed by charring at 150 ºC. IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in cm-1. 
Optical rotations were measured on a Propol automatic polarimeter. 1H and 13C NMR spectra were recorded with a 
Bruker AV 400 (400 MHz and 100 MHz respectively), AV 500 (500 MHz and 125 MHz respectively) or DMX 
600 (600 MHz and 150 MHz respectively). NMR spectra were recorded in CDCl3 unless stated otherwise. 
Chemical shift are relative to tetramethylsilane and are given in ppm. Coupling constants are given in Hz. All 
given 13C spectra are proton decoupled. High resolution mass spectra were recorded on a LTQ-Orbitrap (thermo 
electron). 
 
General method for glycosylations using NIS/TMSOTf: A solution of 1-thio--D-glucopyranoside (donor) and 
acceptor in DCM (0.05 M) was stirred over activated MS3Å for 30 minutes before N-iodosuccinimide (1.3 eq with 
respect to the donor) was added. The mixture was cooled to -40 oC followed by the addition of trimethylsilyl 
trifluoromethanesulfonate (0.1 eq). The mixture was allowed to warm to room temperature. The reaction mixture 
was quenched with triethylamine (5 eq), filtered, diluted with ETOAc and washed with Na2S2O3 (aq). The aqueous 
layer was extracted with EtOAc thrice, after which the combined organic layers were dried over MgSO4, filtered, 
concentrated and purified by fluorous solid phase extraction (FSPE). 
 
General procedure for fluorous solid phase extraction (FSPE): A FSPE Cartridge  preloaded with 10 g of 
fluorous silica gel was eluted  with DMF (20 ml), acetonitrile (30 ml) and 50% acetonitrile in H2O (50 ml) before 
loading the crude product in acetonitrile (1.5 ml). The cartridge was eluted with 50% acetonitrile in H2O (50 ml) 
and 70% acetonitrile in H2O (50 ml) to wash the fluorophobic fraction. Next, fluorophilic fraction was eluted with 







perfluorodecyl)sulfonylethoxycarbonyl--D-glucofuranoside (4): A solution of 
1,2:5,6-O-isopropylidene--D-glucofuranose  3 (0.039 g, 0.14 mmol) in DCM (1.5 ml, 
0.1 M) was cooled to 0 oC before pyridine (36 μl, 0.45 mmol, 3 eq) was added. Next, 
([1H,1H,2H,2H]-perfluorodecyl)sulfonylethoxycarbonyl chloride (FMsc-Cl, 10% in DCM, 0.185 g, 0.30 mmol, 2 
eq) was added drop-wise at 0 oC over the span of 30 minutes. The mixture was allowed to warm to room 
temperature. The reaction mixture was quenched with methanol, diluted with DCM, washed with NaHCO3 (aq) and 
brine, dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to afford 
compound 9 ( 0.120 g, 142 μmol, 95%). TLC (50% n-hexane in EtOAc): Rf = 0.8; []D22: +10.8º (c = 0.5, DCM); 
IR (neat, cm-1): 494, 1023, 1091, 1145, 1199, 1373, 1748; 1H NMR (600 MHz, CDCl3) = 1.28 (s, 3H, CH3 
isopropylidene), 1.29 (s, 3H, CH3 isopropylidene), 1.40 (s, 3H, CH3 isopropylidene), 1.50 (s, 3H, CH3 
isopropylidene), 2.67 (m, 2H, RfCH2CH2SO2(CH2)2-), 3.32 (m, 2H, RfCH2CH2SO2(CH2)2-), 3.40 (m, 2H, 
Rf(CH2)2SO2CH2CH2-),  4.02 (m, 2H, 2xH-6), 4.15 (m, 2H, H-4 and H-5), 4.55 (d, 1H, J = 3.6 Hz, H-3), 4.61 (m, 
2H, Rf(CH2)2SO2CH2CH2-), 5.14 (d, 1H, J = 2.4 Hz, H-2), 5.85 (d, 1H, J = 3.6 Hz, H-1); 
13C NMR (150 MHz, 
CDCl3) = 23.5 (t, J = 22.0 Hz, RfCH2CH2SO2(CH2)2-),  24.5 (CH3 isopropylidene), 25.6  (CH3 isopropylidene), 
26.2  (CH3 isopropylidene), 26.5 (CH3 isopropylidene), 45.8 (RfCH2CH2SO2(CH2)2-), 52.3 (Rf(CH2)2SO2CH2CH2-
), 60.8 (Rf(CH2)2SO2CH2CH2-), 66.7 (C-6), 71.8, 79.1 (C-4 and C-5), 79.8 (C-3), 82.6 (C-2), 104.5 (C-1), 109.1 
(Cq isopropylidene), 112.0 (Cq isopropylidene), 152.6 (C=O FMsc); 
19F NMR (376 MHz, CDCl3) = -126.4, -
123.7, -123.0, -122.2, -122.0, -114.8 (CF2), -81.1 (CF3); HRMS [M+Na]
+ calcd for C25H27O10SNa 865.09457 was 
found 865.09521.  
 
1,2:5,6-di-O-isopropylidene--D-glucofuranoside (Cleavage of FMsc from 4): To a 
solution of 4 (24 mg, 28 μmol) in dioxane (0.6 ml, 0.05 M) was added DBU (1% in 
dioxane, 42 μl, 2.9 μmol, 0.1 eq) and the reaction mixture was stirred for 1 minute. The 
reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with 
NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by 




--D-glucopyranoside (6): A solution of methyl 2,3-di-O-benzyl--D-glucopyranoside 5 
(0.127 g, 0.34 mmol) in DCM (1 ml, 0.3 M) was cooled to -20 oC before pyridine (82 ml, 
1.0 mmol, 3 eq) was added. Next, ([1H,1H,2H,2H]-perfluorodecylsulfonylethoxycarbonyl chloride (FMsc-Cl in 
0.1 ml DCM, 0.419 g, 0.68 mmol, 2 eq) was added drop-wise over the span of 45 minutes. The mixture was 
allowed to warm to room temperature and stirring was continued for 4 hours. The reaction mixture was quenched 
with methanol, diluted with DCM, washed with NaHCO3 (aq) and brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to afford 6 (0.310 g, 0.32 
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1145, 1199, 1749; 1H NMR (600 MHz, CDCl3) = 2.61-2.69 (m, 2H, RfCH2CH2SO2(CH2)2-), 3.30 (m, 2H, 
RfCH2CH2SO2(CH2)2-), 3.33 (s, 3H, CH3 OMe),  3.37 (m, 3H, H-4 and  Rf(CH2)2SO2CH2CH2-), 3.47 (dd, 1H, J = 
3.6 Hz, J = 9.6 Hz, H-2), 3.74 (m, 2H, H-3 and H-5), 4.33 (dd, 1H, J = 5.4 Hz, J = 11.4 Hz, H-6), 4.37 (dd, 1H, J = 
1.8 Hz, J = 11.4 Hz, H-6), 4.55 (t, 2H, J = 4.8 Hz, Rf(CH2)2SO2CH2CH2-), 4.57 (d, 1H, J = 3.6 Hz, H-1), 4.62 (d, 
1H, J = 12.0 Hz, CHH Bn), 4.67 (d, 1H, J = 11.4 Hz, CHH Bn), 4.74 (d, 1H, J = 12.0 Hz, CHH Bn), 4.99 (d, 1H, J 
= 11.4 Hz, CHH Bn), 7.22-7.41 (m, 10H, H arom); 13C NMR (150 MHz, CDCl3) =  24.0 (t, J = 22.5 Hz, 
RfCH2CH2SO2(CH2-)2), 46.3 (RfCH2CH2SO2(CH2-)2), 52.8 (Rf(CH2)2SO2CH2CH2-), 55.2 (CH3 OMe), 61.0 
(Rf(CH2)2SO2CH2CH2-), 67.6 (C-6), 68.8 (C-3 or C-5), 69.7 (C-4), 73.2 (CH2 Bn), 75.4 (CH2 Bn), 79.6 (C-2), 81.0 
(C-3 or C-5), 98.1 (C-1), 128.0-129.0 (CH arom), 137.8 (Cq Bn), 138.5 (Cq Bn), 154.3 (C=O FMsc); 
19F NMR (376 
MHz, CDCl3) = -129.6, -126.7, -126.2, -125.4, -125.2, -117.3 (CF2), -84.3 (CF3); HRMS [M+Na]+ calcd for 




levulinoyl--D-glucopyranosyl)--D-glucopyranoside (8): Disaccharide 
8 was prepared form acceptor 6 (0.055 g, 57.5 μmol, 1 eq) and donor 7 (0.117 g, 172.5 μmol, 3 eq) according to 
the general procedure for glycosylations as described above. The crude product was purified by general procedure 
of FSPE as described above. The side product generated during the evaporation of solvent was removed by silica 
gel chromatography to afford compound 8 (0.055 g, 36 μmol, 63%). TLC (33% EtOAc in toluene): Rf = 0.3; 
[]D22: +34.4º (c = 1, DCM); IR (neat, cm-1): 713, 1147, 1207, 1269, 1732; 1H NMR (500 MHz, CDCl3) = 1.92 
(s, 3H, CH3 Lev), 2.28-2.55 (m, 4H, 2xCH2 Lev), 2.69 (m, 2H, RfCH2CH2SO2(CH2)2-), 3.25 (s, 3H, CH3 OMe), 
3.34 (m, 4H, RfCH2CH2SO2(CH2)2- and Rf(CH2)2SO2CH2CH2-), 3.42 (dd, 1H, J = 3.5 Hz, J = 9.5 Hz, H-2), 3.73 
(m, 2H, H-4 and H-5), 3.79 (m, 1H,  H-5’), 3.96 (t, 1H, J = 9.0 Hz, H-3), 4.19 (dd, 1H, J = 3.0 Hz, J = 11.0 Hz, H-
6), 4.25 (m, 2H, H-6 and H-6’), 4.34 (dd, 1H,  J = 2.0 Hz, J = 12.0 Hz, H-6’), 4.41-4.45 (m, 1H, 
Rf(CH2)2SO2CH2CHH-), 4.48 (d, 1H, J = 3.5 Hz, H-1), 4.56  (m, 2H, Rf(CH2)2SO2CH2CHH- and CHH Bn), 4.67 
(d, 1H, J = 12.0 Hz, CHH Bn), 4.91 (d, 1H, J = 11.5 Hz, CHH Bn), 5.02 (m, 2H, H-1’ and CHH Bn), 5.38-5.46 
(m, 2H,  H-4’ and H-2’), 5.68 (t, 1H, J = 9.5 Hz, H-3’), 7.20-8.02 (m, 25H, H arom); 13C NMR (125 MHz, CDCl3) 
=  27.7 (MeCOCH2CH2COO), 29.3 (CH3 Lev), 29.7 (RfCH2CH2SO2(CH2)2), 37.7 (MeCOCH2CH2COO), 45.9 
(RfCH2CH2SO2(CH2)2), 52.5 (Rf(CH2)2SO2CH2CH2), 55.2 (CH3 OMe), 60.5 (Rf(CH2)2SO2CH2CH2), 62.2 (C-6’), 
66.5 (C-6), 67.6 (C-4 or C-5), 68.5 (C-4’), 71.3 (C-5’), 71.9 (C-2’), 72.4 (C-3’), 73.4 (CH2 Bn), 74.9 (CH2 Bn), 
78.2 (C-4 or C-5), 79.4 (C-2), 79.6 (C-3), 97.9 (C-1), 100.9 (C-1’), 126.7-133.3 (CH arom), 128.8 (Cq Bz), 137.9 
(Cq Bn), 139.0 (Cq Bn), 153.8 (C=O FMsc), 165.0 (C=O Bz), 165.7 (C=O Bz), 165.9 (C=O Bz), 171.3 (C=O 
MeCOCH2CH2COO), 205.5 (C=O MeCOCH2CH2COO-); 
19F NMR (376 MHz, (CDCl3) = -126.4, -123.7, -
123.0, -122.2, -122.0, -114.7 (CF2), -81.1 (CF3);  HRMS [M+Na]


















-D-glucopyranosyl)--D-glucopyranoside (10): Disaccharide 10 was prepared from acceptor 6 (0.045 g, 47 
μmol, 1 eq) and donor 9 (0.094 g, 0.141 mmol, 3 eq) according to the general procedure for glycosylations as 
described above. The crude product was purified by general procedure of FSPE as described above. The side 
product generated during the evaporation of solvent was removed by silica gel chromatography to afford 
compound 10 (0.043 g, 28 μmol, 60%). TLC (50% EtOAc in PE): Rf = 0.6; []D22: +40.4º (c = 0.5, DCM); IR 
(neat, cm-1): 708, 1026, 1091, 1205, 1244, 1733; 1H NMR (400 MHz, CDCl3) = 2.67-2.73 (m, 2H, 
RfCH2CH2SO2(CH2)2-), 3.27 (s, 3H, CH3 OMe), 3.38 (m, 4H, RfCH2CH2SO2(CH2-)2 and Rf(CH2)2SO2CH2CH2-), 
3.44 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 3.75 (m, 2H, H-5 and  H-4), 3.94 (m, 2H, H-3 and  H-5’), 4.24 (m, 3H, 
H-6, H-6 and H-6’), 4.37 (dd, 1H, J = 3.2 Hz, J = 12.0 Hz, H-6’), 4.41-4.47 (m, 1H, Rf(CH2)2SO2CH2CHH-), 4.49 
(d, 1H, J = 3.6 Hz, H-1), 4.55 (m, 2H, Rf(CH2)2SO2CH2CHH- and CHH Bn), 4.69 (d, 1H, J = 12.0 Hz, CHH Bn), 
4.92 (d, 1H, J = 11.6 Hz, CHH Bn), 5.04 (d, 1H, J = 11.6 Hz, CHH Bn), 5.08 (d, 1H, J = 8.0 Hz, H-1’), 5.52 (dd, 
1H, J = 8.0 Hz, J = 9.6 Hz, H-2’), 5.64 (t, 1H, J = 9.6 Hz, H-4’), 5.87 (t, 1H, J = 9.6 Hz, H-3’), 7.19-7.98 (m, 30H, 
H arom); 13C NMR (100 MHz, CDCl3) = 24.1 (t, J = 22.0 Hz, RfCH2CH2SO2(CH2)2-), 54.9 
(RfCH2CH2SO2(CH2)2-), 52.6 (Rf(CH2)2SO2CH2CH-2), 55.3 (CH3 OMe), 60.5 (Rf(CH2)2SO2CH2CH2-), 62.8 (C-
6’), 66.6 (C-6), 69.4 (C-4 or C-5), 72.0 (C-4’), 72.5 (C-5’), 72.6 (C-2’), 73.0 (C-3’), 73.5 (CH2 Bn), 74.9 (CH2 
Bn), 78.1 (C-4 or C-5), 79.4 (C-2), 79.6 (C-3), 98.0 (C-1), 101.0 (C-1’), 126.9-133.3 (CH arom), 128.7 (Cq Bz), 
128.8 (Cq Bz), 128.9 (Cq Bz), 129.6 (Cq Bz), 138.0 (Cq Bn), 139.0 (Cq Bn), 153.9 (C=O FMsc), 165.0 (C=O Bz), 
165.0 (C=O Bz), 165.7 (C=O Bz), 166.0 (C=O Bz); 19F NMR (376 MHz, (CDCl3) = -126.4, -123.4, -123.0, -
122.2, -121.9, -113.9 (CF2), -81.1 (CF3);  HRMS [M+H]
+ calcd for C68H60O19F17S 1535.31726 was found 
1535.31891, [M+Na]+ calcd for C68H58O19F17SNa 1557.29920 was found 1557.30047. 
 
([1H,1H,2H,2H,3H,3H]-perfluoroundecyl)sulfidylethanol (12): NaOH (0.714 g, 
17.9 mmol, 1.5 eq) and 2-mercaptoethanol (2.1 ml, 29.8 mmol, 2.5 eq) were refluxed 
in t-BuOH (40 ml) for 30 minutes. ([1H,1H,2H,2H,3H,3H]-perfluoroundecyl iodide (7.0 g, 11.9 mmol, 1 eq) was 
added and the mixture was refluxed for 2h. After evaporation of all volatiles, the crude product was subjected to 
silica gel column chromatography to give the compound 12 (6.11 g, 11.4 mmol, 95%). TLC (33% EtOAC in 
Toluene): Rf = 0.7; IR (neat, cm
-1): 528, 1197, 3341; 1H NMR (400 MHz, CDCl3) = 1.94 (m, 2H, 
RfCH2CH2CH2S(CH2)2OH), 2.24 (m, 2H, RfCH2(CH)2S(CH)2OH), 2.67 (t, 2H, J = 7.2 Hz,  
Rf(CH2)2CH2S(CH2)2OH), 2.76 (t, 2H, J = 6.0 Hz, Rf(CH2)3SCH2CH2OH), 3.79 (t, 2H, J = 6.0 Hz,  
Rf(CH2)3SCH2CH2OH), 3.87 (s, 1H, OH); 
13C NMR (100 MHz, CDCl3) = 20.2 (RfCH2CH2CH2S(CH2)2OH), 
29.6 (t, J = 22.0 Hz, RfCH2(CH2)2S(CH2)2OH), 30.9 (Rf(CH2)2CH2S(CH2)2OH), 34.4 (Rf(CH2)3SCH2CH2OH), 
60.8 (Rf(CH2)3SCH2CH2OH), 107.8-120.8 (CF); 
19F NMR (376 MHz, CDCl3) = -127.4, -124.4, -123.8, -123.0, -
122.7, -115.1 (CF2), -81.3 (CF3); HRMS [M+H]
+ calcd for C13H12O1F17S1 539.03319 was found 539.03327. 
 
([1H,1H,2H,2H,3H,3H]-perfluoroundecyl)sulfonylethanol (13): 39% AcOOH (4.9 
ml, 28.4 mmol, 2.5 eq) and H2O (2 ml) were added to a solution of 12 (6.11 g, 11.4 
mmol) in ice cooled AcOH (3.8 ml). If gel formation occurred, EtOAc (5 ml) was added. The mixture was stirred 








([1H,1H,2H,2H2,3H,3H]-perfluoroundecyl)sulfonylethoxycarbonyl (FPsc), a fluorous hydroxyl protective group 
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EtOAc, dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to afford white 
crystalline 13 (6.21 g, 10.9 mmol, 96% ). TLC (75% EtOAc in PE): Rf = 0.6; IR (neat, cm
-1): 506, 1115, 3475; 1H 
NMR (400 MHz, (CD3)2CO) = 2.18 (m, 2H, RfCH2CH2CH2SO2(CH2)2OH), 2.42-2.56 (m, 2H, 
RfCH2(CH2)2SO2(CH2)2OH), 3.29 (t, 2H, J = 5.6 Hz,  Rf(CH2)2CH2SO2(CH2)2OH), 3.35 (t, 2H, J = 7.6 Hz, 
Rf(CH2)3SO2CH2CH2OH), 4.03 (dt, 2H, J = 5.2 Hz, J = 5.6 Hz, Rf(CH2)3SO2CH2CH2OH), 4.26 (t, 1H, J = 5.2 Hz, 
OH); 13C NMR (100 MHz, (CD3)2CO) = 13.6 (RfCH2CH2CH2SO2(CH2)2OH), 29.0 (m, 
RfCH2(CH2)2SO2(CH2)2OH), 52.9 (Rf(CH2)2CH2SO2(CH2)2OH), 55.3 (Rf(CH2)3SO2CH2CH2OH), 55.9 
(Rf(CH2)3SO2CH2CH2OH), 111.1-121.0 (CF); 
19F NMR (376 MHz, (CD3)2CO) = -127.2, -124.5, -123.7, -122.8, 
-122.7, -114.7 (CF2), -81.2 (CF3); HRMS [M+H]
+ calcd for C13H12O3F17S1 571.02302 was found 571.02302. 
 
([1H,1H,2H,2H,3H,3H]-perfluoroundecyl)sulfonylethoxycarbonyl chloride 
(14): To the solution of 13 (5.90 g, 10.4 mmol,) in freshly distilled THF (65 ml, 
0.16 M) was added phosgene (20% in toluene, 9.4 ml, 18.6 mmol, 1.8 eq) at 0 ºC and the  reaction mixture was 
stirred for 16 hours. Next the solvents and phosgene were removed in vacuo to give 14 (6.54 g, 10.4 mmol, 
100%); IR (neat, cm-1): 1139, 1769; 1H NMR (400 MHz, CDCl3) = 2.26 (m, 2H, RfCH2CH2CH2SO2(CH2)2O-), 
2.36 (m, 2H, RfCH2(CH2)2SO2(CH2)2O-), 3.18 (t, 2H, J = 7.2 Hz, Rf(CH2)2CH2SO2(CH2)2O-), 3.40 (t, 2H, J = 5.6 
Hz, Rf(CH2)3SO2CH2CH2O-), 4.76 (t, 2H, J = 5.6 Hz, Rf(CH2)3SO2CH2CH2O-); 
13C NMR (100 MHz, CDCl3) = 
13.7 (RfCH2CH2CH2SO2(CH2)2O-), 29.2 (m, RfCH2(CH2)2SO2(CH2)2O-), 51.8 (Rf(CH2)2CH2SO2(CH2)2O-), 53.5 
(Rf(CH2)3SO2CH2CH2O-), 64.4 (Rf(CH2)3SO2CH2CH2O-); 
19F NMR (376 MHz, CDCl3) = -126.5, -123.8, -
123.1, -122.3, -122.0, -114.7 (CF2) , -81.2 (CF3); HRMS [M+H]




perfluoroundecyl)sulfonylethoxycarbonyl--D-glucopyranoside (15): A solution of 5 
(0.153 g, 0.41 mmol) in DCM (1.4 ml, 0.3 M) was cooled to -40 oC before pyridine (0.1 
ml, 1.22 mmol, 3 eq) was added. Next, ([1H,1H,2H,2H,3H,3H]-perfluoroundecyl)sulfonylethoxycarbonyl chloride 
(FPsc-Cl in 0.1 ml DCM, 0.387 g, 0.61 mmol, 1.5 eq) was added drop-wise over the span of 45 minutes. The 
reaction mixture was allowed to warm to room temperature and the stirring was continued for 4 hours. The 
reaction mixture was quenched with methanol, diluted with DCM, washed with NaHCO3 (aq) and brine, dried over 
MgSO4, filtered, concentrated and the crude product was purified by silica gel column chromatography to afford 
15 (0.372 g, 0.38 mmol, 94%). TLC (5% Et2O in DCM): Rf = 0.8; []D22: +20.2º (c = 1, DCM); IR (neat, cm-1): 
734, 1200, 1748, 2927; 1H NMR (400 MHz, CDCl3) = 2.14-2.21 (m, 2H, RfCH2CH2CH2SO2(CH2)2-), 2.23-2.34 
(m, 2H, RfCH2(CH2)2SO2(CH2)2-), 2.72 (s, 1H, C4-OH), 3.09 (t, 2H, J = 7.6 Hz, Rf(CH2)2CH2SO2(CH2-)2), 3.29 (t, 
2H, J = 5.6 Hz, Rf(CH2)3SO2CH2CH2-), 3.36 (s, 3H, CH3 OMe), 3.44 (t, 1H, J = 10.0 Hz, H-4), 3.49 (dd, 1H, J = 
3.6 Hz, J = 9.6 Hz, H-2), 3.73-3.80 (m, 2H, H-3 and H-5), 4.37 (m, 2H, 2xH-6), 4.51 (t, 2H, J = 6.0 Hz, 
Rf(CH2)3SO2CH2CH2-), 4.61 (d, 1H, J = 3.2 Hz, H-1), 4.64 (d, 1H, J = 12.4 Hz, CHH Bn), 4.74 (m, 2H, 2xCHH 
Bn), 4.99 (d, 1H, J = 11.2 Hz, CHH Bn), 7.26-7.35 (m, 10H, H arom); 13C NMR (100 MHz, CDCl3) = 13.4 















52.9 (Rf(CH2)3SO2CH2CH2-), 55.1 (CH3 OMe), 61.0 (Rf(CH2)3SO2CH2CH2-), 67.3 (C-6), 68.9 (C-5), 69.6 (C-4), 
73.0 (CH2 Bn), 75.3 (CH2 Bn), 79.5 (C-2), 81.0 (C-3), 98.0 (C-1), 108.3-118.4 (CF), 127.4-128.4 (CH arom), 
137.8 (Cq Bn), 138.6 (Cq Bn), 154.3 (C=O FPsc); 
19F NMR (376 MHz, CDCl3) = -126.4, -123.7, -123.0, -122.2, -
122.0, -114.8 (CF2), -81.1 (CF3); HRMS [M+Na]





Disaccharide 16 was prepared from acceptor 15 (0.31 g, 0.39 mmol, 1 eq) and donor 9  (0.57 g, 0.84 mmol, 2.6 eq) 
according to the general procedure for glycosylations as described above. The crude product was purified by 
general procedure of FSPE as described above to afford compound 16 (0.46 g, 0.30 mmol, 93%). TLC (5% 
Methanol in DCM): Rf = 0.85; []D22: +24.4º (c = 0.5, DCM); IR (neat, cm-1): 710, 1203, 1722; 1H NMR (400 
MHz, CDCl3) = 1.90 (s, 3H, CH3 Lev), 2.15-2.21 (m, 2H, RfCH2CH2CH2SO2(CH2)2-), 2.25-2.43 (m, 4H, 2xCH2 
Lev), 2.49 (m, 2H, RfCH2(CH2)2SO2(CH2)2-), 3.18 (t, 2H, J = 7.6 Hz, Rf(CH2)2CH2SO2(CH2)2-), 3.25 (s, 3H, CH3 
OMe), 3.26-3.32 (m, 1H, Rf(CH2)3SO2CHHCH2-), 3.38 (m, 1H, Rf(CH2)3SO2CHHCH2-), 3.42 (dd, 1H, J = 4.8 
Hz, J = 11.6 Hz, H-2), 3.72 (m, 1H, H-5), 3.79 (t, 1H, J = 8.8 Hz, H-4), 3.91 (m, 1H,  H-5’), 3.97 (t, 1H, J = 9.2 
Hz, H-3), 4.22 (m, 1H, H-6), 4.26-4.32 (m, 2H, H-6 and H-6’), 4.38 (dd, 1H,  J = 2.0 Hz, J = 12.0 Hz, H-6’), 4.41-
4.47 (m, 1H, Rf(CH2)3SO2CH2CHH-), 4.50 (d, 1H, J = 3.6 Hz, H-1), 4.52-4.58  (m, 2H, Rf(CH2)3SO2CH2CHH- 
and CHH Bn), 4.69 (d, 1H, J = 12.0 Hz, CHH Bn), 4.90 (d, 1H, J = 11.6 Hz, CHH Bn), 5.06 (m, 2H, H-1’ and 
CHH Bn), 5.41-5.49 (m, 2H,  H-4’ and H-2’), 5.72 (t, 1H, J = 9.6 Hz, H-3’), 7.17-8.04 (m, 25H, H arom); 13C 
NMR (100 MHz, CDCl3) = 13.5 (RfCH2CH2CH2SO2(CH2)2-), 27.6 (MeCOCH2CH2COO-), 29.1 (CH3 Lev), 29.3 
(t, J = 22.0 Hz, RfCH2(CH2)2SO2(CH2)2-), 37.6 (MeCOCH2CH2COO-), 51.7 (Rf(CH2)2CH2SO2(CH2)2-), 52.7 
(Rf(CH2)3SO2CH2CH2-), 55.2 (CH3 OMe), 60.5 (Rf(CH2)3SO2CH2CH2-), 62.2 (C-6’), 66.3 (C-6), 67.6 (C-5), 68.5 
(C-4’), 71.6 (C-5’), 72.1 (C-2’), 72.9 (C-3’), 79.3 (CH2 Bn), 74.9 (CH2 Bn), 78.0 (C-4), 79.4 (C-2), 79.4 (C-3), 
97.9 (C-1), 100.7 (C-1’), 108.0-120.4 (CF), 127.9-133.3 (CH arom), 128.8 (Cq Bz), 137.8 (Cq Bn), 138.9 (Cq Bn), 
153.9 (C=O FPsc), 164.9 (C=O Bz), 165.7 (C=O Bz), 165.9 (C=O Bz), 171.3 (C=O MeCOCH2CH2COO-), 205.5 
(C=O MeCOCH2CH2COO-); 
19F NMR (376 MHz, (CDCl3) = -126.4, -123.7, -123.0, -122.2, -122.0, -114.7 
(CF2), -81.1 (CF3);  HRMS [M+H]




D-glucopyranosyl)--D-glucopyranoside (17): To a solution of 16 (0.44 g, 
0.29 mmol) in pyridine (2.4 ml, 0.1 M) and acetic acid (0.6 ml) was added hydrazine hydrate (72 μl, 1.49 mmol, 5 
eq) and the mixture was stirred for 5 minutes, quenched with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl 
(aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered and concentrated. . The crude product was purified by 
general procedure of FSPE as described above to afford compound 16 (0.332 g, 0.23 mmol, 81%). TLC (40% 
Toluene in EtOAc): Rf = 0.6; []D22: +44.0º (c = 1.0, DCM); IR (neat, cm-1): 1044, 1246, 1719, 3395; 1H NMR 
(400 MHz, CDCl3) = 2.20 (m, 2H, RfCH2CH2CH2SO2(CH2)2-), 2.26-2.33 (m, 2H, RfCH2(CH2)2SO2(CH2)2-), 
([1H,1H,2H,2H2,3H,3H]-perfluoroundecyl)sulfonylethoxycarbonyl (FPsc), a fluorous hydroxyl protective group 
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3.14-3.21 (m, 2H, Rf(CH2)2CH2SO2(CH2)2-), 3.28 (m, 4H, CH3 OMe and Rf(CH2)3SO2CHHCH2-), 3.40 (m, 1H, 
Rf(CH2)3SO2CHHCH2-), 3.45 (dd, 1H, J = 3.2 Hz, J = 9.6 Hz, H-2) , 3.52 (d, 1H, J = 4.8 Hz, C4’-OH), 3.69-3.84 
(m, 4H, H-5, H-5’, H-4 and H-4’), 3.96 (t, 1H, J = 9.2 Hz, H-3), 4.20 (d, 1H,  J = 11.2 Hz, H-6’), 4.30 (dd, 1H,  J 
= 2.8 Hz, J = 9.6 Hz, H-6’), 4.39-4.50 (m, 3H, H-6, H-1 and Rf(CH2)3SO2CH2CHH-), 4.54-4.65 (m, 3H, H-6, 
Rf(CH2)3SO2CH2CHH-, and CHH Bn), 4.69 (d, 1H, J = 12.0 Hz, CHH Bn), 4.88 (d, 1H, J = 11.6 Hz, CHH Bn), 
4.99 (d, 1H, J = 8.0 Hz, H-1’), 5.13 (d, 1H, J = 11.6 Hz, CHH Bn), 5.42 (t, 1H, J = 9.6 Hz, H-3’), 5.55 (t, 1H, J = 
9.2 Hz, H-2’), 7.19-8.00 (m, 25H, H arom); 13C NMR (100 MHz, CDCl3) = 13.4 (RfCH2CH2CH2SO2(CH2)2-), 
29.4 (t, J = 22.0 Hz, RfCH2(CH2)2SO2(CH2)2-), 51.7 (Rf(CH2)2CH2SO2(CH2)2-), 52.8 (Rf(CH2)3SO2CH2CH2-), 
55.2 (CH3 OMe), 60.4 (Rf(CH2)3SO2CH2CH2-), 63.0 (C-6’), 66.4 (C-6), 67.7 (C-5), 69.0 (C-4’), 72.1 (C-2’), 73.4 
(CH2 Bn), 74.4 (C-5’), 75.0 (CH2 Bn), 75.8 (C-3’), 78.2 (C-4), 79.1 (C-2), 79.6 (C-3), 98.0 (C-1), 100.9 (C-1’), 
108.1-120.4 (CF), 126.9-133.3 (CH arom), 128.8 (Cq Bz), 128.9 (Cq Bz), 129.4 (Cq Bz), 137.9 (Cq Bn), 139.1 (Cq 
Bn), 154.0 (C=O FPsc), 165.1 (C=O Bz), 166.8 (C=O Bz), 167.0 (C=O Bz); 19F NMR (376 MHz, (CDCl3) = -
126.5, -123.7, -123.1, -122.3, -122.0, -114.7 (CF2) , -81.1 (CF3 );  HRMS [M+H]
+ calcd for C67H58O18F17S 
1445.30724 was found 1445.30859,  [M+Na]+ calcd for C62H57O18F17SNa 1467.28864 was found 1467.28959. 
 





-D-glucopyranosyl}--D-glucopyranosyl]--D-glucopyranoside (19): To the solution of 17 (0.288 g, 0.20 mmol) 
and 18 (0.394 mg, 0.60 mmol, 3 eq) in DCM (2 ml)  was added triflic acid (5% in DCM, 67 μl, 0.02 mmol, 0.1 eq) 
at -20 ºC and the mixture was stirred at same temperature for 15 minutes before TLC showed complete 
disappearance of the acceptor. The mixture was diluted with EtOAc and washed with NaHCO3 (aq) and brine, dried 
over MgSO4, filtered, concentrated and purified by FPSE to give 19 (0.312 mg, 0.16 mmol, 78%). TLC (50% 
Toluene in EtOAc): Rf = 0.65; []D22: +2.6º (c = 1.0, DCM); IR (neat, cm-1): 710, 1069, 1728; 1H NMR (400 MHz, 
CDCl3) = 0.76 (s, 9H, 3xCH3 TBDS), 0.84 (s, 9H, 3xCH3 TBDS), 2.11 (s, 3H, CH3 Lev), 2.13-2.25 (m, 3H, 
RfCH2CH2CH2SO2(CH2)2-) and MeCOCHHCH2COO-), 2.49 (m, 1H, H-6’’), 2.51-2.58 (m, 3H, 
MeCOCH2CH2COO- and MeCOCHHCH2COO-), 2.67 (m, 2H, RfCH2(CH2)2SO2(CH2)2-), 2.75-2.81(m, 1H, H-
5’’), 3.24 (m, 5H, CH3 OMe, Rf(CH2)2CHHSO2(CH2)2- and Rf(CH2)3SO2CHHCH2-), 3.35-3.46 (m, 4H, H-2, H-
4’’, H-6’’ and Rf(CH2)3SO2CHHCH2-), 3.57  (m, 1H, Rf(CH2)3SO2CHHCH2-), 3.63 (m, 1H, H-5), 3.80 (m, 1H, H-
2’’), 3.85-3.92 (m, 3H, H-3, H-4 and H-4’), 4.00 (m, 1H, H-5’), 4.06 (d, 1H, J = 10.4 Hz, H-6), 4.12 (d, 1H,  J = 
12.4 Hz, H-6’), 4.23 (d, 1H,  J = 8.4 Hz, H-1’’), 4.38 (dd, 1H, J = 2.8 Hz, J = 11.6 Hz, H-6), 4.46 (d, 1H, J = 3.6 
Hz, H-1), 4.51-4.57 (m, 2H, CHH Bn and Rf(CH2)3SO2CH2CHH-), 4.68-4.76  (m, 2H, Rf(CH2)3SO2CH2CHH- and 
CHH Bn), 4.84 (m, 3H, H-6’, H-3’’ and  CHH Bn), 4.97 (d, 1H, J = 8.0 Hz, H-1’), 5.17 (d, 1H, J = 11.6 Hz, CHH 
Bn), 5.44 (dd, 1H, J = 8.4 Hz, J = 10.0 Hz, H-2’), 5.73 (t, 1H, J = 9.6 Hz, H-3’), 7.12-8.04 (m, 26H, H arom and 
NH); 13C NMR (100 MHz, CDCl3) = 14.5 (RfCH2CH2CH2SO2(CH2)2-), 19.5 (Cq TBDS), 22.2 (Cq TBDS), 26.6 




29.6 (CH3 Lev), 37.9 (MeCOCH2CH2COO-), 50.5 (RfC(CH2)2CH2SO2(CH2)2-), 53.3 (Rf(CH2)3SO2CH2CH2-), 
55.3 (CH3 OMe), 55.4 (C-4’’), 60.2 (Rf(CH2)3SO2CH2CH2-), 62.1 (C-6’), 64.7 (C-6’’), 66.0 (C-6), 67.6 (C-5), 
70.6 (C-5’’), 71.9 (C-2’), 72.6 (C-3’), 72.6 (C-4), 73.6 (CH2 Bn), 73.9 (C-3’’), 74.4 (C-5’), 75.0 (CH2 Bn), 75.7 
(C-3), 78.7 (C-4’ and C-2), 79.6 (C-2’’), 92.2 (CCl3),  98.3 (C-1), 100.8 (C-1’’), 101.1 (C-1’), 108.3-118.5 (CF), 
127.0-133.7 (CH arom), 128.4 (Cq Bz), 128.6 (Cq Bz), 128.7 (Cq Bz), 137.9 (Cq Bn), 139.2 (Cq Bn), 154.0 (C=O 
FPsc), 162.3 (C=O TCA), 165.2 (C=O Bz), 165.4 (C=O Bz), 166.8 (C=O Bz), 172.2 (C=O MeCOCH2CH2COO-), 
205.5 (C=O MeCOCH2CH2COO-); 
19F NMR (376 MHz, (CDCl3) = -126.4, -123.7, -123.0, -122.2, -122.0, -
114.6 (CF2) , -81.1 (CF3 );  HRMS [M+H]







eno-pyranosyl}--D-glucopyranosyl]--D-glucopyranoside (20): When the synthesis of 19 was carried at 0 ºC, 
two fluorous products were obtained after FSPE. 19 was separated from 20 (14%) by silica gel column 
chromatography. TLC (50% Toluene in EtOAc): Rf = 0.75; []D22: +52.8º (c = 0.8, DCM); IR (neat, cm-1): 731, 
1264; 1H NMR (400 MHz, CDCl3) = 0.94 (s, 9H, 3xCH3 TBDS), 0.99 (s, 9H, 3xCH3 TBDS), 2.11-2.35 (m, 4H, 
RfCH2CH2CH2SO2(CH2)2- and RfCH2(CH2)2SO2(CH2)2-), 3.07 (t, 2H, J = 7.6 Hz, Rf(CH2)2CH2SO2(CH2)2-), 3.19-
3.26 (m, 5H, CH3 OMe, Rf(CH2)3SO2CH2CH2-), 3.41 (dd, 1H, J = 3.6 Hz, J = 9.2 Hz, H-2), 3.68 (m, 5H, H-4, H-
5, H-6’’, H-5’, H-5’’), 3.97 (t, 1H, J = 9.2 Hz, H-3), 4.03-4.11 (m, 2H, H-6 and H-6’), 4.16 (dd, 1H, J = 3.6 Hz, J 
= 11.6 Hz, H-6’’), 4.23 (dd, 1H, J = 3.2 Hz, J = 11.6 Hz, H-6), 4.30 (t, 1H, J = 9.2 Hz, H-4’), 4.34-4.47 (m, 3H, H-
4’’ and Rf(CH2)3SO2CH2CH2-), 4.49 (d, 1H,  J = 3.6 Hz, H-1), 4.52 (d, 1H, J = 12.4 Hz, CHH Bn), 4.65 (d, 1H, J 
= 12.0 Hz, CHH Bn), 4.70 (dd, 1H, J = 3.0 Hz, J = 12.0 Hz, H-6’), 4.90 (d, 1H, J = 12.0 Hz, CHH Bn), 4.97-5.08 
(m, 3H, ,H-1’, H-1’’ and  CHH Bn), 5.38 (dd, 1H, J = 8.0 Hz, J = 9.6 Hz, H-2’), 5.61 (t, 1H, J = 9.6 Hz, H-3’), 
6.86 (s, 1H, H-3’’),  7.15-8.06 (m, 26H, H arom and NH); 13C NMR (100 MHz, CDCl3) = 13.6 
(RfCH2CH2CH2SO2(CH2)2-), 20.0 (Cq TBDS), 22.3 (Cq TBDS), 26.8 (3xCH3 TBDS), 27.3 (3xCH3 TBDS), 29.5 (t, 
J = 22.0 Hz, RfCH2(CH2)2SO2(CH2)2-), 52.0 (RfC(CH2)2CH2SO2(CH2)2-), 52.8 (Rf(CH2)3SO2CH2CH2-), 55.3 (CH3 
OMe), 60.2 (Rf(CH2)3SO2CH2CH2-), 62.5 (C-6), 66.1 (C-6’’), 66.6 (C-6’), 67.7, 68.5, 72.9, 77.4 (C-4, C-5, C-5’ 
and C-5’’), 69.5 (C-4’’), 71.2 (C-4’), 72.6 (C-2’), 73.3 (CH2 Bn), 74.6 (CH2 Bn), 76.4 (C-3’), 78.9 (C-3), 79.6 (C-
2), 92.2 (CCl3),  92.6 (C-1’’), 98.0 (C-1), 99.6 (C-1’), 118.2 (C-3’’), 120.9 (C-2’’), 126.5-134.0 (CH arom), 128.4 
(Cq Bz), 128.6 (Cq Bz), 128.7 (Cq Bz), 137.9 (Cq Bn), 138.9 (Cq Bn), 153.9 (C=O FPsc), 159.9 (C=O TCA), 165.1 
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  The development of suitable protecting groups is an important objective in 
synthetic organic chemistry. Although numerous protecting groups for hydroxyl functions 
are available,1 the palette of protecting groups that is commonly applied en route to an 
oligosaccharide is quite limited. Benzyl ethers (Bn)2 and benzoyl (Bz)3 or pivaloyl (Piv)4 
esters are usually selected as permanent protecting groups, to be removed only at the end of 
the synthesis of the target oligosaccharide. Among the temporary protecting groups that 
allow chain elongation by selective deprotection, the levulinoyl (Lev),5 the 9-
fluorenylmethoxycarbonyl (Fmoc),6 the p-methoxybenzyl (PMB) ether,7 and silyl ethers 
such as tert-butyldimethylsilyl (TBDMS)8 and tert-butyldiphenylsilyl (TBDPS)9 are most 
often used. In addition, diol protecting groups, such as the benzylidene acetal,10 and the 
4 
CHAPTER 
The methylsulfonylethoxymethyl  
(Msem) as a hydroxyl protecting 





isopropylidene11 and di-tert-butylsilyl ketal12 are often employed. With the current state of 
the art in oligosaccharide synthesis it is becoming increasingly clear that the nature of the 
protecting group at each position on the core of the reacting donor and acceptor glycosides.  
 




may exert influence on the stereochemical outcome and yield of a glycosylation reaction. 
Consequently, not only the armed-disarmed concept on the reactivity of glycosyl donors is 
continuously adjusted and expanded,13 but also the knowledge of the stereodirecting power 
of various substituents on the core of the glycosyl donors is progressing.14 A striking 
example of the influence of a remote protecting group is presented by the 4,6-O-
benzylidene protection in mannose donors that allow the easy introduction of the 
challenging 1,2-cis mannose linkage.15 On the other hand, the cis-directing power of the 
4,6-O-benzylidene acetal in mannopyranose donors can be overshadowed by the presence 
of bulky ether or participating acyl groups at the C-3 OH.16 In this framework alkoxymethyl 
protecting groups have recently attracted attention.16,17 A range of alkoxymethyl groups, 
such as the cyanoethoxymethyl group have been developed in the field of RNA synthesis.18 
Protecting groups at the C-2 hydroxyl of an RNA building block must meet strict 
requirements to prevent both unwanted removal en route to the fully protected 
oligoribonucleotide and phosphate diester migration at the end of the synthesis. The 
endeavors on the methylsulfonylethoxycarbonyl (Msc) group 1, as described in Chapter 2,19 
together with the favorable properties of the cyanoethoxymethyl group in RNA chemistry, 
in terms of intermediate stability and ease of removal at the end of the oligo nucleotide 
assembly were an incentive to explore the methylene analogue of the Msc group in 
oligosaccharide synthesis. In this chapter the methylsulfonylethoxymethyl (Msem, 2) is 
introduced for the protection of carbohydrates and its applicability in the synthesis of 
1,3-O-mannotriose is demonstrated.  
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Results and discussion: 
 
The most efficient way to introduce various alkoxymethyl protecting groups relies 
on the use of thiomethyl intermediates.5b,20 Therefore it was decided to explore two 
complementary strategies to introduce the methylsulfonylethoxymethyl (Msem) group on a  
hydroxyl function. In the first approach, an alkoxymethyl thiomethyl ether reagent is 
prepared while in the second procedure, the hydroxyl function to be protected is converted 
into the corresponding methylthiomethyl ether. First attention was focused on the former 
approach and to this end commercially available methylsulfonylethanol 3 was converted to 
thiomethyl ether 4 in 57% yield by treatment with dimethylsulfoxide (DMSO) and acetic 
anhydride (Ac2O) in acetic acid (Scheme 1). Thiomethyl ether reagent 4 can be used for the 
introduction of the Msem group at hydroxyl functions using chemistry developed for 
glycosylations of thioglycosides. Condensation of methyl 2,3,4-tri-O-benzyl--D-
glucopyranoside 7 with reagent 4 under the influence of N-iodosuccinimide (NIS) and 
trimethylsilyltriflate (TMSOTf) produced Msem protected 8 in 70% yield (Scheme 1).  The 
preparation of Msem protected 10 from methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 
using reagent 4 and the same activator system indicate that this procedure is also suitable to 
protect secondary hydroxyl functions with the Msem group. Using the milder iodonium di-
sym-collidine perchlorate (IDCP) as iodonium source, the condensation of methyl glycoside 
7 and thiomethyl ether 4 led to the isolation of Msem protected 8 in 63% yield. The yield of 
this reaction could be increased to 79% by activation of 4 with diphenylsulfoxide (Ph2SO) 
in combination with trifluoromethanesulfonic anhydride (Tf2O) and an excess of tri-tert-
butylpyrimidine (TTBP) as a proton scavenger. This reaction was accompanied by the 
formation of side-product 13.  
Since reagent 4 and thioglycosides can both be activated with iodonium or 
sulfonium ions, orthogonal conditions were sought that are suitable for introduction of the 
Msem group at hydroxyl functions of thioglycosides. To this end, the thiomethyl ether 4 
was transformed into methylsulfonylethoxymethyl chloride 5 by treatment with sulfuryl 
chloride in DCM. Unfortunately, attempts to introduce the Msem group to the primary 
hydroxyl in compound 7 with methylsulfonylethoxymethyl chloride 5, employing either 




failed and resulted only in the recovery of starting compound 7. Apparently, the chloride 5 
is not stable under the applied conditions. Since thioglycosides can withstand acidic 
conditions, attention was shifted to acetyl acetal 6, which was produced by reaction of 
thioether 4 with AcOH under the influence of NIS in 95% yield. Unfortunately the reaction 
of (2-(methylsulfonyl)ethoxy)methyl acetate 6 and methyl 2,3,6-tri-O-benzyl--D-
glucopyranoside 9 under influence of TfOH or SnCl4 mainly led to the formation of the 
methylene acetal 11 instead of the desired Msem protected 10, indicating that the Msem can 
be introduced using acidic conditions, but that the resulting ketal also reacts under these 
conditions.   
 

















































































Reagents and conditions; a) AcOH, Ac2O, DMSO, RT, 48 h, 57%; b) SO2Cl2, DCM, RT, 2 h, 100%; c) NIS, 
AcOH, DCM, -20 ºC to RT, 2 h, 95%; d) NIS, TMSOTf, DCM, -20 ºC to RT, 24h; e) IDCP, DCM, RT, 2h; f) 
DPS, TTBP, Tf2O, DCM, -60 ºC, 2h. g) NaH, MTM-Cl, DMF, 1h, 73%. 
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The second approach, in which a hydroxyl function in a monosaccharide is firstly 
transformed into the methylthiomethyl ether and subsequently into the Msem ether was 
next pursued. 2,3,4-Tri-O-benzyl--D-glucopyranoside 9 was converted into fully protected 
12 by treatment with sodium hydride and methylthiomethyl chloride (MTM-Cl) in DMF 
(Scheme 1). Condensation of thiomethyl ether 12 with 2-(methylsulfonyl)ethanol 3 using 
the NIS/TfOH combination gave methyl 2,3,6-tri-O-benzyl-4-O-
methylsulfonylethoxymethyl--D-glucopyranoside 10 in only 34% yield. The low yield can 
be explained by the unwanted formation of methylene acetal 11. Employing IDCP (4 
equivalents) as a more mildly activating system improved the yield of 10 to 64% but did 
not completely circumvent the formation of side product 11. The fluorous analogue of the 
Msem group could also be constructed under these conditions in combination with 
([1H,1H,2H,2H]-perfluorodecyl)sulfonylethanol as a nucleophile. Because of the low 
reactivity of this alcohol, the side product 11 prevailed in the reaction mixture and the 
fluorous Msem protected glucose 14 was obtained in unproductive yield.    
With two methods at hand for the introduction of the Msem group, the most 
favorable conditions for cleavage of the Msem group were sought. Therefore, 2,3,4-tri-O-
benzyl-6-O-methylsulfonylethoxymethyl--D-glucopyranoside 8 was subjected to 
conditions that normally effectuate -elimination. As summarized in Table 1, the Msem 
group is reasonably stable under basic conditions, and significantly more robust than its 
carbonate counterpart. The use of 2 equivalents 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
required 3h at elevated temperature (100 ºC) to completely remove the Msem group (Table 
1, entry 1). Addition of thiophenol as the scavenger retarded the time for cleavage 
considerably (Table 1, entry 2). The deblocking of the Msem group with the aid of 5 
equivalents of potassium tert-butoxide (KOtBu)  reached completion after 24 hours at 40 ºC 
(Table 1, entry 3). Gratifyingly, treatment of 8 with a catalytic amount of tetrabutyl 
ammonium fluoride (TBAF, 0.1 equivalents) led to the cleavage of the Msem group after 
24 hours at room temperature (Table 1, Entry 4). 
The feasibility of the Msem group as hydroxyl protecting group in oligosaccharide 
synthesis was investigated in the context of the construction of 1,2-cis-mannosidic bonds.   
In a seminal study of the group of Crich, it was discovered that glycosylations using 4,6-O-




of -mannosides with high stereoselectivity.15 Although the presence of 4,6-O-benzylidene 
acetal in several types of mannose donors proved to be effective to obtain -selective 
mannosylations, the nature of protective groups at the 3-OH position has also been shown 
to have a major effect on the /-ratio. For instance, it has become clear that the bulky 3-O-
tert-butyldimethylsilyl ether reduces the -selectivity by a steric interaction with the C-2 
hydroxyl protecting group,21 while 3-O-carboxylate esters essentially give pure 
mannosides, presumably via neighboring group participation.16 In this respect, the 
comparison of the here presented Msem group and the methylsulfonylethoxycarbonyl 
(Msc) group, both relatively small protecting groups and having the methylsulfonylethoxy 
moiety in common, is relevant. 
 
Table 1: Conditions for cleavage of the Msem group.  
 
 
Entry Conditions Conc. Temperature Time Yield 
1 DBU, DMF    2 eq 100º C       3h 91 
2 DBU, DMF, PhSH    2 eq   100º C      20h 93 
3 KOtBu, MeOH   5 eq    40º C      24h 89 
4  TBAF, THF  0.1 eq  RT  24h 94  
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In Chapter 2, it was described that the Msc carbonate is an orthogonally removable 
hydroxyl protecting group that efficiently provides anchimeric assistance during 
glycosylation reactions. It was shown that the Ph2SO /Tf2O mediated condensation of 3-O-
Msc donor 17a with acceptor 18 led to the predominant formation of the -
mannopyranoside linkage (Scheme 2). This result underlines that not only carboxylate 
esters but also carbonates such as the Msc-group at the C-3 hydroxyl of benzylidene 
mannosides direct mannosylation reactions towards the  products. To investigate the 
effect of the Msem ether instead of the Msc carbonate in a similar condensation, the 
synthesis of donor 17b was required (Scheme 2). Guided by ample literature precedent 
describing the use of tin ketals to introduce alkoxymethyl ethers, the regioselective 
alkylation of the 2,3-O-dibutylstannylidene of diol 15 with methylsulfonylethoxymethyl 
chloride 5 was undertaken. A mixture of 15 and dibutyltin oxide in toluene was heated for 2 
hours and after evaporation of the solvents, the crude product was treated with Msem-Cl 5  
 




















17a R = Msc





















19a R = Msc = >10:1











Reagents and conditions; f) TTBP, Ph2SO, Tf2O, DCM, -78 º C-RT, 2h; h) i- Bu2SnO, tol,  Reflux, 2h: ii- Msem-
Cl, CsF, TBABr, tol, 18 h, 81% ; i) NaH, DMF, 0 ºC, 15 min, 75%. 
 
in the presence of cesium fluoride and tetrabutylammonium bromide (TBABr). 3-O-Msem 




Ph2SO /Tf2O mediated condensation of 3-O-Msem donor 17b with acceptor 18 led to the 
predominant formation of a cis-mannopyranoside linkage (: (Scheme 2). The 
outcome of this glycosylation indicates that the Msem group does not act as a remote 
neighboring group and is sterically minimally intrusive, allowing the selective formation of 
the -mannoside bond in line with a comparable study of Codée et al. on the use of 
[triisopropyl)silyloxy]methyl group.16a 
 
The glycosylating properties of 3-O-Msem protected mannopyranose 17b were 
further examined in a set of Ph2SO /Tf2O-mediated condensation with a range of different 
nucleophiles (Table 2). Surprisingly, the coupling with primary acceptor 7 furnished the - 
and -isomers of disaccharide 20 in almost equal amounts (Table 2, Entry 1, 20). 
Secondary alcohol 9, which has previously been shown to be a relatively challenging 
substrate to -mannosylate, reacted with donor 17b to provide the -disaccharide in a/3 
ratio (Table 2, Entry 2, 21). When glucosamine acceptor 22, also a notoriously difficult 
substrate for the -mannosylation reaction, was employed, equal amounts of  and  
products were obtained (Table 2, Entry 3, 23).Condensation of donor 17b with methyl 4,6-
O-benzylidine-3-O-benzyl--D-mannopyranoside 24, on the other hand gave disaccharide 
25 with good -selectivity again (= 1:5, Table 1, Entry 4, 25). The same result, in terms 
of stereoselectivity and yield was obtained earlier (see Scheme 2) with the corresponding 2-
O-benzyl acceptor 18. Executing this reaction for a longer period at  -78 ºC led to the same 
selectivity and a slight increase in yield (Table 2, Entry 5,19b). Finally, the use of 1,2:5,6-
di-O-isopropylidene-3-O--D-glucofuranose 26 led to the formation disaccharide 27 in 1:10 
 ratio (Table 2, Entry 6, 27). These experiments clearly show that the glycosylations of 
17b can proceed with good to moderate 1,2-cis selectivity. However, the reactivity of the 
hydroxyl function in the acceptor glycoside also plays an important role. Although poor 
selectivities for acceptors 9 and 22 have been reported before,22,23 the outcome of the 
mannosylation of primary alcohol 7 stands in sharp contrast to the -slective 
mannosylations commonly reported for this acceptor.14,15a This result highlights how minor 
changes in a glycosylation system can result in major changes in the outcome of the 
reaction, and for this unexpected result there is currently no adequate explanation.  
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Table 2: Glycosylation of donor 17b with various acceptors.f 
 
 
Entry Acceptor Time Temp. Yield 
1 
 
2h -78 oC to -72 oC  74 4:5 
2 
 
4h -78 oC to 0 oC  72 1:3 
3 
 
4h -78 oC to 0 oC  70 1:1 












2h -78 oC to -60 oC  75 1:10 




Finally the assembly of -1,3-mannotriose 31 was undertaken as depicted in 
Scheme 3. To this end, the - and -anomers of compound 19b were separated by silicagel 
column chromatography and the Msem group in -dimer 19b was cleaved by treatment 
with the TBAF to give disaccharide 28 in 60% yield (Scheme 3). Apart from target 28, a 
substantial amount of side product 29 was isolated, the formation of which can be explained 
by Michael addition of the released (methylsulfonyl)ethene to the free C-3 hydroxyl in 28. 
Notably this side reaction has not been observed for any other Msem substrate investigated 
so far. To circumvent the formation of side product 29, piperidine was added to the reaction 
mixture to scavenge the released vinylsulfone. In this case disaccharide 28 was obtained in 
88% yield. Elongation of 28 by preactivation of 2 equivalents of thioglycoside 17b with 
Ph2SO/Tf2O in the presence of an excess of TTBP furnished trisaccharide 30  in 83% yield, 
as an anomeric mixture (: = 1:5). Also in this case, the - and -anomers could be 
separated by silica gel chromatography. Anomerically pure 30 was then deprotected in two 
steps. First, the Msem group in 30 was removed by treatment with TBAF in the presence of 
piperidine and subsequent hydrogenolysis of the remaining benzylidene and benzyl groups 
using palladium hydroxide on charcoal and hydrogen gas led to the isolation of 




The methylsulfonylethoxymethyl (Msem) group has been introduced as a new 
hydroxyl protecting group that meets the requirements for productive oligosaccharide 
synthesis. It can be introduced at primary and secondary hydroxyl functions of O-
glycosides with thiomethyl ether reagent 4 and a thiophilic activator.  For installation of the 
Msem-group at the hydroxyl functions of thioglycosides, the conversion of the hydroxyl 
functions into dibutylstannylidene acetals followed by reaction with Msem-Cl 5 is the 
method of choice. The methylsulfonylethoxymethyl ether is sterically unbiased, does not 
provide remote neighboring group participation and is easily removed by a catalytic amount 
of TBAF in the presence of piperidine as scavenger. The usefulness of the Msem group is 
illustrated by the synthesis of an all cis-linked 1,3-O-mannotrioside. 
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Reagents and conditions; f) TTBP, Ph2SO, Tf2O, DCM, -78 º C-RT, 2h; j) TBAF, piperdine, THF, 24 h; k) 




General: Dichloromethane was refluxed with P2O5 and distilled before use. Trifluoromethanesulfonic anhydride 
was distilled from P2O5. Traces of water in donor and acceptor glycosides, diphenylsulfoxide and TTBP were 
removed by co-evaporation with toluene. Molecular sieves 3Å were flame dried before use. All other chemicals 
(Acros, Fluka, Merck, Fluorous Technologies Inc.) were used as received. Column chromatography was 
performed on Screening Devices silica gel 60 (0.040-0.063 mm). Size exclusion chromatography was performed 
on Sephadex LH20 (eluent MeOH/DCM = 1/1). Gel filtration was performed on Sephadex HW40 (0.15 M 
Et3NHOAc in H2O). TLC analysis was conducted on DC-alufolien (Merck, kiesel gel 60, F245). Compounds were 
visualized by UV absorption (245 nm), by spraying with an aqueous solution of KMnO4 (20%) and K2CO3 (10%), 
by spraying with 20% H2SO4 in ethanol or by spraying with a solution of (NH4)6Mo7O24·4H2O (25g/L) and 
(NH4)4Ce(SO4)4·2H2O (10g/L) in 10% H2SO4 (aq) followed by charring at 150 ºC. IR spectra were recorded on a 




polarimeter. 1H and 13C NMR spectra were recorded with a Bruker AV 400 (400 MHz and 100 MHz respectively), 
AV 500 (500 MHz and 125 MHz respectively) or DMX 600 (600 MHz and 150 MHz respectively). NMR spectra 
were recorded in CDCl3 unless stated otherwise. Chemical shift are relative to tetramethylsilane and are given in 
ppm. Coupling constants are given in Hz. All given 13C spectra are proton decoupled. High resolution mass spectra 
were recorded on a LTQ-Orbitrap (thermo electron). 
 
General method for glycosylations using Ph2SO/Tf2O: A solution of 1-thio--D-mannopyranoside (donor), 
diphenylsulfoxide (1.3 eq), and tri-tert-butylpyrimidine (3 eq) in DCM (0.05 M) was stirred over activated MS3Å 
for 30 minutes. The mixture was brought to -78 oC before triflic acid anhydride (1.3 eq) was added.  The mixture 
was allowed to warm to -60 oC in 15 minutes followed by the addition of the acceptor (1.5 eq). The reaction 
mixture was stirred at the temperature described in table 2. The reaction mixture was quenched with triethylamine 
(5 eq), filtered, diluted with DCM and washed with water. The aqueous layer was extracted with DCM thrice, the 
combined organic layers were dried over MgSO4, filtered, concentrated and purified by size exclusion and silica 
gel column chromatography. 
 
((Methylsulfonylethoxy)methyl)methylsulfane (4): To a solution of 
methylsulfonylethanol 3 (6.55 g, 52.8 mmol)  in DMSO (15 ml, 211 mmol, 4 eq) was 
added acetic acid (6 ml, 106 mmol, 2 eq) and acetic anhydride (9.9 ml, 106 mmol, 2 eq). The reaction mixture was 
stirred for 48 hours. The mixture was neutralized by careful addition of NaHCO3 (s), extracted using a large excess 
of EtOAc, dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to afford 4 
(5.54 g, 30.0 mmol, 57% ) as yellow a oil. TLC (75% EtOAc in toluene): Rf = 0.75; IR (neat, cm
-1): 730, 1129, 
1286; 1H NMR (400 MHz, (CDCl3) = 2.15 (s, 3H, -CH2SCH3), 2.99 (s, 3H, CH3SO2-), 3.31 (t, 2H, J = 5.2 Hz,  
MeSO2CH2CH2OCH2SCH3), 3.95 (t, 2H, J = 5.6 Hz, MeSO2CH2CH2OCH2SCH3), 4.68 (s, 2H, 
MeSO2(CH2)2OCH2SCH3); 
13C NMR (100 MHz, (CDCl3) = 13.3  (-CH2SCH3), 42.0 (CH3SO2-), 53.9 
(MeSO2CH2CH2OCH2SCH3), 60.9 (MeSO2CH2CH2OCH2SCH3), 74.7 (MeSO2(CH2)2OCH2SCH3); HRMS 
[M+NH4]
+ calculated for C5H16O3S2N 202.05661, found  202.05662.  
 
Methylsulfonylethoxymethyl chloride (5): To a solution of 
((methylsulofnylethoxy)methyl)methylsulfane 4 (1.39 g, 7.55 mmol)  in DCM (25 ml, 0.3 
M) was added sulfuryl chloride (0.6 ml, 7.6 mmol, 1 eq) and the mixture was stirred for 2 hours. Next the solvents 
were removed in vacuo to give 5; IR (neat, cm-1): 643, 944, 1112, 1288; 1H NMR (400 MHz, (CDCl3) = 2.92 (s, 
3H, CH3SO2-), 3.27 (t, 2H, J = 5.2 Hz,  MeSO2CH2CH2OCH2Cl), 4.07 (t, 2H, J = 5.6 Hz, 
MeSO2CH2CH2OCH2Cl), 5.46 (s, 2H, MeSO2(CH2)2OCH2Cl); 
13C NMR (100 MHz, (CDCl3) = 42.5 (CH3SO2-), 
53.9 (MeSO2CH2CH2OCH2Cl), 63.6 (MeSO2CH2CH2OCH2Cl), 81.9 (MeSO2(CH2)2OCH2Cl); HRMS [M+NH4]
+ 
calculated for C4H13ClO3S2N 190.02992, found  190.02882. 
 
Methylsulfonylethoxymethylacetate (6): To a solution of 
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M) was added N-iodosuccinimide (1.52 g, 6.83 mmol, 1.2 eq). The mixture was cooled to -20 oC followed by the 
addition of acetic acid (0.65 ml, 11.4 mmol, 2 eq). The mixture was allowed to warm to rt and was stirred for 2 
hours. The reaction mixture was quenched with triethylamine (5eq), filtered, diluted with DCM and washed with 
Na2S2O3 (aq). The aqueous layer was extracted with DCM thrice and the combined organic layers were dried over 
MgSO4, filtered, concentrated and purified by silica gel column chromatography to afford 6 (1.06 g, 5.41 mmol, 
95% ). TLC (66% EtOAc in PE): Rf = 0.6; IR (neat, cm
-1): 489, 961, 1124, 1285, 1740; 1H NMR (400 MHz, 
(CDCl3) = 2.12 (s, 3H, CH3 -OAc), 2.98 (s, 3H, CH3SO2-), 3.26 (t, 2H, J = 5.2 Hz, MeSO2CH2CH2OCH2OAc), 
4.09 (t, 2H, J = 5.6 Hz, MeSO2CH2CH2OCH2OAc), 5.27 (s, 2H, MeSO2(CH2)2OCH2OAc); 
13C NMR (100 MHz, 
(CDCl3) = 20.7 (CH3 OAc), 42.8 (CH3 CH3SO2-), 54.7 (CH2 MeSO2CH2CH2OCH2OAc), 63.5 (CH2 
MeSO2CH2CH2OCH2OAc), 88.0 (CH2 MeSO2(CH2)2OCH2OAc); HRMS [M+Na]
+ calculated for C6H12O5S1Na 




Method I: A solution of methyl 2,3,4-tri-O-benzyl--D-glucopyranoside 7 (0.525 g, 1.14 
mmol) and ((methylsulfonylethoxy)methyl)methylsulfane 4 (0.314 g, 1.70 mmol, 1.5 eq) in DCM (23 ml, 0.05 M) 
was stirred over activated MS3Å for 30 minutes before N-iodosuccinimide (0.304 g, 1.36 mmol, 1.2 eq) was 
added. The mixture was cooled to -20 oC followed by the addition of trimethylsilyltrifluoromethanesulfonate (10% 
in DCM, 0.41 ml, 0.23 mmol, 0.2 eq). The reaction mixture was stirred for 1.5 hours. The reaction mixture was 
quenched with triethylamine (5eq), filtered, diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer 
was extracted with DCM thrice, the combined organic layers were dried over MgSO4, filtered, concentrated and 
purified by silica gel column chromatography to get 8 (0.570 g, 0.949 mmol, 84%). 
Method II: A solution of ((methylsulfonylethoxy)methyl)methylsulfane 4 (0.058 g, 0.31 mmol, 1.5 eq), diphenyl 
sulfoxide (0.083 g, 0.41 mmol, 1.3 eq), and tri-tert-butylpyrimidine (0.234 g, 0.942 mmol, 3 eq) in DCM (6.3 ml, 
0.05 M) was stirred over activated MS3Å for 30 minutes. The mixture was brought to -60 oC before triflic acid 
anhydride (69 μl, 0.41 mmol, 1.3 eq) was added.  The mixture was allowed to warm to -40 oC in 15 minutes 
followed by the addition of methyl 2,3,4-tri-O-benzyl--D-glucopyranoside 7 (0.097 g, 0.21 mmol, 1 eq). The 
reaction mixture was stirred for 1 hour. The reaction mixture was quenched with triethylamine (5 eq), filtered, 
diluted with DCM and washed with water. The aqueous layer was extracted with DCM thrice, the combined 
organic layers were dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to 
afford 8 (0.099 g, 0.165 mmol, 79%). 
Method III: A solution of  methyl 2,3,4-tri-O-benzyl--D-glucopyranoside 7 (0.102 g, 0.22 mmol) and 
((methylsulfonylethoxy)methyl)methylsulfane 4 (0.061 g, 0.33 mmol, 1.5 eq) in DCM (4.5 ml, 0.05 M) was stirred 
over activated MS3Å for 30 minutes before iodonium di-sym-collidine perchlorate (IDCP, 0.412 g, 0.88 mmol, 8 
eq) was added in the dark. The reaction mixture was stirred in the dark for 24 hours. The reaction mixture was 
quenched with NH4Cl (aq), filtered, diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer was 









over MgSO4, filtered, concentrated and purified by silica gel column chromatography to get 8 (0.070 g, 0.12 
mmol, 63%). 
TLC (50% EtOAc in PE): Rf = 0.4; []D22: +43.0º  (c = 1.0, DCM); IR (neat, cm-1): 696, 1026, 1717; 1H NMR (400 
MHz, CDCl3) = 2.91 (s, 3H, CH3 Msem), 3.15 (t, 2H, J = 5.2 Hz, MeSO2CH2CH2OCH2-), 3.38 (s, 3H, OMe), 
3.50-3.55 (m, 2H, H-2 and H-4), 3.73-3.77 (m, 3H, H-5 and 2xH-6), 3.88-4.03 (m, 3H, H-3 and 
MeSO2CH2CH2OCH2-), 4.57-4.63 (m, 3H, H-1, MeSO2(CH2)2OCHH- and CHH Bn), 4.65-4.70 (m, 2H, 
MeSO2(CH2)2OCHH- and CHH Bn), 4.78-4.82 (m, 2H, 2xCHH Bn), 4.92 (d, 1H, J = 11.2 Hz, CHH Bn), 4.99 (d, 
1H, J = 10.8 Hz, CHH Bn), 7.26-7.37 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 42.8 (CH3 Msem), 55.0 
(MeSO2CH2CH2OCH2-), 55.2 (CH3 OMe), 61.8 (MeSO2CH2CH2OCH2-), 66.8 (C-6), 69.7 (C-5), 73.3 (CH2 Bn), 
74.9 (CH2 Bn), 75.7 (CH2 Bn),  77.5, 79.8 (C-2 and C-4), 82.0 (C-3), 95.8 (MeSO2(CH2)2OCH2-), 98.1 (C-1), 
127.6-128.4 (CH arom), 138.0 (Cq Bn), 138.2 (Cq Bn), 138.6 (Cq Bn); HRMS [M+Na]
+ calculated for 
C32H40O9S1Na 623.22852, found 623.22834.  
 
Methyl 2,3,4-tri-O-benzyl--D-glucopyranoside (7) (Cleavage of Msem from 8): 
Method I: To a solution of 8 (24 mg, 40 μmol) in DMF (0.8 ml, 0.05 M) was added DBU 
(1 M in DMF, 80 μl, 80 μmol, 2 eq) and the reaction mixture was heated at 100 ºC for 3 
hours. The reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 
and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by silica gel column 
chromatography to afford methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 7 (17 mg, 36 μmol, 91%). 
Method II: To a solution of 8 (35 mg, 58 μmol) in DMF (1.2 ml, 0.05 M) was added thiophenol (0.2 M in DMF, 
0.3 ml, 64 μmol, 1.1 eq) and DBU (1 M in DMF, 116 μl, 116 μmol, 2 eq) and the reaction mixture was heated at 
100 ºC for 20 hours. The reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with 
NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by 
silica gel column chromatography to afford methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 7 (25 mg, 54 μmol, 
93%). 
Method III: To a solution of 8 (24 mg, 40 μmol) in MeOH (0.8 ml, 0.05 M) was added KOtBu (23 mg, 200 μmol, 
5 eq) and the reaction mixture was heated at 40 ºC for 24 hours. The reaction mixture was neutralized with NH4Cl 
(aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and concentrated. 
The crude product was purified by silica gel column chromatography to afford methyl 2,3,6-tri-O-benzyl--D-
glucopyranoside 7 (16 mg, 35 μmol, 89%). 
Method IV: To a solution of 8 (34 mg, 57 μmol) in THF (1.1 ml, 0.05 M) was added TBAF (0.1 M in DMF, 57 μl, 
5.7 μmol, 0.1 eq) and the reaction mixture was stirred for 24 hours. The reaction mixture was neutralized with 
NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to afford methyl 2,3,6-tri-O-
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Method I: A solution of  methyl 2,3,6-tri-O-benzyl-4-O-methylthiomethyl--D-glucopyranoside 9 (0.160 g, 0.31 
mmol) and methylsulfonylethanol (0.095 g, 0.77 mmol, 2.5 eq) in DCM (3 ml, 0.1 M) was stirred over activated 
MS3Å for 30 minutes before N-iodosuccinimide (0.102 g, 0.48 mmol, 1.5 eq) was added. The mixture was cooled 
to -20o C followed by the addition of triflic acid (1% in DCM, 0.4 ml, 0.045 mmol, 0.14 eq). The mixture was 
allowed to warm to room temperature. The reaction mixture was quenched with triethylamine (5 eq), filtered, 
diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer was extracted with DCM thrice, the combined 
organic layers were dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to 
provide 10 (0.062 g, 0.10 mmol, 34%) and side product 11 (0.029 g, .08 mmol, 25%). 
Method II: A solution of  methyl 2,3,6-tri-O-benzyl-4-O-methylthiomethyl--D-glucopyranoside 9 (0.200 g, 
0.381 mmol) and methylsulfonylethanol (0.118 g, 0.95 mmol, 2.5 eq) in DCM (7.6 ml, 0.1 M) was stirred over 
activated MS3Å for 30 minutes before iodonium di-sym-collidine perchlorate (IDCP, 0.712 g, 1.524 mmol, 4eq) 
was added in dark. The mixture was stirred in the dark for 24 hours. The reaction mixture was quenched with 
NH4Cl (aq), filtered, diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer was extracted with DCM 
thrice, the combined organic layers were washed with NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, 
filtered, concentrated and purified by silica gel column chromatography to provide 10 (0.146 g, 0.24 mmol, 64%). 
and side product 11 (0.024 g, .06 mmol, 16%). 
Method III: A solution of methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 (0.553 g, 1.2 mmol) and 
((methylsulfonylethoxy)methyl)methylsulfane 4 (0.330 g, 1.8 mmol, 1.5 eq) in DCM (24 ml, 0.05 M) was stirred 
over activated MS3Å for 30 minutes before N-iodosuccinimide (0.320 g, 1.435 mmol, 1.2 eq) was added. The 
mixture was cooled to -20 oC followed by the addition of trimethylsilyltrifluoromethanesulfonate (10% in DCM, 
0.43 ml, 0.239 mmol, 0.2 eq). The mixture was stirred for 2 hours. The reaction mixture was quenched with 
triethylamine (5 eq), filtered, diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer was extracted 
with DCM thrice, the combined organic layers were dried over MgSO4, filtered, concentrated and purified by 
silica gel column chromatography to get 10 (0.530 g, 0.74 mmol, 70%). 
TLC (50% EtOAc in PE): Rf = 0.4; []D22: +70.4º  (c = 1.0, DCM); IR (neat, cm-1): 524, 1027, 1311; 1H NMR (400 
MHz, CDCl3) = 2.75 (s, 3H, CH3 Msem), 2.78-2.90 (m, 2H, MeSO2CH2CH2OCH2-), 3.39 (s, 3H, OMe), 3.54 
(dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 3.60-3.67 (m, 3H, H-4 and 2xH-6), 3.71 (m, 1H, H-5), 3.75 (m, 2H, 
MeSO2CH2CH2OCH2-), 3.88 (t, 1H, J = 9.6 Hz, H-3), 4.50 (d, 1H, J = 12.0 Hz, CHH Bn), 4.59-4.68 (m, 5H, H-1, 
MeSO2(CH2)2OCHH- and 3xCHH Bn), 4.73-4.78 (m, 2H, MeSO2(CH2)2OCHH- and CHH Bn), 5.02 (d, 1H, J = 
10.8 Hz, CHH Bn), 7.23-7.35 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 42.6 (CH3 Msem), 54.6 
(MeSO2CH2CH2OCH2-), 55.1 (CH3 OMe), 62.3 (MeSO2CH2CH2OCH2-), 68.4 (C-6), 69.6 (C-5), 72.9 (CH2 Bn), 
73.2 (CH2 Bn), 75.1 (C-4), 75.3 (CH2 Bn),  79.8 (C-2), 81.0 (C-3), 96.2 (MeSO2(CH2)2OCH2-), 97.6 (C-1), 127.5-
128.3 (CH arom), 137.7 (Cq Bn), 138.3 (Cq Bn); HRMS [M+Na]




Methyl 2,3-di-O-benzyl-4,6-O-methylidine--D-glucopyranoside (11): A solution of 









M) was brought to -30 oC before the addition of methylsulfonylethoxymethylacetate 6 (0.099 g, 51 mmol, 2 eq) 
followed by the addition of tin tetrachloride (45 μl, 380 mmol, 1.5 eq). The TLC analysis showed that compound 
10 started to appear after 15 minutes while starting material was still present in addition to a side product. On 
continuing stirring, the amount of side product increased with the consumption of starting material and compound 
10. After 20 hours all the starting material is gone and the compound 11 (0.062 g, 16 mmol, 63%) is the only 
product; TLC (50% toluene in EtOAc): Rf = 0.7; []D22: +57.8º  (c = 1.0, DCM); IR (neat, cm-1): 696, 1049; 1H 
NMR (400 MHz, CDCl3) = 3.31 (t, 1H, J = 9.6 Hz, H-4), 3.38-3.44 (m, 4H, H-6 and CH3 OMe), 3.50 (dd, 1H, J 
= 3.6 Hz, J = 9.2 Hz, H-2), 3.72 (m, 1H, H-5), 3.96 (t,1H, J = 9.2 Hz, H-3), 4.11 (dd, 1H, J = 4.8 Hz, J = 10.0 Hz, 
H-6), 4.55 (d, 1H, J = 4.0 Hz, H-1), 4.60 (d, 1H, J = 6.0 Hz, CHH methylene), 4.65 (d, 1H, J = 12.0 Hz, CHH Bn), 
4.80-4.89 (m, 2H, 2xCHH Bn), 4.87 (d, 1H, J = 11.2 Hz, CHH Bn), 5.07 (d, 1H, J = 6.4 Hz, CHH methylene), 
7.24-7.35 (m, 10H, H arom); 13C NMR (100 MHz, CDCl3) = 55.3 (CH3 OMe), 62.4 (C-5), 68.8 (C-6), 73.6 (CH2 
Bn), 75.2 (CH2 Bn), 78.5 (C-3), 79.3 (C-2), 82.0 (C-4), 93.7 (CH2 methylene), 99.1 (C-1), 125.8-130.2 (CH arom), 
138.0 (Cq Bn), 138.7 (Cq Bn); HRMS [M+NH4]
+ calculated for C22H30O6N 404.20676, found  404.20671.  
 
Methyl 2,3,6-tri-O-benzyl-4-O-methylthiomethyl--D-glucopyranoside (12): 
To a solution of methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 (0.907 g, 2.1 
mmol) in DMF (4.2 ml, 0.05 M) was added methylthiomethyl chloride (0.43 ml, 
5.2 mmol, 2.5 eq). The reaction mixture was brought to 0º C before sodium hydride (60% in oil, 0.150 g, 3.75 
mmol, 1.8 eq) was added in small portions and the stirring was continued for 1 hour. The reaction mixture was 
diluted with diethyl ether and washed with NH4Cl (aq), NaHCO3 (aq) and brine, dried over MgSO4, filtered, 
concentrated and purified by silica gel chromatography to get compound 12 (0.802 g, 1.5 mmol, 73%). TLC (50% 
toluene in EtOAc): Rf = 0.8; []D22: +178.0º  (c = 0.3, DCM); IR (neat, cm-1): 530, 1049; 1H NMR (400 MHz, 
CDCl3) = 1.99 (s, 3H, CH3 MTM), 3.38 (s, 3H, CH3 OMe), 3.52 (dd, 1H, J = 3.6 Hz, J = 9.6 Hz, H-2), 3.57 (t, 
1H,  J = 10.0 Hz, H-4), 3.64-3.74 (m, 3H, H-5 and 2xH-6), 3.94 (t, 1H, J = 9.2 Hz, H-3), 4.56 (m, 2H, 2xCHH 
Bn), 4.60-4.62 (m, 2H, H-1 and CHH Bn), 4.68 (d, 1H,  J = 10.8 Hz, CHH MeSCHH-), 4.74-4.78 (m, 3H, CHH 
MeSCHH- and 2xCHH Bn), 4.97 (d, 1H,  J = 10.8 Hz, CHH Bn), 7.24-7.37 (m, 15H, H arom); 13C NMR (100 
MHz, CDCl3) = 14.7 (CH3 MTM), 55.2 (CH3 OMe), 68.8 (C-6),  69.7 (C-5), 73.3 (CH2 Bn), 73.4 (CH2 Bn), 75.6 
(CH2 Bn), 76.1 (C-4), 76.7 (CH2 MeSCH2-), 79.9 (C-2), 81.8 (C-3), 97.9 (C-1), 127.6-128.4 (CH arom), 138.0 (Cq 
Bn), 138.0 (Cq Bn), 138.5 (Cq Bn); HRMS [M+Na]
+ calculated for C30H36O6S1Na 574.21248, found 574.21196.  
 
Di-(2-(methylsulfonyl)ethoxy)methane (13): Collected as by-product during 
the preparation of the compound 8 (Method II) (14 mg, 54 μmol, 17% w.r.t to 
the compound 4 used in the reaction). TLC (50% EtOAc in PE): Rf = 0.75; IR (neat, cm
-1): 1029, 1277; 1H NMR 
(400 MHz, (CDCl3) = 3.01 (s, 6H, 2xCH3 CH3SO2-), 3.30 (t, 4H, J = 5.6 Hz, 2x CH2 ((MeSO2CH2CH2O)2CH2), 
4.02 (t, 4H, J = 5.6 Hz, 2x CH2 ((MeSO2CH2CH2O)2CH2), 4.75 (s, 2H, ((MeSO2(CH2)2O)2CH2); 
13C NMR (100 
MHz, (CDCl3) = 43.1 (2xCH3 CH3SO2-), 54.8 (2xCH2 ((MeSO2CH2CH2O)2CH2), 61.8 (2xCH2 
((MeSO2CH2CH2O)2CH2), 95.4 (CH2 ((MeSO2(CH2)2O)2CH2); HRMS [M+H]
+ calculated for C7H17O6S2 
261.04611, found 261.04626, [M+NH4]
















perfluorodecyl)sulfonylethoxymethyl--D-glucopyranoside (14): A solution of 
methyl 2,3,6-tri-O-benzyl-4-O-methylthiomethyl--D-glucopyranoside 12 (0.145 g, 
0.28 mmol) and ([1H,1H,2H,2H]-perfluorodecyl)sulfonylethanol (0.384 g, 0.70 mmol, 2.5 eq) in DCM (5.6 ml, 
0.05 M) was stirred over activated MS3Å for 30 minutes before iodonium di-sym-collidine perchlorate (IDCP, 
0.712 g, 1.52 mmol, 4 eq) was added in the dark. The mixture was stirred in the dark for 24 hours. The reaction 
mixture was quenched with NH4Cl (aq), filtered, diluted with DCM and washed with Na2S2O3 (aq). The aqueous layer 
was extracted with DCM thrice, the combined organic layers were washed with NH4Cl (aq), NaHCO3 (aq) and brine, 
dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to get 14 (0.036 g, 
0.03 mmol, 11%) and the side product 11 (0.033 g, 0.9 mmol, 31%); TLC (50% EtOAc in PE): Rf = 0.9; []D22: 
+23.2º  (c = 0.6, DCM); IR (neat, cm-1): 696, 1042; 1H NMR (400 MHz, CDCl3) = 2.54-2.69 (m, 2H, CH2 
RfCH2CH2SO2(CH2)2OCH2O-), 2.75-2.88 (m, 2H, CH2 Rf(CH2)2SO2CH2CH2OCH2O-), 3.18 (m, 2H, CH2 
RfCH2CH2SO2(CH2)2OCH2O-), 3.39 (s, 3H, OMe), 3.54-3.59 (m, 2H, H-2 and H-4), 3.62-3.66 (m, 2H, 2xH-6), 
3.69 (m, 1H, H-5), 3.74 (m, 2H, CH2 Rf(CH2)2SO2CH2CH2OCH2O-), 3.87 (t, 1H, J = 9.6 Hz, H-3), 4.50 (d, 1H, J 
= 12.0 Hz, CHH Bn), 4.60-4.67 (m, 5H, H-1, CH2 Rf(CH2)2SO2(CH2)2OCHHO- and 3xCHH Bn), 4.73 (d, 1H, J = 
6.4 Hz, Rf(CH2)2SO2(CH2)2OCHHO-), 4.75 (d, 1H, J = 12.4 Hz, CHH Bn), 5.05 (d, 1H, J = 10.4 Hz, CHH Bn), 
7.26-7.37 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 24.1 (RfCH2CH2SO2(CH2)2OCH2O-), 46.5 
(RfCH2CH2SO2(CH2)2OCH2O-), 53.7 (Rf(CH2)2SO2CH2CH2OCH2O-), 55.3 (CH3 OMe), 62.1 
(Rf(CH2)2SO2CH2CH2OCH2O-), 68.5 (C-6), 69.8 (C-5), 73.3 (CH2 Bn), 73.6 (CH2 , Bn), 75.4 (C-2 or C-4), 75.5 
(CH2 Bn),  80.1 (C-2 or C-4), 81.1 (C-3), 96.4 (Rf(CH2)2SO2(CH2)2OCH2O-), 97.9 (C-1), 127.6-128.5 (CH arom), 
137.8 (Cq Bn), 137.9 (Cq Bn), 138.6 (Cq Bn); HRMS [M+Na]




mannopyranoside (16): To a solution of phenyl 4,6-O-benzylidene-1-thio--D-
mannopyranoside (15) (3.0 g, 8.3 mmol) in toluene (55 ml, 0.15 M) was added 
dibutyltin oxide (2.18 g, 8.77 mmol, 1.05 eq) and the reaction mixture was refluxed for 2 hours. The solvents were 
evaporated and the residue was co-evaporated with toluene. The mixture was re-dissolved in toluene (55ml) 
followed by the addition of tetrabutylammonium bromide (3.23 g, 10 mmol, 1.2 eq), cesium fluoride (1.51 g, 10 
mmol, 1.2 eq) and methylsulfonylethoxymethyl chloride (1.86 g, 10.8 mmol, 1.3 eq) and stirring was continued 
for 18 hours. The reaction mixture was diluted with EtOAc, washed with NaHCO3 (aq and extracted thrice with 
EtOAc. The combined organic layers were washed with brine, dried over MgSO4, filtered, concentrated and 
purified by silica gel chromatography to get 16 (3.48 g, 6.85 mmol, 82%); TLC (66% EtOAc in PE): Rf = 0.4; 
[]D22: -225.0º  (c = 1, DCM); IR (neat, cm-1): 696, 732, 1020, 1310; 1H NMR (400 MHz, CDCl3) = 2.83 (s, 3H, 
CH3 Msem), 2.95-3.01 (m, 1H, CHH MeSO2CHHCH2OCH2-), 3.10-3.17 (m, 1H, CHH MeSO2CHHCH2OCH2-), 
3.32 (d, 1H, J = 2.8 Hz, 2-OH), 3.45 (m, 1H, H-5), 3.85-3.93 (m, 3H, H-3, H-6 and CHH MeSO2CH2CHHOCH2-), 
3.98-4.04 (m, 1H, CHH MeSO2CH2CHHOCH2-), 4.10 (t, 1H, J = 9.6 Hz, H-4),  4.29 (dd, 1H, J = 4.8 Hz, J = 10.4 















MeSO2(CH2)2CHHO-), 4.95 (s, 1H, H-1), 5.53 (s, 1H, CH benzylidene), 7.22-7.42 (m, 10H, H arom); 
13C NMR 
(100 MHz, CDCl3) = 42.6 (CH3 Msem), 54.5 (CH2 MeSO2CH2CH2OCH2-), 61.5 (CH2 MeSO2CH2CH2OCH2-), 
68.2 (C-6), 71.1 (C-5), 71.3 (C-2), 76.0 (C-3), 77.0 (C-4), 87.8 (C-1), 94.5 (CH2 MeSO2(CH2)2OCH2-), 101.6 (CH 
benzylidene), 125.9-130.9 (CH arom), 134.2 (Cq SPh), 137.1 (Cq CHPh); CH Gated NMR (100 MHz, CDCl3) 




-D-mannopyranoside (17b): To a solution of phenyl 4,6-O-benzylidene-3-
methylsulfonylethoxymethyl-1-thio--D-mannopyranoside (16) (3.3 g, 6.65 mmol) 
in DMF (33 ml, 0.2 M) was added benzyl bromide (2 ml, 17.0 mmol, 2.5 eq) and  tetrabutylammonium iodide 
(2.46 g, 6.65 mmol, 1 eq). The reaction mixture was brought to 0 ºC and sodium hydride (60%, 0.266 g, 6.65 
mmol, 1 eq) was added subsequently in small portions. The reaction mixture was allowed to warm to rt and 
stirring was continued for 2 hours. The reaction mixture was quenched with NH4Cl (aq), diluted with EtOAc, 
washed with NH4Cl (aq), NaHCO3 (aq),brine, dried over MgSO4, filtered, concentrated and purified by silica gel 
chromatography to get 17b (2.91g, 4.97 mmol, 75%); TLC (50% EtOAc in PE): Rf = 0.6; []D22: -30.2º  (c = 1, 
DCM); IR (neat, cm-1): 738, 1089, 1282; 1H NMR (400 MHz, CDCl3) = 2.76 (s, 3H, CH3 Msem), 2.83-2.89 (m, 
1H, CHH MeSO2CHHCH2OCH2-), 3.02-3.09 (m, 1H, CHH MeSO2CHHCH2OCH2-), 3.42 (m, 1H, H-5), 3.80-3.96 
(m, 4H, H-3, H-6 and CH2 MeSO2CH2CH2OCH2-), 4.16-4.20 (m, 2H, H-2 and H-4), 4.27 (dd, 1H, J = 4.8 Hz, J = 
10.4 Hz, H-6), 4.71 (d, 1H, J = 6.8 Hz, CHH MeSO2(CH2)2OCHH-), 4.79 (d, 1H, J = 6.8 Hz, CHH 
MeSO2(CH2)2OCHH-), 4.82 (d, 1H, J = 11.2 Hz, CHH Bn),  4.91 (s, 1H, H-1), 4.99 (d, 1H, J = 10.8 Hz, CHH 
Bn), 5.53 (s, 1H, CH benzylidene), 7.22-7.50 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 42.5 (CH3 
Msem), 54.4 (CH2 MeSO2CH2CH2OCH2-), 61.4 (CH2 MeSO2CH2CH2OCH2-), 68.1 (C-6), 71.4 (C-5), 75.8 (CH2 
Bn), 76.4 (C-3), 77.5, 78.7 (C-2 and C-4), 88.7 (C-1), 94.0 (CH2 MeSO2(CH2)2OCH2-), 101.4 (CH benzylidene), 
125.9-131.1 (CH arom), 134.5 (Cq SPh), 137.2, 137.5  (Cq CHPh and Cq Bn); CH Gated NMR (100 MHz, CDCl3) 




-D-mannopyranoside (19b): Disaccharide 19b was prepared from 
donor 17b (0.26 g, 0.44 mmol, 1 eq) and acceptor 18 (0.248 g, 0.67 
mmol, 1.5 eq) according to the general procedure for glycosylations as described above at -78 °C to afford 
compound 19b (0.317 g, 0.37 mmol, 84%,  = 1:5). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.66; []D22: -2.5º (c = 0.4, DCM); IR (neat, cm-1): 698, 1067; 1H NMR (400 
MHz, CDCl3) = 2.64 (s, 3H, CH3 Msem), 2.70-2.77 (m, 1H, MeSO2CHHCH2OCH2-), 2.95 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.38 (s, 3H, CH3 OMe), 3.78-3.89 (m, 8H, H-2, H-2’, H-6, H-6’, MeSO2CH2CH2OCH2- 
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H-3’, H-4’ and H-5’), 4.18-4.29 (m, 4H, H-6 or H-6’, CHH Bn and two of the H-3, H-4, H-5, H-3’, H-4’ and H-
5’), 4.42 (d, 1H, J = 12.4 Hz, CHH Bn), 4.59 (d, 1H, J = 7.2 Hz, MeSO2(CH2)2OCHH-), 4.70-4.77 (m, 4H, H-1 or 
H-1’, 2xCHH Bn and MeSO2(CH2)2OCHH-), 5.34 (s, 1H, H-1 or H-1’), 5.57 (s, 1H, CH benzylidene), 5.64 (s, 1H, 
CH benzylidene), 7.02-7.53 (m, 20H, H arom); 13C NMR (100 MHz, CDCl3) = 42.7 (CH3 Msem), 54.8 
(MeSO2CH2CH2OCH2-), 55.0 (CH3 OMe), 61.6 (MeSO2CH2CH2OCH2-), 63.9, 64.8, 72.9, 73.9, 76.3, 77.7, 78.1, 
79.2  (C-2, C-3, C-4, C-5, C-2’, C-3’, C-4’, and C-5’), 68.8, 68.9 (C-6 and C-6’), 72.5 (CH2 Bn), 73.2 (CH2 Bn), 
94.6 (MeSO2(CH2)2OCH2-), 99.69, 99.7(C-1 and C-1’), 101.8 (CH benzylidene), 102.2 (CH benzylidene), 125.3-
129.3 (CH arom), 137.5, 137.6, 137.6 (2xCq benzylidene and 2xCq Bn); CH Gated NMR (100 MHz, CDCl3) 
99.69 (J = 173 Hz, C-1), 99.71 (J = 177 Hz, C-1’); HRMS [M+Na]+ calculated for C45H52O14SNa 871.29700  
found 871.29542.
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.4; []D22: -68.4º (c = 1.0, DCM); IR (neat, cm-1): 750, 1088; 1H NMR (400 
MHz, CDCl3) = 2.74 (s, 3H, CH3 Msem), 2.82 (dt, 1H, J = 4.8 Hz, J = 15.2 Hz, MeSO2CHHCH2OCH2-), 3.01-
3.08 (m, 1H, MeSO2CHHCH2OCH2-), 3.14 (m, 1H, H-5’), 3.38 (CH3 OMe), 3.61 (dd, 1H, J = 3.2 Hz, J = 9.6 Hz, 
H-3’), 3.69-3.92 (m, 7H, H-2, H-2’, H-5, H-6, H-6’ and MeSO2CH2CH2OCH2-), 4.05 (t, 1H, J = 9.6 Hz, H-4’), 
4.17-4.22 (m, 2H,  H-4 and H-6’), 4.27 (dd, 1H, J = 4.4 Hz, J = 9.6 Hz, H-6), 4.33 (dd, 1H, J = 3.2 Hz, J = 10.4 
Hz, H-3), 4.47 (s, 1H, H-1’), 4.56 (d, 1H, J = 7.2 Hz, MeSO2(CH2)2OCHH-),  4.66-4.76 (m, 4H, 3xCHH Bn and 
MeSO2(CH2)2OCHH-), 4.80 (s, 1H, H-1), 4.96 (d, 1H, J = 12.0 Hz, CHH Bn), 5.46 (s, 1H, CH benzylidene), 5.63 
(s, 1H, CH benzylidene), 7.19-7.51 (m, 20H, H arom); 13C NMR (100 MHz, CDCl3) = 42.6 (CH3 Msem), 54.7 
(MeSO2CH2CH2OCH2-), 54.9 (CH3 OMe), 61.2 (MeSO2CH2CH2OCH2-), 64.0 (C-2, C-2’ or C-5), 67.6 (C-5’), 
68.5 (C-6’), 68.8 (C-6), 73.1 (CH2 Bn), 73.6 (C-3), 74.6 (CH2 Bn), 74.8 (C-3’), 75.2 (C-2, C-2’ or C-5) 76.0 (C-2, 
C-2’ or C-5), 77.4 (C-4’), 77.6(C-4), 93.9 (MeSO2(CH2)2OCH2-), 99.1 (C-1’), 99.5 (C-1), 101.6 (CH benzylidene), 
101.6 (CH bBenzylidene), 126.0-129.1 (CH arom), 137.4, 137.5, 137.8, 138.4 (2xCq benzylidene and 2xCq Bn); 
CH Gated NMR (100 MHz, CDCl3) 99.1 (J = 155 Hz, C-1’), 99.5 (J = 172 Hz, C-1); HRMS [M+Na]+ 




glucopyranoside (20): Disaccharide 20 was prepared from donor 17b 
(0.147 g, 0.25 mmol, 1 eq) and acceptor 7 (0.174 g, 0.38 mmol, 1.5 eq) 
according to the general procedure for glycosylations as described above to afford compound 20 (0.171 g, 0.18 
mmol, 74%,  = 4:5). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.65; []D22: +52.2º (c = 0.5, DCM); IR (neat, cm-1): 697, 1027; 1H NMR (400 
MHz, CDCl3) = 2.74 (s, 3H, CH3 Msem), 2.77-2.83 (m, 1H, MeSO2CHHCH2OCH2-), 2.98-3.05 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.36 (s, 3H, CH3 OMe), 3.48 (t, 1H, J = 9.2 Hz, H-4), 3.51 (dd, 1H, J = 3.6 Hz, J = 10.0 
Hz, H-2), 3.65 (dd, 1H,  J = 1.6 Hz, J = 11.2 Hz, H-6), 3.71 (m, 1H, H-5), 3.80-3.90 (m, 6H, H-6, H-2’, H-5’, H-6’ 




3.6 Hz, H-1), 4.60 (d, 1H, J = 11.2 Hz, CHH Bn), 4.68-4.72 (m, 4H, 3xCHH Bn and MeSO2(CH2)2OCHH-), 4.75-
4.82 (m, 3H, 2xCHH Bn and MeSO2(CH2)2OCHH-), 4.90 (d, 1H, J = 1.2 Hz, H-1’), 4.93 (d, 1H, J = 11.2 Hz, 
CHH Bn), 5.00 (d, 1H, J = 10.4 Hz, CHH Bn), 5.55 (s, 1H, CH benzylidene), 7.25-7.42 (m, 25H, H arom); 13C 
NMR (100 MHz, CDCl3) = 42.8 (CH3 Msem), 54.8 (MeSO2CH2CH2OCH2-), 55.2 (CH3 OMe), 61.6 
(MeSO2CH2CH2OCH2-), 64.3 (C-5), 66.2 (C-6’), 68.7 (C-6), 69.7 (C-2’or C-5’), 73.3 (CH2 Bn), 73.4 (CH2 Bn), 
73.6 (C-3 or C-4’), 74.9 (CH2 Bn), 75.9 (CH2 Bn), 76.6 (C-2’ or C-5’), 77.4 (C-4), 78.1 (C-3’), 80.0 (C-2), 82.0 
(C-3 or C-4’), 94.7 (MeSO2(CH2)2OCH2-), 98.0 (C-1), 99.2 (C-1’), 100.8 (CH benzylidene), 126.1-129.1 (CH 
arom), 137.5, 137.8, 138.0, 138.1, 138.4 (Cq benzylidene and  4xCq Bn); CH Gated NMR (100 MHz, CDCl3) 
97.9 (J = 166 Hz, C-1), 99.2 (J = 170 Hz, C-1’); HRMS [M+Na]+ calculated for C52H60O14SNa 963.35960, 
found 963.35948.
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.4; []D22: +1.5º (c = 0.5, DCM); IR (neat, cm-1): 696, 1026; 1H NMR (400 
MHz, CDCl3) = 2.73 (s, 3H, CH3 Msem), 2.79-2.85 (m, 1H, MeSO2CHHCH2OCH2-), 3.01-3.08 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.29 (m, 1H, H-5’), 3.36 (s, 3H, CH3 OMe), 3.45 (t, 1H, J = 9.6 Hz, H-4), 3.50 (dd, 1H, J 
= 3.6 Hz, J = 9.6 Hz, H-2), 3.55 (dd, 1H, J = 5.2 Hz, J = 10.4 Hz, H-6), 3.70 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz, H-
3’), 3.74-3.87 (m, 4H, H-5, H-2’, and MeSO2CH2CH2OCH2-), 3.90 (t, 1H, J = 10.0 Hz, H-6’), 4.01-4.10 (m, 2H, 
H-3 and H-4’), 4.14 (dd, 1H, J = 1.6 Hz, J = 10.4 Hz, H-6), 4.28 (dd, 1H, J = 4.8 Hz, J = 10.4 Hz, H-6), 4.31 (s, 
1H, H-1’), 4.51 (d, 1H, J = 7.2 Hz, MeSO2(CH2)2OCHHO-) 4.54-4.60  (m, 2H, H-1, CHH Bn), 4.64-4.69 (m, 2H, 
CHH Bn and MeSO2(CH2)2OCHHO-), 4.73 (d, 1H, J = 12.4 Hz, CHH Bn), 4.79 (d, 1H, J = 12.4 Hz, CHH Bn), 
4.83 (d, 1H, J = 11.2 Hz, CHH Bn), 4.87 (d, 1H, J = 11.6 Hz, CHH Bn), 4.92 (d, 1H, J = 12.0 Hz, CHH Bn), 5.01 
(d, 1H, J = 10.8 Hz, CHH Bn), 5.53 (s, 1H, CH benzylidene), 7.23-7.44 (m, 25H, H arom); 13C NMR (100 MHz, 
CDCl3) = 42.6 (CH3 Msem), 54.7 (MeSO2CH2CH2OCH2-), 55.1 (CH3 OMe), 61.2 (MeSO2CH2CH2OCH2-), 67.6 
(C-5’), 68.5 (C-6’), 68.6 (C-6), 69.6 (C-2’), 73.3 (CH2 Bn), 74.7 (CH2 Bn), 74.7 (C-3’), 74.7 (CH2 Bn), 75.1 (C-5), 
75.7 (CH2 Bn), 77.6 (C-4), 77.6 (C-4’), 79.8 (C-2), 82.0 (C-3), 93.8 (MeSO2(CH2)2OCH2-), 97.8 (C-1), 101.7 (CH 
benzylidene), 102.2 (C-1’), 126.0-129.2 (CH arom), 137.4, 138.0, 138.2, 138.3, 138.7 (Cq benzylidene and  4xCq 
Bn); CH Gated NMR (100 MHz, CDCl3) 97.8 (J = 168 Hz, C-1), 102.2 (J = 156 Hz, C-1’); HRMS [M+Na]+ 




glucopyranoside (21): Disaccharide 21 was prepared from donor 17b 
(0.117 g, 0.2 mmol, 1 eq) and acceptor 9 (0.138 g, 0.3 mmol, 1.5 eq) 
according to the general procedure for glycosylations as described above to afford compound 21 (0.135 g, 0.14 
mmol, 72%,  = 1:3). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.45; 
1H NMR (400 MHz, CDCl3) = 2.80 (m, 4H, CH3 Msem and 
MeSO2CHHCH2OCH2-), 3.00-3.13 (m, 1H, MeSO2CHHCH2OCH2-), 3.41 (s, 3H, CH3 OMe), 3.55 (m, 1H, one of 
the H-2, H-2’, H-3, H-3’, H-4, H-4’), 3.76 (m, 6H, (H-5 or H-5’), 2xH-6 and 2xH-6’ and one of the H-2, H-2’, H-
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3, H-3’, H-4, H-4’), 3.84 (m, 4H,  (H-5 or H-5’) and MeSO2CH2CH2OCH2- and one of the H-2, H-2’, H-3, H-3’, 
H-4, H-4’), 3.98 (m, 2H, two of the H-2, H-2’, H-3, H-3’, H-4, H-4’), 4.09 (m, 1H, one of the H-2, H-2’, H-3, H-
3’, H-4, H-4’), 4.20 (d, 1H, J = 12.0, CHH Bn), 4.25 (d, 1H, J = 12.0, CHH Bn), 4.68  (m, 8H, H-1, 5xCHH Bn 
and MeSO2(CH2)2OCH2-),  5.17 (d, 1H, J = 12.0 Hz, CHH Bn), 5.41 (s, 1H, H-1’), 5.54 (s, 1H, CH benzylidene), 
7.23-7.43 (m, 25H, H arom); 13C NMR (100 MHz, CDCl3) = 42.7 (CH3 Msem), 54.8 (MeSO2CH2CH2OCH2-), 
55.4 (CH3 OMe), 61.5 (MeSO2CH2CH2OCH2-), 65.1 (C-5 or C-4), 68.6, 69.1 (C-6 and C-6’), 69.6 (C-2’ or C5’), 
73.0 (CH2 Bn), 73.1 (CH2 Bn), 73.4 (C-3 or C-4’), 73.6 (CH2 Bn), 74.8 (CH2 Bn), 76.2 (C-4 or C-5), 77.5 (C-2’ or 
C-5’), 77.8 (C-3’), 79.9 (C-2), 81.6 (C-3 or C-4’), 94.4 (MeSO2(CH2)2OCH2-), 97.7 (C-1), 100.5 (C-1’), 101.8 
(CH benzylidene), 126.0-129.1 (CH arom), 137.5, 138.0, 138.3, 138.3, 139.4 (Cq benzylidene and  4xCq Bn); 
HRMS [M+Na]+ calculated for C52H60O14SNa 963.35960, found 963.36029.
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.35; []D22: +7.2º (c = 0.5, DCM); IR (neat, cm-1): 696, 1026; 1H NMR (400 
MHz, CDCl3) = 2.76 (s, 3H, CH3 Msem), 2.80-2.83 (m, 1H, MeSO2CHHCH2OCH2-), 3.05-3.13 (m, 2H, H-5’ 
and MeSO2CHHCH2OCH2-), 3.41 (s, 3H, CH3 OMe), 3.48-3.58 (m, 3H, H-2, H-3 and H-6’), 3.61-3.68 (m, 3H, H-
5, H-6 and H-6), 3.75-3.83 (m, 3H, H-2’ and MeSO2CH2CH2OCH2-), 3.87 (t, 1H, J = 9.2 Hz, H-3’), 3.94-4.02 (m, 
2H, H-4 and H-4’), 4.09 (dd, 1H, J = 5.2 Hz, J = 10.8 Hz, H-6’), 4.46 (d, 1H, J = 12.0, CHH Bn), 4.53-4.57  (m, 
2H, H-1’ and MeSO2(CH2)2OCHH-), 4.60-4.85 (m, 8H, H-1 and 6xCHH Bn and MeSO2(CH2)2OCHH-), 5.05 (d, 
1H, J = 10.8 Hz, CHH Bn), 5.46 (s, 1H, CH benzylidene), 7.23-7.43 (m, 25H, H arom); 13C NMR (100 MHz, 
CDCl3) = 42.8 (CH3 Msem), 54.6 (MeSO2CH2CH2OCH2-), 55.4 (CH3 OMe), 61.1 (MeSO2CH2CH2OCH2-), 67.3 
(C-5’), 68.5, 68.6 (C-6 and C-6’), 69.7 (C-5), 73.4 (CH2 Bn), 73.6 (CH2 Bn), 75.0 (C-3), 75.1 (CH2 Bn), 75.3 (CH2 
Bn), 76.7 (C-2’), 77.4 (C-4 or C-4’), 77.9 (C-4 or C-4’), 79.0 (C-2), 80.3 (C-3’), 94.0 (MeSO2(CH2)2OCH2-), 98.4 
(C-1), 101.4 (C-1’), 101.6 (CH Benzylidene), 126.1-129.2 (CH arom), 137.5, 138.0, 138.3, 138.3, 139.4 (Cq 
Benzylidene and  4xCq Bn); CH Gated NMR (100 MHz, CDCl3) 98.4 (J = 170 Hz, C-1), 101.4 (J = 156 Hz, C-




D-mannopyranosyl)--D-glucopyranoside (23): was prepared from 
donor 17b (0.142 g, 0.24 mmol, 1 eq) and acceptor 22 ( 0.168 g, 0.36 
mmol, 1.5 eq) according to the general procedure for glycosylations as described above to afford compound 23 
(0.177 g, 0.19 mmol, 78%,  = 1:1). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.5; []D22: +58.4º (c = 0.5, DCM); IR (neat, cm-1): 733, 1311, 1717; 1H NMR 
(400 MHz, CDCl3) = 2.78-2.85 (m, 4H, CH3 Msem and  MeSO2CHHCH2OCH2-), 3.03-3.10 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.37 (s, 3H, CH3 OMe), 3.70-3.83 (m, 6H, H-2, H-4, H-5, H-6, H-6’ and (H-6 or H-6’)), 
3.84-3.89 (m, 3H, H-5’ and MeSO2CH2CH2OCH2-), 3.95 (t, 1H, J = 9.2 Hz, H-4’), 4.01 (dd, 1H,  J = 2.8 Hz, J = 
10.0 Hz, H-3’), 4.08-4.15 (m, 3H, H-3, H-2’ and (H-6 or H-6’)), 4.21-4.32 (m, 2H, 2xCHH Bn), 4.55-4.78 (m, 7H, 




(s, 1H, H-1), 5.55 (s, 1H, CH benzylidene), 7.12-7.54 (m, 25H, H arom); 13C NMR (100 MHz, CDCl3) = 42.8 
(CH3 Msem), 54.4 (C-2’ or C-3), 54.8 (MeSO2CH2CH2OCH2-), 55.3 (CH3 OMe), 61.6 (MeSO2CH2CH2OCH2-), 
65.3 (C-5’), 67.0 (CH2 Cbz), 68.6, 69.2 (C-6 and C-6’), 70.5 (C-2, C-5 or C-4’), 73.0 (CH2 Bn), 73.3 (C-3’), 73.6 
(CH2 Bn), 73.8 (CH2 Bn), 76.0 (C-4), 77.4 (C-2, C-5 or C-4’), 78.0 (C-2’ or C-3), 81.1 (C-2, C-5 or C-4’), 94.5 
(MeSO2(CH2)2OCH2-), 99.0 (C-1), 100.4 (C-1’), 101.8 (CH benzylidene), 126.2-129.2 (CH arom), 137.6, 137.9, 
137.9 (Cq benzylidene and  2xCq Bn), 155.8 (C=O Cbz); CH Gated NMR (100 MHz, CDCl3) 99.0 (J = 169 Hz, 
C-1), 100.4 (J = 174 Hz, C-1’); HRMS [M+H]+ calculated for C53H62NO15S 984.38347, found 984.38438, 
[M+Na]+ calculated for C53H61NO15SNa 1006.36541, found 1006.36591. 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.35 []D22: +16.4º (c = 0.5, DCM); IR (neat, cm-1): 522, 1028, 1717; 1H 
NMR (400 MHz, CDCl3) = 2.76 (s, 3H, CH3 Msem), 2.78-2.85 (m, 1H, MeSO2CHHCH2OCH2-), 3.06-3.15 (m, 
2H, MeSO2CHHCH2OCH2- and H-5’), 3.36 (s, 3H, CH3 OMe), 3.46 (t, 1H, J = 10.0 Hz, H-6’), 3.53 (t, 1H, J = 
9.6 Hz, H-4), 3.59 (dd, 1H, J = 2.8 Hz, J = 10.0 Hz, H-3’), 3.65-3.68 (m, 2H, 2xH-6), 3.83 (m, 4H, H-2’, H-3 and 
MeSO2CH2CH2OCH2-), 3.95-4.03 (m, 2H, H-2 and H-4’), 4.04-4.12 (m, 2H, H-5, H-6’), 4.50-4.59 (m, 4H, H-1, 
2xCHH Bn and MeSO2(CH2)2OCHH-), 4.71-4.74 (m, 3H, H-1’ and CHH Bn and MeSO2(CH2)2OCHH-), 4.80 (m, 
2H, NH and CHH Bn), 4.87 (d, 1H, J = 12.0 Hz, CHH Bn), 5.00-5.12 (m, 3H, CHH Bn and 2xCHH Cbz), 5.45 (s, 
1H, CH benzylidene), 7.23-7.43 (m, 25H, H arom); 13C NMR (100 MHz, CDCl3) = 42.9 (CH3 Msem), 54.6 
(MeSO2CH2CH2OCH2-), 55.3 (CH3 OMe), 61.1 (MeSO2CH2CH2OCH2-), 66.8 (CH2 Cbz), 67.2 (C-5’), 68.5 (C-6 
and C-6’), 70.5 (C-3), 73.5 (CH2 Bn), 74.3 (CH2 Bn), 75.0 (C-3), 75.1 (CH2 Bn), 75.3 (CH2 Bn), 76.7 (C-2’), 77.8 
(C-4’), 77.9 (C-2 and C-5), 78.5 (C-4), 94.0 (MeSO2(CH2)2OCH2-), 98.9 (C-1), 101.6 (CH benzylidene), 101.8 (C-
1’), 126.0-129.2 (CH arom), 137.5, 138.0, 138.3, 138.3, 139.4 (Cq benzylidene and  4xCq Bn), 155.9 (C=O Cbz); 
CH Gated NMR (100 MHz, CDCl3) 98.9 (J = 173 Hz, C-1), 101.6 (J = 157 Hz, C-1’); HRMS [M+H]+ 
calculated for C53H62NO15S 984.38347, found 984.38458; [M+Na]
+ calculated for C53H61NO15SNa 1006.36541, 




mannopyranoside (25): Disaccharide 25 was prepared from donor 17b 
(0.112 g, 0.19 mmol, 1 eq) and acceptor 24 (0.107 g, 0.29 mmol, 1.5 eq) 
according to the general procedure for glycosylations as described above to 
afford compound 20 (0.117 g, 0.14 mmol, %,  = 1:5). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.6; []D22: -8.5º (c = 0.3, DCM); IR (neat, cm-1): 696, 1040, 1312; 1H NMR 
(400 MHz, CDCl3) = 2.81.2.87 (m, 4H, CH3 Msem and MeSO2CHHCH2OCH2-), 3.04-3.11 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.37 (s, 3H, CH3 OMe), 3.77-3.94 (m, 7H, H-5, H-5’, H-6, H-6’, MeSO2CH2CH2OCH2-
and one of the H-2, H-2’, H-3, H-3’, H-4, H-4’), 3.98 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz,  one of the H-2, H-2’, H-3, 
H-3’, H-4, H-4’), 4.00-4.17 (m, 4H, four of the H-2, H-2’, H-3, H-3’, H-4, H-4’), 4.27 (m, 2H, H-6 and H-6’), 4.42 
(d, 1H, J = 12.0 Hz, CHH Bn), 4.51 (d, 1H, J = 12.0 Hz, CHH Bn), 4.67-4.69 (m, 3H, H-1, CHH Bn and 
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MeSO2(CH2)2OCHH-), 4.81-4.85 (m, 2H, CHH Bn and MeSO2(CH2)2OCHH-), 5.33 (d, 1H, J = 0.8 Hz, H-1’), 
5.58 (s, 1H, CH benzylidene), 5.69 (s, 1H, CH benzylidene), 7.23-7.54 (m, 20H, H arom); 13C NMR (100 MHz, 
CDCl3) = 42.9 (CH3 Msem), 54.8 (CH3 OMe), 54.9 (MeSO2CH2CH2OCH2-), 61.5 (MeSO2CH2CH2OCH2-), 
63.9, 64.6 (C-5 and C-5’), 68.6, 68.7 (C-6 and C-6’), 72.6, 75.4, 76.3, 76.5, 78.3, 79.0 (C-2, C-2’, C-3, C-3’, C-4 
and C-4’), 73.0 (CH2 Bn), 73.7 (CH2 Bn), 94.5 (MeSO2(CH2)2OCH2-), 100.3 (C-1’), 101.1 (C-1), 101.4 (CH 
benzylidene), 101.8 (CH benzylidene), 126.0-129.2 (CH arom), 137.4, 137.5, 137.8, 138.3 (2xCq benzylidene and 
2xCq Bn); CH Gated NMR (100 MHz, CDCl3) 100.3 (J = 170 Hz, C-1’), 101.1 (J = 171 Hz, C-1); HRMS 
[M+Na]+ calculated for C45H52O14SNa 871.29700, found 871.29667.
-anomer: 
 TLC (33% Toluene in EtOAc): Rf = 0.35; []D22: -61.8º (c = 1.0, DCM); IR (neat, cm-1): 696, 1084, 1312; 1H 
NMR (400 MHz, CDCl3) = 2.77 (s, 3H, CH3 Msem), 2.84 (dt, 1H, J = 3.6 Hz, J = 16.4 Hz, 
MeSO2CHHCH2OCH2-), 3.04-3.11 (m, 1H, MeSO2CHHCH2OCH2-), 3.30-3.38 (m, 4H, CH3 OMe and H-5’), 
3.71-3.82 (m, 5H, H-3, H-5, H-6 and MeSO2CH2CH2OCH2-), 3.88 (t, 1H, J = 10.4 Hz, H-6’), 3.94-3.98 (m, 2H,  
H-3 and H-2’), 4.09-4.18 (m, 2H, H-4 and H-4’), 4.23 (m, 1H, H-2), 4.27-4.30 (m, 2H, H-6 and H-6’), 4.53 (d, 1H, 
J = 6.8 Hz, MeSO2(CH2)2OCHH-), 4.69 (s, 1H, H-1’), 4.72-4.79 (m, 4H, H-1, 2xCHH Bn and 
MeSO2(CH2)2OCHH-), 4.93 (d, 1H, J = 12.0 Hz, CHH Bn), 5.06 (d, 1H, J = 12.4 Hz, CHH Bn), 5.51 (s, 1H, CH 
benzylidene), 5.55 (s, 1H, CH benzylidene), 7.23-7.39 (m, 20H, H arom); 13C NMR (100 MHz, CDCl3) = 42.7 
(CH3 Msem), 54.7 (MeSO2CH2CH2OCH2-), 54.9 (CH3 OMe), 61.1 (MeSO2CH2CH2OCH2-), 64.0 (C-3’ or C-5), 
67.8 (C-5’), 68.5 (C-6’), 68.9 (C-6), 71.4 (CH2 Bn), 74.0 (C-3 or C-2’), 74.3 (C-3’ or C-5), 74.5 (CH2 Bn), 75.4 
(C-3 or C-2’), 75.8 (C-2), 77.5 (C-4’), 78.7 (C-4), 93.8 (MeSO2(CH2)2OCH2-), 99.5 (C-1), 101.2 (C-1’), 101.6 
(CH benzylidene), 101.6 (CH benzylidene), 126.0-129.1 (CH arom), 137.3, 137.5, 138.2, 138.8 (2xCq benzylidene 
and 2xCq Bn); CH Gated NMR (100 MHz, CDCl3) 99.5 (J = 167 Hz, C-1), 101.2 (J = 153 Hz, C-1’); HRMS 




glucofuranoside (27): Disaccharide 27 was prepared from donor 17b 
(0.147 g, 0.25 mmol, 1 eq) and acceptor 26 (0.098 g, 0.38 mmol, 1.5 eq) according to the general procedure for 
glycosylations as described above to afford compound 27 (0.139 g, 0.187 mmol, 75%,  = 1:10). 
-anomer: 
TLC (50% Toluene in EtOAc): Rf = 0.6; []D22: +50º (c = 0.5, DCM); IR (neat, cm-1): 697, 1026; 1H NMR (400 
MHz, CDCl3) = 1.33 (s, 3H, CH3 isopropylidene), 1.36 (s, 3H, CH3 isopropylidene), 1.43 (s, 3H, CH3 
isopropylidene), 1.51 (s, 3H, CH3 isopropylidene), 2.84-2.88 (m, 4H, CH3 Msem and MeSO2CHHCH2OCH2-), 
3.07-3.10 (m, 1H, MeSO2CHHCH2OCH2-), 3.79-3.92 (m, 5H, H-2’, H-5’, H-6’ and MeSO2CH2CH2OCH2-), 4.00 
(dd, 1H, J = 3.2 Hz, J = 10.0 Hz, H-3’), 4.05-4.08 (m, 2H, H-4 and H-6), 4.15-4.20 (m, 2H, H-4’ and H-6), 4.23 
(m, 1H, H-5), 4.31-4.35 (m, 2H, H-3’ and H-6), 4.57 (d, 1H, J = 3.6 Hz, H-2), 4.62 (d, 1H, J = 7.2 Hz, 
MeSO2(CH2)2OCHH-),  4.66 (d, 1H, J = 12.4 Hz, CHH Bn), 4.76-4.79 (m, 2H, CHH Bn and 




(m, 10H, H arom); 13C NMR (100 MHz, CDCl3) = 25.4 (CH3 isopropylidene), 26.2 (CH3 isopropylidene), 26.8 
(CH3 isopropylidene), 26.9 (CH3 isopropylidene), 42.8 (CH3 Msem), 54.8 (MeSO2CH2CH2OCH2-), 61.6 
(MeSO2CH2CH2OCH2-), 65.0 (C-5’), 67.8 (C-6), 68.7 (C-6’), 72.4 (C-5), 73.0 (C-3’), 73.0 (CH2 Bn), 75.9 (C-2’), 
78.0 (C-4’), 80.1 (C-3), 81.4 (C-4), 84.0 (C-2), 94.7 (MeSO2(CH2)2OCH2-), 99.4 (C-1’), 101.7 (CH benzylidene), 
105.2 (C-1), 109.5 (Cq isopropylidene), 112.2 (Cq isopropylidene), 125.9-129.2 (CH arom), 137.3, 137.6 (Cq 
benzylidene and Cq Bn); CH Gated NMR (100 MHz, CDCl3) 99.4 (J = 172 Hz, C-1), 105.2 (J = 181 Hz, C-1’); 
HRMS [M+Na]+ calculated for C36H48O14SNa 759.26570, found 759.26596.
-anomer: 
TLC (50% Toluene in EtOAc): Rf = 0.4; []D22: -43.0º (c = 0.5, DCM); IR (neat, cm-1): 697, 733, 1025; 1H NMR 
(400 MHz, CDCl3) = 1.33 (s, 3H, CH3 isopropylidene), 1.34 (s, 3H, CH3 isopropylidene), 1.44 (s, 3H, CH3 
isopropylidene), 1.51 (s, 3H, CH3 isopropylidene),  2.80 (s, 3H, CH3 Msem), 2.82-2.88 (m, 1H,  
MeSO2CHHCH2OCH2-), 3.08-3.15 (m, 1H, MeSO2CHHCH2OCH2-), 3.35 (m, 1H, H-5’), 3.73-3.85 (m, 3H, H-3’ 
and MeSO2CH2CH2OCH2-), 3.90-3.96 (m, 2H, H-2’ and C-6’), 4.05-415 (m, 3H, 2xH-6 and H-4’), 4.30-4.32 (m, 
3H, H-3, H-4 and H-6’), 4.42 (m, 1H, H-5), 4.51 (d, 1H, J = 4.0 Hz, H-2), 4.55 (d, 1H, J = 6.8 Hz, 
MeSO2(CH2)2OCHH-),  4.64 (s, 1H, H-1’), 4.70-4.74 (m, 2H, CHH Bn and MeSO2(CH2)2OCHH-), 4.88 (d, 1H, J 
= 12.0 Hz, CHH Bn), 5.56 (s, 1H, CH benzylidene), 5.93 (d, 1H, J = 3.6 Hz, H-1), 7.15-7.45 (m, 10H, H arom); 
13C NMR (100 MHz, CDCl3) = 25.4 (CH3 isopropylidene), 26.2 (CH3 isopropylidene), 26.5 (CH3 
isopropylidene), 26.6 (CH3 isopropylidene), 42.8 (CH3 Msem), 54.5 (MeSO2CH2CH2OCH2-), 61.0 
(MeSO2CH2CH2OCH2-), 66.0 (C-6), 67.7 (C-5’), 68.3 (C-6’), 72.9 (C-5), 74.4 (C-3’), 74.8 (CH2 Bn), 75.9 (C-2’), 
77.6 (C-4’), 80.3, 80.9 (C-3 and C-4), 82.6 (C-2), 93.9 (MeSO2(CH2)2OCH2-), 100.2 (C-1’), 101.5 (CH 
benzylidene), 104.8 (C-1), 108.6 (Cq isopropylidene), 111.9 (Cq isopropylidene), 125.2-129.1 (CH arom), 137.2, 
137.8 (Cq benzylidene and  Cq Bn); CH Gated NMR (100 MHz, CDCl3)  (J = 154 Hz, C-1), 104.8 (J = 




Method I (Without scavenger): To a solution of methyl 2-O-benzyl-
4,6-O-benzylidene-3-O-(2-O-benzyl-4,6-O-benzylidene3-O-
methysulfonylethoxymethyl--D-mannopyranosyl)--D-mannopyranoside 19b( (0.340 g, 0.40 mmol) in THF (4 
ml, 0.1 M) was added tetrabutylammonium fluoride (0.05 M/THF, 0.8 ml, 0.04 mmol, 0.1 eq). The reaction mixture 
was stirred for 24 hours. The reaction mixture was quenched with NH4Cl (aq), diluted with EtOAc, washed with 
NH4Cl (aq), NaHCO3 (aq), brine, dried over MgSO4, filtered, concentrated and purified by silica gel chromatography 
to give 28 (0.175 g, 0.248 mmol, 62%) and 29 (0.091 g, 0.111 mmol, 27%). 
Method II (With scavenger): To a solution of methyl 2-O-benzyl-4,6-O-benzylidene-3-O-(2-O-benzyl-4,6-O-
benzylidene3-O-methysulfonylethoxymethyl--D-mannopyranosyl)--D-mannopyranoside 19b( (0.148g, 0.17 
mmol) in THF (3.5 ml, 0.05 M) was added pipperdine (35 μl, 0.35 mmol, 2 eq) followed by the addition of 
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mixture was quenched with NH4Cl(aq), diluted with EtOAc, washed with NH4Cl(aq), NaHCO3(aq), brine, dried over 
MgSO4, filtered, concentrated and purified by silica gel chromatography to give 28 (0.114 g, 0.160 mmol, 92%). 
TLC (50%  EtOAc in PE): Rf = 0.8; []D22: -48.0º (c = 0.6, DCM); IR (neat, cm-1): 535, 698, 1093; 1H NMR (500 
MHz, CDCl3) = 2.59 (bs, 1H, OH-3’), 3.12 (m, 1H, H-5’), 3.35 (CH3 OMe), 3.63.-3.71 (m, 2H, H-5’ and H-6’), 
3.71 (d, 1H, J = 4.0 Hz, H-2’), 3.79-3.88 (m, 4H, H-2, H-5, H-6, H-4’), 4.11-4.15 (m, 2H, H-4 and H-6’), 4.25 (dd, 
1H, J = 4.0 Hz, J = 9.5 Hz, H-6), 4.30 (dd, 1H, J = 3.5 Hz, J = 10.0 Hz, H-3), 4.44 (s, 1H, H-1’), 4.58-4.62 (m, 
2H, 2xCHH Bn), 4.70 (d, 1H, J = 12.0 Hz, CHH Bn), 4.79 (s, 1H, H-1), 4.97 (d, 1H, J = 11.0 Hz, CHH Bn), 5.20 
(bs, 1H, CH benzylidene), 5.57 (s, 1H, CH benzylidene), 7.16-7.49 (m, 20H, H arom); 13C NMR (125 MHz, 
CDCl3) = 54.8 (CH3 OMe), 64.0 (C-2 or C-5), 66.6 (C-5’), 68.5 (C-6’), 68.7 (C-6), 70.0 (C-3’), 72.6 (C-3), 72.9 
(CH2 Bn), 74.3 (C-2 or C-5), 74.5 (CH2 Bn), 77.1 (C-4 and C-2’), 79.7 (C-4’), 98.0 (C-1’), 99.4 (C-1), 101.4 (CH 
benzylidene), 101.8 (CH benzylidene), 126.1-128.9 (CH arom), 137.2, 137.4, 137.5, 138.0 (2xCq benzylidene and 
2xCq Bn); CH Gated NMR (100 MHz, CDCl3) 98.0 (J = 158 Hz, C-1’), 99.4 (J = 168 Hz, C-1); HRMS 
[M+H]+ calculated for C41H45O11 713.29564, found 713.29657; [M+Na]
+ calculated for C41H44O11Na 735.27758, 




mannopyranoside (29): Collected as a side product during the 
preparation of 28 by the cleavage of Msem without scavenger 
(0.91 g, 0.111 mmol, 27 %). TLC (50%  EtOAc in PE): Rf = 0.6; 
[]D22: -33.4º (c = 1.0, DCM); IR (neat, cm-1): 730, 1061; 1H NMR (400 MHz, CDCl3) = 2.79 (s, 3H, CH3 Mse), 
3.01-3.16 (m, 2H, MeSO2CH2CH2-), 3.36 (m, 1H, H-5’), 3.39 (CH3 OMe), 3.70-3.80 (m, 3H, H-2’, H-6’ and 
MeSO2CH2CHH2-), 3.80-3.93 (m, 4H, H-2, H-5, H-6 and MeSO2CH2CHH2-), 4.04 (t, 1H, J = 8.8 Hz, H-4’), 4.08-
4.20 (m, 2H,  H-4 and H-6’), 4.29 (dd, 1H, J = 4.4 Hz, J = 10.0 Hz, H-6), 4.32 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz, H-
3), 4.39 (s, 1H, H-1’), 4.58 (d, 1H, J = 12.4 Hz, CHH Bn), 4.63 (d, 1H, J = 11.6 Hz, CHH Bn), 4.74 (d, 1H, J = 
12.4 Hz, CHH Bn), 4.82 (s, 1H, H-1), 4.96 (d, 1H, J = 11.6 Hz, CHH Bn), 5.26 (bs, 1H, CH benzylidene), 5.63 (s, 
1H, CH benzylidene), 7.19-7.50 (m, 20H, H arom); 13C NMR (100 MHz, CDCl3) = 43.1 (CH3 Mse), 54.9 (CH3 
OMe), 55.3 (MeSO2CH2CH2-), 63.8 (MeSO2CH2CH2-), 64.0 (C-2 or C-5), 67.0 (C-5’), 68.6 (C-6’), 68.8 (C-6), 
72.6 (C-3), 72.9 (CH2 Bn), 74.2 (CH2 Bn), 74.4 (C-2 or C-5), 74.9 (C-2’), 77.2 (C-4), 77.3 (C-4’), 77.7 (C-3’), 
99.1 (C-1’), 99.4 (C-1), 101.2 (CH benzylidene), 101.8 (CH benzylidene), 126.0-129.0 (CH arom), 137.2, 137.5, 
137.6, 138.2 (2xCq benzylidene and 2xCq Bn); CH Gated NMR (100 MHz, CDCl3) 99.1 (J = 160 Hz, C-1’), 


























28 (0.144 g, 0.20 mmol, 1 eq) according to the general procedure for glycosylations as described above at -78 ºC 
yielding compound 35 (0.199 g, 0.17 mmol, 83%,  = 1:5). 
-anomer: 
TLC (33% Toluene in EtOAc): Rf = 0.66; []D22: -2.5º (c = 0.4, DCM); IR (neat, cm-1): 698, 1067; 1H NMR (400 
MHz, CDCl3) = 2.59 (s, 3H, CH3 Msem), 2.72-2.76 (m, 1H, MeSO2CHHCH2OCH2-), 2.91-2.98 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.05-3.10 (m, 1H, H-5’) 3.36 (s, 3H, CH3 OMe), 3.68 (dd, 1H, J = 3.2 Hz, J = 10.0 Hz, 
H-3’), 3.75-3.92 (m, 10H, H-2, H-2’, H-2’’, H-6, H-6’, H-6’’, MeSO2CH2CH2OCH2- and two of the H-3, H-4, H-
5, H-3’’, H-4’’ and H-5’’), 4.01-4.36 (m, 10H, H-1’, H-4’, H-6, H-6’, H-6’’, CHH Bn and four of the H-3, H-4, H-
5, H-3’’, H-4’’ and H-5’’), 4.39 (d, 1H, J = 12.0 Hz, CHH Bn), 4.56-4.60 (m, 2H, CHH Bn and 
MeSO2(CH2)2OCHH-), 4.73-4.79 (m, 3H, 2xCHH Bn and MeSO2(CH2)2OCHH-), 4.85 (s, 1H, H-1), 4.97 (d, 1H, J 
= 12.0 Hz, CHH Bn), 5.27 (s, 1H, H-1’’), 5.55 (s, 1H, CH benzylidene), 5.59 (s, 1H, CH bnzylidene), 5.63 (s, 1H, 
CH benzylidene), 7.03-7.51 (m, 30H, H arom); 13C NMR (100 MHz, CDCl3) = 42.8 (CH3 Msem), 54.8 
(MeSO2CH2CH2OCH2-), 55.0 (CH3 OMe), 61.5 (MeSO2CH2CH2OCH2-), 64.0, 64.8, 67.4, 72.9, 72.9, 74.2, 76.2, 
76.5, 78.0, 78.2, 78.2, 78.6 (C-2, C-3, C-4, C-5, C-2’, C-3’, C-4’, C-5’, C-2’’, C-3’’, C-4’’, and C-5’’), 68.6, 68.8 
(C-6, C-6’ and C-6’’), 72.6 (CH2 Bn), 72.7 (CH2 Bn), 75.0 (CH2 Bn), 94.8 (MeSO2(CH2)2OCH2-), 98.7, 99.1, 99.8 
(C-1, C-1’ and C-1’’), 101.7 (CH benzylidene), 101.8 (CH benzylidene), 102.0 (CH benzylidene), 126.1-129.3 
(CH arom), 137.5, 137.6, 137.6 (3xCq benzylidene and 3xCq Bn); HRMS [M+Na]
+ calculated for C65H72O19SNa 
1211.42807, found 1211.42847. 
-anomer: 
 TLC (33% Toluene in EtOAc): Rf = 0.45; []D22: -136.4º (c = 1.0, DCM); IR (neat, cm-1): 698,  1092; 1H NMR 
(400 MHz, CDCl3) = 2.72 (s, 3H, CH3 Msem), 2.72-2.82 (m, 1H, MeSO2CHHCH2OCH2-), 2.99-3.00 (m, 1H, 
MeSO2CHHCH2OCH2-), 3.10-3.15 (m, 2H, H-5’ and H-5”), 3.40 (CH3 OMe), 3.52 (dd, 1H, J = 3.2 Hz, J = 10.0 
Hz, H-3’ or H-3’’), 3.71 (m, 1H, H-2’ or H-2”), 3.75 (m, 1H, MeSO2CH2CHHOCH2-), 3.82-3.95 (m, 8H, H-2, H-
5, H-6, (H-2’ or H-2’’), (H-3’ or H-3’’), H-6’, H-6” and MeSO2CH2CHHOCH2-), 4.01 (m, 1H, H-4’ or H-4”), 4.08 
(m, 1H,  H-4’or H-4’’), 4.15-4.22 (m, 3H, H-4, H-6’ and H-6”), 4.28 (dd, 1H, J = 3.6 Hz, J = 9.2 Hz, H-6), 4.34-
4.38 (m, 2H, H-3 and (H-1’ or H-1’’), 4.43 (s, 1H, H-1’or H-1’’), 4.49 (d, 1H, J = 6.8 Hz, MeSO2(CH2)2OCHH-), 
4.64 (d, 1H, J = 7.2 Hz, MeSO2(CH2)2OCHH-), 4.66-4.75 (m, 3H, 3xCHH Bn), 4.78 (d, 1H, J = 12.0 Hz, CHH 
Bn), 4.85 (s, 1H, H-1), 4.96 (d, 1H, J = 12.0 Hz, CHH Bn), 5.04 (d, 1H, J = 12.0 Hz, CHH Bn), 5.46 (s, 1H, CH 
Benzylidene), 5.48 (s, 1H, CH Benzylidene), 5.58 (s, 1H, CH Benzylidene), 7.15-7.48 (m, 30H, H arom); 13C 
NMR (100 MHz, CDCl3) = 42.5 (CH3 Msem), 54.7 (MeSO2CH2CH2OCH2-), 55.0 (CH3 OMe), 61.3 
(MeSO2CH2CH2OCH2-), 64.0, 74.2, 74.2, 74.4 (C-2, C-3 C-2’and C-5), 67.5, 67.8 (C-5’ and C-5”), 68.5, 68.6 (C-
6’ and C-6”), 68.8 (C-6), 72.7 (CH2 Bn), 72.8 (C-3), 74.3 (CH2 Bn), 74.5 (CH2 Bn), 74.6 (C-2”), 75.2 (C-3”), 77.0, 
(C-4”), 77.3 (C-4), 77.4 (C-4’), 93.7 (MeSO2(CH2)2OCH2-), 98.1, 98.4 (C-1’ and C-1”), 99.2 (C-1), 101.5 (CH 
Benzylidene), 101.7 (CH Benzylidene), 101.7 (CH Benzylidene), 125.3-129.7 (CH arom), 137.3, 137.4, 137.5, 
137.5, 138.3, 138.6 (3xCq Benzylidene and 3xCq Bn); CH Gated NMR (100 MHz, CDCl3) 98.1 (J = 153 Hz, C-
1’ or C-1”),98.1 (J = 155 Hz, C-1’ or C-1”), 99.2 (J = 167 Hz, C-1); HRMS [M+Na]+ calculated for 
C65H72O19SNa 1211.42807, found 1211.42842. 
 




mannopyranosyl)--D-mannopyranoside (31): To a 
solution of methyl 2-O-benzyl-4,6-O-benzylidene-3-O-[2-
O-benzyl-4,6-O-benzylidene-3-O-(2-O-benzyl-4,6-O-benzylidene3-O-methysulfonylethoxymethyl--D-
mannopyranosyl)--D-mannopyranosyl] -D-mannopyranoside 30 (40 mg, 35 μmol) in THF (0.7 ml, 0.05 M) was 
added pipperdine (7 μl, 70 μmol, 2 eq) followed by the addition of tetrabutylammonium fluoride (0.01M, 0.35 ml, 
3.5 μmol, 0.1 eq). The reaction mixture was stirred for 24 hours. The reaction mixture was quenched with 
NH4Cl(aq), diluted with EtOAc, washed with NH4Cl(aq), NaHCO3(aq), brine, dried over MgSO4, filtered, concentrated 
and purified by silica gel chromatography to get methyl 2-O-benzyl-4,6-O-benzylidene-3-O-[2-O-benzyl-4,6-O-
benzylidene-3-O-(2-O-benzyl-4,6-O-benzylidene--D-mannopyranosyl)--D-mannopyranosyl)--D-
mannopyranoside. The resulting compound was dissolved in MeOH (1 ml) and H2O (0.7 ml) before the addition of 
catalytic amount of Pd(OH)2 on charcoals. The reaction was stirred for 24 hours under an H2-atmosphere and 
filtered and purified by Gel filteration to afford the desired trisaccharide 31 (11 mg, 21 μmol, 60%); 1H NMR (600 
MHz, CDCl3) = 3.30-3.37 (m, 5H, H-5, (H-5’ or H-5’’) and CH3 OMe),  3.49 (t, 1H, J = 9.6 Hz, H-4’ or H-4’’), 
3.58-3.61 (m, 2H, H-5 and (H-3’ or H-3’’)), 3.63-3.67 (m, 5H, H-4, (H-4’ or H-4”), H-6, H-6’ and H-6’’), 3.83-
3.88 (m, 3H, H-6, H-6’, H-6”), 3.91 (dd, 1H, J = 2.4 Hz, J = 9.6 Hz, H-3’ or H-3’’), 3.95 (dd, 1H, J = 3.0 Hz, J = 
9.6 Hz, H-3), 3.98 (d, 1H, J = 2.4 Hz, H-2’ or H-2’’), 4.06 (s, 1H, H-2), 4.19 (s, 1H, H-2’ or H-2’’), 4.73 (s, 1H, 
H-1), 4.74 (s, 1H, H-1’ or H-1’’), 4.79 (s, 1H, H-1’ or H-1’’); 13C NMR (150 MHz, CDCl3) =  53.7 (CH3 OMe), 
61.8, 61.9 (C-6, C-6’and C-6’’), 66.1, 66.2 (C-4 and C-4’), 67.8, 67.9 (C-2 and C-4’ or C-4’’), 68.7, 71.7 (C-2 and 
C-2’’), 73.3, 73.8 ((C-5’ or C-5’’) and (C-3’ or C-3”)), 77.0, 77.3 (C-5’and C-5’’), 78.2, 79.8 (C-3’ and C-3’’) 
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  The synthesis of peptides by solid phase procedures has reached a high level of 
efficiency and oligopeptides up to a length of 50 amino acids are routinely prepared1. 
Nonetheless, present state of the art in solid phase peptide synthesis (SPPS) dictates that the 
outcome of a specific peptide synthesis cannot always be predicted. Although in a standard 
SPPS protocol the reagents and protected amino acid building blocks are used in  five or 
more fold excess, the required near quantitative yields in the corresponding reactions are 
not always attained. In the elongation cycle of SPPS, comprising the removal of the 
terminal amino-protecting group and coupling of a suitably protected amino acid to the 
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CHAPTER 
A two-step fluorous capping 





growing peptide chain, the condensation step is most often incomplete. Consequently the 
solid phase synthesis of an oligopeptide is accompanied by the formation of truncated and 
deletion sequences. The accumulation of these unwanted sequences, in particular the (n-1) 
peptides frequently complicates the purification of the target full-length product2.  
 
Figure 1: The fluorous capping reagent PFD-OH and the FMsc protecting group. 
 
 
The advent of light-fluorous techniques, in which compounds differing in fluorine 
content are separated by chromatography using a fluorous stationary phase, offers an 
opportunity to improve the purification of oligopeptides obtained by SPPS3. Two 
approaches can be distinguished. In the first approach a suitable fluorous protecting group 
is developed and installed at the N-terminal end of the target oligopeptide in the final stage 
of the solid phase synthesis. The fluorous protecting group survives the subsequent 
cleavage of the peptide from the solid support and the fluorous target peptide is separated 
from the non-fluorous impurities by fluorous HPLC or fluorous solid phase extraction (F-
SPE) 4.  Final steps of this approach entail the removal of the fluorous protecting group and 
the isolation of the target oligopeptide. Several examples of fluorous protecting groups are 
reported5. An example of such a protecting group is the [1H,1H,2H,2H]-
perfluorodecylsulfonylethoxycarbonyl (FMsc, Figure 1) group, the application of which in 
carbohydrate chemistry is described in chapter 36. In the second approach the intermediate 
and immobilized oligopeptides that resist elongation en route to the target peptide are 
capped after every condensation step in the SPPS cycle with a fluorous reagent, making the 
truncated and deletion sequences fluorous and leaving the target compound untouched7. 
The final step of the second approach entails the separation of the non-fluorous target 
peptide from the fluorous impurities by fluorous HPLC or fluorous solid phase extraction 
(F-SPE).  
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Figure 2: General elongation cycle of the SPPS approach, using a two step fluorous capping 
procedure and ensuing isolation of the target peptide using fluorous techniques. 
             
Reagents and conditions; a) Piperdine (20% in NMP), 15 min.; b) Fmoc-amino acid, HCTU, Dipea, NMP; c) 
Azidoacetic acid, HCTU, NMP, 20 min; d) Boc2O, Dipea, NMP, 30 min; e) PMe3, H2O, dioxane, 2h; g) PFD-OH, 
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The present chapter describes the exploration of a fluorous capping approach in 
SPPS. Capping of incomplete sequences in standard SPPS is commonly done with acetic 
anhydride and it seems obvious to replace acetic anhydride with a suitable fluorous 
anhydride. However anhydrides with sufficient fluorine content are not commercially 
available and the corresponding acids are rather expensive. Therefore a new SPPS protocol 
endowed with a two-step fluorous capping procedure was designed (Figure 2). Each 
elongation cycle of this SPPS protocol entails (a) Fmoc removal, (b) coupling of the next 
suitably protected amino acid and (c) capping with azidoacetic acid under influence of 
HCTU. In this way the azidoacetyl group is introduced at the amino functions of 
intermediate sequences that failed to react in the condensation steps en route to the 
oligopeptide target. After completion of the SPPS the Fmoc protecting group in the target 
peptide is replaced with the Boc group (d). In the next event the azides in the immobilized 
incomplete sequences are reduced to amino functions (e) and made fluorous by 
condensation with (1H,1H,2H,2H)-perfluoroundecanoic acid (PFD-OH, 2, Figure 1, g). 
Finally the immobilized oligopeptides are deprotected, cleaved from the solid support (h) 
and purified by fluorous HPLC (i) or fluorous solid phase extraction (F-SPE, j).   
 
Results and discussion:  
The feasibility of the two-step capping strategy was examined with the aid of the 
synthesis of model peptide GEPKPAG (10). The manual SPPS of this heptamer was 
executed in such a manner, that deletion sequences were deliberately obtained (Figure 3). In 
the SPPS protocol the Fmoc group was removed with piperidine and 5 equivalents of the 
required amino acids building blocks were used in presence of the activator HCTU and 
Dipea as base. When the SPPS to 10 had reached the stage of the pentamer 3 with a free 
amino function, 25% of the resin 3 was taken out and the immobilized pentamer PKPAG 3 
was condensed with azidoacetic acid under influence of HCTU and Dipea for 20 minutes 
(Figure 3). The reaction went to completion, as determined by the chloranil test and the 
resulting azidoacetyl capped immobilized pentamer 4 was remixed with the untreated resin 
3 (Figure 3). The next amino acid was coupled and the terminal amino function was 
unmasked to give resin 5 (Figure 3). Next, 25% of the resin containing immobilized 
hexamer 5 and azidoacetyl capped 4 was taken aside as described above, capped with an 
Two-step fluorous capping strategy for purication in SPPS. 
111 
 
azidoacetyl group to give 6 and remixed with the rest of the resin still containing 4 and 5 
(Figure 3). The last Boc-protected amino acid Gly was coupled to give full length protected 
peptide 7 (Figure 3). The Boc group was used instead of Fmoc protection because the Fmoc 
group is not stable during the forthcoming reduction with trimethylphosphine8.  
 






































































Reagents and conditions; c) Azidoacetic acid, HCTU, NMP, 20 min; e) PMe3, H2O, dioxane, 2h; g) PFD-OH, 




To analyze the product distribution a small part of the thus obtained resin mixture 
was subjected to standard deblocking and cleavage conditions. The resin mixture 
containing Boc protected heptamer together with the deliberately introduced azidoacetyl 
capped deletion sequences pentamer and hexamer was treated with TFA/TIS/H2O 
(95:2.5:2.5) to remove the Boc group, the amino acid side chain protecting groups and to 
release the peptides from the resin9. Analysis by LC-MS showed the presence of three 
major peaks which correspond to the target heptamer (10) and the azidoacetyl capped 
pentamer (8) and hexamer (9) (Figure 4a).  
Next, conditions were explored that allow complete reduction of the azides to 
amino functions.  The resin was treated with trimethylphosphine in a mixture of H2O and 
1,2-dioxane for 2 hours. The reduction of azide to amine was ensured by repetition of the 
reductive treatment10. The result was substantiated by LC-MS analysis of the crude 
mixture, obtained by subjecting a small amount of resin to the standard 
deprotection/cleavage conditions (Figure 4b). The remaining resin 7, 11 and 12, having 
deletion sequences with free amine functions was treated with (1H,1H,2H,2H)-
perfluoroundecanoic acid (PFD-OH, 1), the condensing agent HCTU and Dipea in NMP 
(Figure 3). After completion of the reaction (11 to 15 and 12 to 16), as monitored by the 
TNBS test11, the peptides were released from the resin and the crude mixture containing 10, 
17 and 18 was analyzed by LC-MS which showed two peaks, representing target heptamer 
and the fluorous peptides, respectively Figure 4c). The crude mixture was conveniently 
purified by fluorous solid phase extraction (FSPE) using a stepwise gradient of acetonitrile 
in H2O with 0.1%TFA. Mixtures of acetonitrile/H2O/TFA (20/79.9/0.1) and 
acetonitrile/H2O/TFA (50/49.9/0.1) were used to elute the target peptide 10 (Figure 4d). 
The fluorous penta- and hexamer were eluted with acetonitrile/H2O/TFA (90/9.9/0.1) and 
acetonitrile/TFA (99.9/0.1), respectively (Figure 4e). The overall yield of 10 obtained after 
FSPE was 17% (Table 1, Entry 1).   
 
To further ascertain the feasibility of the two-step capping procedure in 
oligopeptide synthesis, the decapeptide VEAAIDYIDA (19), a peptide derived from acyl 
carrier protein, was selected as a suitable model5b,12. Following the manual SPPS procedure 
described above tetrameric and nonameric deletion sequences were deliberately produced 
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by taking out 20% of the resin at the corresponding stage, capping it with the azidoacetyl 
group and remixing it with the rest of the resin.  After completion of the sequence, the 
Fmoc-group on the last amino acid residue was removed and the Boc group was installed 
by treatment with di-tert-butyl-dicarbonate (Boc2O) and Dipea
13. A small portion of the 
resin was subjected to standard deblocking and cleavage conditions and the obtained 
mixture was analyzed (Figure 5a)14. The resin mixture containing the crude mixture of 
target peptide and two azido capped tetrameric and nonameric deletion sequences was 
treated with trimethylphosphine (PMe3) and the resulting free amines in the deletion 
sequences were coupled with fluorous PFD-OH (1). The peptide was cleaved from the resin 
and analyzed (Figure 5b). Target peptide 19 could be conveniently purified by FSPE 
(Figure 5c) and was isolated in 7% overall yield (Table 1, Entry 2). 
 
Figure 4: LC Chromatograms of GEPKPAG. a) after synthesis; b) after reduction; c) after fluorous 




To investigate whether the two-step capping procedure could be transferred to 
automatic SPPS, the assembly of nonadecamer SSKKSGSYSGSKGSKRRIL 20 using an 
automated peptide synthesizer and Fmoc chemistry was undertaken. To ensure the 
acquirement of deletion sequences, 2 eq. instead of the usual 5 eq. of protected amino acid 
















from the usual 45 minutes to 30 minutes. After each coupling, the unreacted resin bound 
amino functions were capped by reaction with azidoacetic acid in combination with HCTU 
and Dipea. After the completion of the target sequence, the Fmoc at the N-terminal end was 
quantitatively replaced by the Boc group, as shown by the TNBS test. A small portion of 
the resin was taken out, subjected to standard deblocking and cleavage conditions. The 
 
Figure 5: LC Chromatograms. a) crude peptide 19 after synthesis; b) crude peptide 19 after fluorous 
capping; c) peptide 19 after FSPE; d) crude peptide 20 after synthesis; e) crude peptide 20 after 
fluorous capping; f) peptide 20 after FSPE; g) crude peptide 21 after synthesis; h) crude peptide 21 
after fluorous capping; i) peptide 21 after FSPE; j) crude peptide 22 after synthesis; k) peptide 22 
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mixture comprising target peptide and deletion sequences was analyzed (Figure 5d). The 
remaining resin was subjected to reducing conditions and the obtained amino functions on 
the unwanted sequences were provided with a fluorous tail by condensation with PFD-OH 
(1). The peptide was released from the resin and analyzed (Figure 5e). The crude mixture 
was easily purified by FSPE to give target peptide 20 (Figure 5f) in 9% overall yield (Table 
1, Entry 3). 
 
Similarly peptide EPLTSLTPR-Abu-NTAWNRLKL 21, part of an envelope 
protein of the Moloney virus, containing a 2-aminobutyric acid residure (Abu) as an 
isosteric replacement for Cysteine (Cys) was prepared on an automated peptide synthesizer 
using Fmoc chemistry combined with azidoacetic acid capping (Fmoc/AzidoAc protocol)15. 
This time the usual excess of amino acid building blocks and the coupling time were 
employed, minimizing the formation of deletion sequences. At the final stage of the SPPS 
the Fmoc group was replaced with the Boc group. A small portion of the resin was 
subjected to standard deblocking and cleavage conditions and the obtained mixture was 
analyzed (Figure 5g). The crude target oligopeptide 21 (Figure 5h) was obtained by the 
same sequence of events as described for the preparation of oligopeptide 20. Finally, FSPE 
purification gave target peptide 21 (Figure 5i) in 21% overall yield (Table 1, Entry 4). 
As a last example BDSTLRLBVQSTHVDIRTLEDLLMGTLGIVPBIBSQKP 22, 
a peptide derived from E7 protein of HPV16 was assembled using the Fmoc/AzidoAc 
protocol on automated peptide synthesizer.16 Again 2-aminobutyric acid residue was 
introduced as the isostere of Cys. The LC chromatograms of the non-fluorous reaction 
mixture and the crude reaction mixture containing the fluorous deletion peptides are shown 
in figures 5j and 5k respectively. Pure target peptide 22 (Figure 5l) was obtained by F-




Table 1: Yields of different peptides. 
 
Entry Peptide  Yield 
1 GEPKPAG (10)  17% 
2 VEAAIDYIDA (19) 7% 
3 SSKKSGSYSGSKGSKRRIL (20) 9% 
4 EPLTSLTPRBNTAWNRLKL (21) 21% 





      This chapter described the successful implementation of a two-step fluorous 
capping procedure in an otherwise standard SPPS protocol allowing the improved isolation 
of five natural and artificially designed oligopeptides. In the elongation cycle of the SPPS 
protocol amino functions of unwanted sequences were provided with the azidoacetyl group 
and in the final stage of the oligopeptide synthesis the thus appended azides were reduced 
to amine functions and subsequently capped with a fluorous tail. The fluorous deletion 




General: All chemicals used in the solid phase peptide synthesis, with the exception of the HCTU were from 
Biosolve (The Netherlands) and used as received. HCTU was purchased IRIS Biotech GmbH (Germany). Resins 
were bought at Rapp Polymere GmbH (Germany). (1H,1H,2H,2H)-perfluoroundecanoic acid was bought at 
Fluorous Technologies Inc. Fmoc amino acids were from SENN Chemicals. Fmoc amino acids used in the 
synthesis were: Fmoc-Abu-OH, Fmoc-Ala-OH, Fmoc-Arg-(Pmc)-OH, Fmoc-Asn-(Trt)-OH, Fmoc-Asp-(tBu)-OH, 
Fmoc-Gln-(Trt)-OH, Fmoc-Glu-(tBu)-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-His-(Boc)-OH, Fmoc-Leu-OH, 
Fmoc-Lys-(Boc)-OH, Fmoc-Met-OH, Fmoc-Pro-OH, Fmoc-Ser-(tBu)-OH, Fmoc-Thr-(tBu)-OH, Fmoc-Trp-
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(Boc)-OH, Fmoc-Tyr-(tBu)-OH, Fmoc-Val-OH. Azidoacetic acid was prepared according to the literature 
procedure
17
. Analytical LC/MS was conducted on a JASCO system using an Alltima C18 analytical column (5 μm 
particle size, flow 1.0 ml/min). Absorbance was measured at 214 nm and 254 nm. Solvent system: A: 100% H2O, 
B: 100% acetonitrile, C: 1% TFA (aq). Gradients of B in 10% C were applied over 13 minutes.
 
 
General cycle of peptide syntheis: The solid phase peptide synthesis was performed on ABI 433A (Applied 
Biosystems) applying Fmoc based protocol starting either from Rink amide MBHA resin or Tentagel preloaded 
with Fmoc-Leu-OH (Wang linker). Alternatively a mechanical shaker was used and the reagents were introduced 
manually (manual peptide synthesis). The synthesis was performed on 50 μmol according to established methods. 
The consecutive steps performed in each cycle were: 
1) Deprotection of the Fmoc group with 20% piperdine in NMP for 15 minutes; 2) DMF wash; 3) Coupling of the 
appropriate amino acid applying a five-fold excess. Generally the Fmoc amino acid (0.25 mmol) were dissolved in 
0.25 M HCTU in NMP (1 ml), the resulting solution was transferred to the reaction vessel followed by 0.5 ml of 1 
M DIPEA in NMP to initiate the coupling; 4) DMF wash; 5) Capping with azidoacetic acid as described in the 
general procedure for azide capping; 6) DMF wash 
 
General procedure for azide capping: To the resin bound peptide (1 eq) was added azidoacetic acid (0.2 
M/NMP, 5 eq), HCTU (0.25 M/NMP, 5 eq) and DIPEA (1 M/NMP, 10 eq). The mixture was shaken for 20 
minutes. Next, solvents were drained off and the resin was subsequently washed with DMF. 
 
General procedure for reduction of azide: To the suspension of resin bound peptide (1 eq) in dioxane was added 
trimethylphosphine (1 M /toluene, 8 eq) and H2O (222 eq). The mixture was shaken for 2 hours. Next, the solvents 
were drained off and the resin was washed with NMP. The procedure was repeated once more and the solvents 
were drained off and the resin was subsequently washed with NMP and DCM. 
General procedure for fluorous capping: To the suspension of resin bound peptide (1 eq) in NMP was added 
(1H,1H,2H,2H)-perfluoroundecanoic acid (5 eq), HCTU (5 eq) and DIPEA (10 eq). The mixture was shaken for 1 
hour. Next, solvents were drained off and the resin was subsequently washed with NMP and DCM. 
 
General procedure for introduction of Boc: To the suspension of resin bound peptide (1 eq) in NMP was added 
di-tert-butyl-dicarbonate (Boc2O, 5 eq) and DIPEA (5 eq), the mixture was shaken for 30 minutes. Next, solvents 
were drained off and the resin was subsequently washed with NMP and DCM. 
 
General procedure for cleaving the peptide from the resin: To the resin bound peptide (10 μmol, 1 eq) in a 
cartridge with a filter was added a cocktail of TFA/TIS/H2O (95/2.5/2.5). The mixture was kept for 1 hour with 
occasion swirling. Next, the solvents were filtered into cold diethyl ether. The mixture was centrifuged, the diethyl 





General procedure for fluorous solid phase extraction (FSPE): A FSPE cartridge preloaded with 2 g of 
fluorous silica gel was eluted with acetonitrile (10 ml) and acetonitrile/H2O/TFA (20/79.9/0.1, 15 ml). The crude 
peptide was dissolved in the minimum amount of water and acetonitrile was added to help in dissolution if 
necessary, followed by loading to the cartridge. The cartridge was eluted with acetonitrile/H2O/TFA (20/79.9/0.1, 
10 ml) and acetonitrile/H2O/TFA (50/49.9/0.1, 15 ml) to elute the target peptide. Next, fluorous capped truncated 
sequences were eluted with acetonitrile/H2O/TFA (90/9.9/0.1, 15 ml) and acetonitrile/TFA (99.9/0.1, 10 ml). 
 
Gly-Glu-Pro-Lys-Pro-Ala-Gly-NH2 (10): Resin bound peptide 10 was prepared using ABI 433A (Applied 
Biosystems) according to general cycle of peptide synthesis. At pentamer stage after deprotection, 25% of the 
resin was taken out and capped with azidoacetyl according to the general procedure as described above. The two 
resins were remixed, and next amino acid was coupled and Fmoc was deprotected. Again 25% of the resin was 
taken out and capped with azidoacetyl. The two resins were remixed, and synthesis was continued according to the 
general procedure. Boc-Gly-OH was coupled as the last amino acid residue. The crude peptide was washed with 
NMP and DCM and air dried. A small amount of the peptide was cleaved according to the general procedure for 
the cleavage of peptide from the resin described above and subjected to the LCMS. The remainder of the resin was 
reduced, coupled with PFD-OH and cleaved from the resin according to the respective general procedures 
described above. The peptide was cleaved (40 mg, Initial loading = 0.34 mmol/g, final loading 0.30 mmol/g, 11.9 
µmol) according to the general procedure for the cleavage of peptide from the resin described above and small 
amount was subjected to the LCMS. The crude peptide was purified by FSPE according to the general procedure 
as described above to afford peptide 10 (1300 µg, 1.99 µmol, 17% ). LCMS: 00-20% B, RT = 4.51 min; ESI-MS: 
[M+H]+ 654.6 (calc. 654.7). 
 
Val-Glu-Ala-Ala-Ile-Asp-Tyr-Ile-Asp-Ala-NH2 (19): Resin bound peptide 19 was prepared manually using 
peptide synthetic cycle as described above. At tetramer stage after deprotection, 20% of the resin was taken out 
and  capped with azidoacetyl according to the general procedure as described above. The two resins were remixed, 
and standard cycle was followed. Next amino acid was coupled and Fmoc was deprotected. At nonamer stage after 
deprotection, again 20% of the resin was taken out and capped with azidoacetyl. The two resins were remixed, and 
synthesis was continued according to the general procedure. Next, the Boc group was introduced to the full length 
peptide according to the general procedure as described above. The crude peptide was washed with NMP and 
DCM and air dried. A small amount of the peptide was cleaved according to the general procedure for the 
cleavage of peptide from the resin described above and subjected to the LCMS. The remainder of the resin was 
reduced, coupled with PFD-OH and cleaved from the resin according to the respective general procedures 
described above. The peptide was cleaved (30 mg, Initial loading = 0.58 mmol/g, final loading 0.37 mmol/g, 11.2 
µmol) according to the general procedure for the cleavage of peptide from the resin described above and small 
amount was subjected to the LCMS. The crude peptide was purified by FSPE according to the general procedure 
as described above to afford peptide 19 (900 µg, 0.84 µmol, 7% ). LCMS: 00-50% B, RT = 4.59 min; ESI-MS: 
[M+H]+ 1078.5 (calc. 1078.2). 
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Ser-Ser-Lys-Lys-Ser-Gly-Ser-Tyr-Ser-Gly-Ser-Lys-Gly-Ser-Lys-Arg-Arg-Ile-Leu-OH (20): Resin bound 
peptide 20 was prepared using ABI 433A (Applied Biosystems) according to general cycle of peptide synthesis. 
Next, the Boc group was introduced to the full length peptide according to the general procedure as described 
above. The crude peptide was washed with NMP and DCM and air dried. A small amount of the peptide was 
cleaved according to the general procedure for the cleavage of peptide from the resin described above and 
subjected to the LCMS. The remainder of the resin was reduced, coupled with PFD-OH and cleaved from the resin 
according to the respective general procedures described above. The peptide was cleaved (25 mg, Initial loading = 
0.26 mmol/g, final loading 0.18 mmol/g, 4.54 µmol) according to the general procedure for the cleavage of peptide 
from the resin described above and small amount was subjected to the LCMS. The crude peptide was purified by 
FSPE according to the general procedure as described above to afford peptide 20 (800 µg, 0.4 µmol, 9% ). LCMS: 
00-90% B, RT = 3.88 min; ESI-MS: [M+H]2+ 1007.7 (calc. 1007.7), [M+H]3+ 672.1 (calc. 672.1).  
 
Glu-Pro-Leu-Thr-Ser-Leu-Thr-Pro-Agr-Abu-Asn-Thr-Ala-Trp-Asn-Agr-Leu-Lys-Leu-OH (21): Resin 
bound peptide 21 was prepared using ABI 433A (Applied Biosystems) according to general cycle of peptide 
synthesis. Next, the Boc group was introduced to the full length peptide according to the general procedure as 
described above. The crude peptide was washed with NMP and DCM and air dried. A small amount of the peptide 
was cleaved according to the general procedure for the cleavage of peptide from the resin described above and 
subjected to the LCMS. The remainder of the resin was reduced, coupled with PFD-OH and cleaved from the resin 
according to the respective general procedures described above. The peptide was cleaved (17 mg, Initial loading = 
0.26 mmol/g, final loading 0.18 mmol/g, 3.0 µmol) according to the general procedure for the cleavage of peptide 
from the resin described above and small amount was subjected to the LCMS. The crude peptide was purified by 
FSPE according to the general procedure as described above to afford peptide 21 (1400 µg, 0.64 µmol, 21% ). 
LCMS: 00-90% B, RT = 4.55 min; ESI-MS: [M+H]2+ 1099.0 (calc. 1098.8), [M+H]3+ 733.2 (calc. 732.9).  
 
Abu-Asp-Ser-thr-Leu-Arg-Leu-Abu-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg-Thr-Leu-Glu-Asp-Leu-Leu-
Met-Gly-Thr-Leu-Gly-Ile-Val-Pro-Abu-Ile-Abu-Ser-Gln-Lys-Pro-OH (22): Resin bound peptide 22 was 
prepared using ABI 433A (Applied Biosystems) according to general cycle of peptide synthesis. Next, the Boc 
group was introduced to the full length peptide according to the general procedure as described above.  The crude 
peptide was washed with NMP and DCM and air dried. A small amount of the peptide was cleaved according to 
the general procedure for the cleavage of peptide from the resin described above and subjected to the LCMS. The 
remainder of the resin was reduced, coupled with PFD-OH and cleaved from the resin according to the respective 
general procedures described above. The peptide was cleaved according to the general procedure for the cleavage 
of peptide from the resin described above and small amount was subjected to the LCMS. The crude peptide was 
purified by FSPE according to the general procedure as described above to afford peptide 22 in 7% yield. LCMS: 
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An efficient organic synthesis of fragments of biopolymers and analogues thereof 
cannot be reached without a proper use of protective groups. In oligonucleotide and 
oligopeptide synthesis the applied protective groups generally ensure the regioselective 
introduction of the phosphodiester and peptide linkages between the monomeric 
nucleosides and amino acids respectively, as well as minimization of unwanted side 
reactions en route to the target compounds. Thanks to the developed protective groups and 
improved coupling methods to introduce phosphate and peptide linkages, DNA and peptide 
fragments consisting of dozens of monomeric residues can be prepared with the aid of fully 
automated solid phase procedures. Despite these advances the search for new protective 
groups in the field of nucleic acid and peptide chemistry still goes on. For instance, 
improvement of the overall yield in the synthesis of RNA fragments and the synthesis of 
6 
CHAPTER 





nucleic acid peptide conjugates may benefit from the development of new tailor made 
protective groups. Compared with the present state of the art in nucleic acid and peptide 
chemistry the synthesis of oligosaccharides has been relatively slow to mature, 1 which can 
be explained by the increased structural complexity of carbohydrates. Carbohydrates may 
occur either as straight or branched chains and may contain various monosaccharides 
differing in the number, nature and configuration of the substituents. Moreover, the 
glycosidic linkage between the constituting monosaccharides can occur in two 
diastereomeric forms. In the synthesis of naturally occurring and artificially designed 
oligosaccharides the protective group strategy2 and the glycosylation procedure3 play a 
decisive role to attain a productive and stereoselective glycosylation reaction. In this respect 
it is of interest to note that the protective groups installed on the glycosylating partners 
(donor and acceptor), not only dictate the regioselectivity4 and the yield of the 
glycosylation reactions but also influence the stereoselective outcome.5  
This thesis reports on the development of new protective groups that can be 
applied for the synthesis of biopolymer fragments with a focus on oligosaccharides. 
Chapter 1 reviews recent advances on protective groups and protective group 
manipulations in the field of carbohydrate chemistry. With the objective to diminish the 
efforts to prepare sufficient amounts of suitably protected monosaccharides, several groups 
have reported on the development of one-pot protocols, entailing up to five reaction steps. 
One procedure starts from anomerically protected per-silylated carbohydrate monomers and 
gave access to a wide array of differentially protected monosaccharide donors and 
acceptors. A lot of attention has been paid to the design of protective groups for the C-2 
hydroxyl, that are able to induce the stereoselective formation of 1,2-cis glycosidic bonds. 
An impressive example is presented by the development of two C-2 OH protecting groups 
capable of promoting the formation of 1,2-cis glycosidic bonds by neigbouring group 
participation, reported by the group of Boons. The discovery of Crich and co-workers that 
4,6-benzylidene mannosyl donors react in a highly -selective fashion was followed by 
studies on the influence of protecting groups at the C-2 and C-3 positions of these donors 
and led to the development of various propargyl ethers as minimally intrusive hydroxyl 
protecting groups. Silyl protecting groups are becoming increasingly popular in 
carbohydrate chemistry as exemplified by the introduction of the 4,6-di-tert-butylsilylene 
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(DTBS) as a more acid stabile alternative for the usual cylic ketals and acetals. A row of 
new trans-directing protecting groups for the glucosamine nitrogen function has also been 
reported. Contrary, Kerns and co-workers introduced oxazolidinone protected glucosamine 
donors that stereoselectively provided 1,2-cis linked products. Subsequent studies revealed 
that the stereochemical outcome of 2,3-oxazolidinone-N-acetyl and 2,3-oxazolidinone-N-
benzyl protected glucosamine donors could be controlled by the (Lewis)-acidity of the 
employed activator systems. 
Several types of protecting groups were published that not only mask a specific 
functional group on the carbohydrate core, but also add an extra functionality to the 
carbohydrate building block. For instance, protective groups have been developed which 
impart colour to the substrate, allowing an easy detection during purification procedures or 
monitoring of the glycosylation efficiency during automated synthesis. A number of 
protective groups provided with purification handles became available through the 
development of fluorous chemistry and ionic liquids.  
 




Chapter 2 describes the first application of the methylsulfonylethoxycarbonyl 
(Msc) group (1, Figure 1) as protecting group for hydroxyl functions in oligosaccharide 
synthesis. The Msc group can be introduced using conditions, commonly used to install the 
9-fluorenylmethyl carbonate (Fmoc). Contrary, the Msc group is less lipophilic, less bulky 




elimination using mildly basic conditions and is orthogonal with the levulinoyl (Lev) 
group. The Msc group was used in donor and acceptor glycosides and was stable during 
glycosylation reactions. When the Msc group was placed at the C-2 hydroxyl, it provided 
anchimeric assistance while unwanted orthoester formation was prevented.  
It would be interesting to evaluate the Msc group as an amino protecting group in 
oligosaccharide synthesis. Protection of the glucosamine nitrogen function with the Msc 
group would afford a glycosyl donor (e.g. 4a, Figure 1), having a sterically unbiased, 
participating group.  
In bioorganic chemistry fluorous solid phase extraction (FSPE) has emerged a new 
purification method. In this context a number fluorous protecting groups to facilitate the 
purification of oligopeptides, (oligo)nucleotides and oligosaccharides is reported. Chapter 
3 deals with the evaluation of fluorous counterparts of the Msc group as purification 
handles in carbohydrate chemistry. The [1H, 1H, 2H, 2H]-
perfluorodecylsulfonylethoxycarbonyl (FMsc, 2, Figure 1) group, known as a fluorous 
protective group for amines was found to be too labile for the protection of hydroxyl 
functions of carbohydrates. Increasing the distance between the sulfonyl functionality and 
the perfluoro moiety by an additional methylene group led to the development of the 
[1H,1H,2H,2H,3H,3H]-perfluoroundecylsulfonylethoxycarbonyl (FPsc, 3, Figure 1) group 
as a sufficiently stable hydroxyl protecting group. The FPsc group was applied in the 
assembly of a trisaccharide and found to be orthogonal with levulinyl (Lev) group.  
These results indicate that it is worthwhile to investigate whether the FPsc group 
can be applied for the purification of oligosaccharides and glycopeptides that are assembled 
by solid phase procedures. In this context the FPsc group can also be used as purification 
handle at amino functions such as in glucosamine derivative 4b (Figure 1). In addition it 
would be interesting to investigate whether the FPsc can function as a fluorous handle to 
facilitate the purification of different classes of biomolecules, such as oligonucleotides and 
conjugates thereof. 
Chapter 4 describes the methylsulfonylethoxymethyl (Msem) group as a new 
hydroxyl protecting group, that increases the palette of ether based protecting groups in 
carbohydrate chemistry. Several methods for the introduction of the Msem group were 
investigated. The Msem group can be introduced at primary and secondary hydroxyl 
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functions of O-glycosides using the thiomethylether of 2-(methylsulfonyl)ethanol and a 
thiophilic activator. Diol thioglycosides can be selectively protected by the conversion of 
the hydroxyl functions into dibutylstannylidene acetals followed by reaction with  
(methylsulfonylethoxy)methyl chloride (Msem-Cl). The Msem group proved to be 
relatively base stabile and could be easily removed by a catalytic amount of TBAF in the 
presence of piperidine as scavenger. Application of the Msem group in the synthesis of an 
all cis-linked 1,3-O-mannotrioside showed that this group is sterically unbiased and does 
not provide remote participation.  
The properties of the Msem group indicate that is valuable to investigate whether 
the Msem group can function as a protecting group for the C-2-OH function in RNA 
synthesis. Accordingly, protected nucleoside 5 (Figure 2) may be accessible by the 
synthetic route devised for the introduction of the cyanoethoxymethyl group at the same 
position of RNA building blocks.6  
 

































































Reagents and conditions; a) NIS, TMSOTf, DCM, -20 ºC to RT, 24h, 72%; b) NaH, Methylthiomethylchloride, 





Conversely, it would be interesting to explore protecting groups that are specifically 
developed to improve RNA synthesis for their application in carbohydrate chemistry. 
Preliminary results on the use of the cyanoethoxymethyl group in carbohydrate chemistry 
are depicted in figure 2. The required 3-(methylthiomethoxy)propanenitrile 7 was prepared 
in 60% yield by treating cyanoethanol with dimethylsulfoxide, acetic acid and acetic 
anhydride. Condensation of methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 with 
thiomethyl ether 7 under the agency of N-iodosuccinimide (NIS) and trimethylsilyltriflate 
(TMSOTf) produced cyanoethoxymethyl protected glucoside 11 in 72% yield (Figure 2). 
Alternatively, 2,3,4-tri-O-benzyl--D-glucopyranoside 9 was converted into 
methylthiomethyl ether 8 by treatment with sodium hydride and methylthiomethyl chloride 
(MTM-Cl) in DMF. Reaction of 10 and cyanoethanol under influence of IDCP (4 
equivalents) as activating agent led to the isolation of the desired monosaccharide 11 (53% 
yield) together with side product 13. The cyanoethoxymethyl group could be removed from 
2,3,6-tri-O-benzyl-4-O-cyanoethoxymethyl--D-glucopyranoside 11 by treatment with 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) for 6h at room temperature to give 9 in 93% yield 
(Figure 2). Alternatively, treatment of 11 with tetrabutylammonium fluoride (TBAF, 0.1 
equivalents) for 30 minutes led to the removal of the cyanoethoxymethyl group in 96% 
yield. The development of a fluorous version of the methylsulfonylethoxymethyl (Msem) 
group may be also be advantageous, as the Msem group is a non-participating and more 
base stabile in comparison with the perfluoroundecylsulfonylethoxycarbonyl (FPsc, see 
Chapter 3) group. In a preliminary experiment fluorous glucoside 12 could be prepared in 
11% yield. 
Two approaches can be distinguished for the application of fluorous techniques to purify 
fragments of biopolymers prepared with the aid of solid phase procedures In the first 
approach a suitable fluorous protecting group is used and installed in the final stage of the 
solid phase synthesis to give the fluorous target oligomer. Examples of such fluorous 
protecting groups are discussed in Chapter 1 and 3. In the second approach intermediate 
oligomers that resist elongation en route to the target compound are capped after every 
condensation step in the solid phase cycle with a fluorous reagent, making the truncated and 
deletion sequences fluorous and leaving the target compound untouched. Chapter 5 
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narrates the idea of a new two-step fluorous capping procedure. Five oligopeptides were 
prepared by regular solid phase peptide synthesis, in which the standard capping procedure 
was replaced by treatment with azidoacetic acid, HCTU and Dipea. After the completion of 
the synthesis of the target oligopeptide, the azides in the truncated and deletion sequences 
were reduced to amines and subsequently capped with  (1H,1H,2H,2H)-
perfluoroundecanoic acid. The fluorous sequences were separated from the target peptide 
by fluorous solid phase extraction (FSPE) or by Fluorous HPLC (F-HPLC). 
It is envisaged that the number of reaction steps in this fluorous capping strategy 
can be reduced by replacing the azide reduction and ensuing capping with a fluorous 
carboxylic acid by a Huisgen 1,3-dipolar cycloaddition  (click reaction) with a suitable 
alkyne.7  
 
Figure 3: fluorous capping strategy using click chemistry. 
 
Reagents and conditions; f) i- Piperdine (20% in NMP)15 min.; ii- Fmoc-amino acid, HCTU, Dipea, NMP; iii-
Azidoacetic acid, HCTU, NMP, 20 min; g) CuSO4, Sodium ascorbat; h) i- TFA, TIS, H2O, 45 min; ii- FSPE or F-
HPLC. 
 
Following the same coupling cycle as described in Chapter 5, immobilized target 
oligopeptide 15 and a number of azido functionalized deletion sequences 16 will be 
obtained at the end of the synthesis (Figure 3). With the aid of alkyne 17 the deletion 
sequences 16 will be made fluorous by a copper catalyzed click reaction. Removal of the 
protecting groups and cleavage from the solid support will provide target oligopeptide 19 
and fluorous sequences 20. Target peptide 19 can be separated from the fluorous impurities 







General: Dichloromethane was refluxed with P2O5 and distilled before use. All other chemicals (Acros, Fluka, 
Merck, Fluorous Technologies Inc.) were used as received. Column chromatography was performed on Screening 
Devices silica gel 60 (0.040-0.063 mm). Compounds were visualized by UV absorption (245 nm), by spraying 
with an aqueous solution of KMnO4 (20%) and K2CO3 (10%), by spraying with 20% H2SO4 in ethanol or by 
spraying with a solution of (NH4)6Mo7O24·4H2O (25g/L) and (NH4)4Ce(SO4)4·2H2O (10g/L) in 10% H2SO4 (aq) 
followed by charring at 150 ºC. IR spectra were recorded on a Shimadzu FTIR-8300 and are reported in cm-1. 
Optical rotations were measured on a Propol automatic polarimeter. 1H and 13C NMR spectra were recorded with a 
Bruker AV 400 (400 MHz and 100 MHz respectively), AV 500 (500 MHz and 125 MHz respectively) or DMX 
600 (600 MHz and 150 MHz respectively). NMR spectra were recorded in CDCl3 unless stated otherwise. 
Chemical shift are relative to tetramethylsilane and are given in ppm. Coupling constants are given in Hz. All 
given 13C spectra are proton decoupled. High resolution mass spectra were recorded on a LTQ-Orbitrap (thermo 
electron). 
 
((Cyanoethoxy)methyl)methylsulfane (7) : To a solution of cyanoethanol 6 (4.16 ml, 
58.4 mmol)  in DMSO (18 ml, 234 mmol, 4 eq) was added acetic acid (7 ml, 117 mmol, 2 
eq) and acetic anhydride (12 ml, 117 mmol, 2 eq). The reaction mixture was stirred for 48 hours. The mixture was 
neutralized by careful addition of NaHCO3 (s), extracted using a large excess of EtOAc, dried over MgSO4, filtered, 
concentrated and purified by silica gel column chromatography to afford 7 (5.54 g, 30.0 mmol, 60% ) as a yellow 
a oil. TLC (75% EtOAc in PE): Rf = 0.75; IR (neat, cm
-1): 730, 1129, 1286; 1H NMR (400 MHz, (CDCl3) = 2.16 
(s, 3H, -CH2SCH3), 2.66 (t, 2H, J = 6.0 Hz,  NCCH2CH2OCH2SCH3), 3.73 (t, 2H, J = 6.0 Hz, 
NCCH2CH2OCH2SCH3), 4.68 (s, 2H, NC(CH2)2OCH2SCH3); 
13C NMR (100 MHz, (CDCl3) = 13.7  (-
CH2SCH3), 18.6 (NCCH2CH2OCH2SCH3), 62.2 (NCCH2CH2OCH2SCH3), 75.1 (NC(CH2)2OCH2SCH3); HRMS 
[M+Na]+ calculated for C5H9OSN 154.02971, found  154.02962.  
 
 Methyl 2,3,6-tri-O-benzyl-4-O-cyanoethoxymethyl--D-glucopyranoside (11): 
Method I: A solution of Methyl 2,3,6-tri-O-benzyl-4-O-methylthiomethyl--D-glucopyranoside 10 (0.203 g, 
0.387 mmol) and cyanoethanol (66 μl, 0.968 mmol, 2.5 eq) in DCM (7.7 ml, 0.05M) was stirred over activated 
MS3Ǻ for half an hour before Iodo dicollidine perchlorate (0.724 g, 1.548 mmol, 4eq) was added in dark. The 
mixture was stirred in dark for 24 hours. The reaction mixture was quenched with NH4Cl, filtered, diluted with 
DCM and washed with Na2S2O3. The aqueous layer was extracted with DCM thrice, the combined organic layer 
was washed with NH4Cl, NaHCO3 and brine, dried over MgSO4, filtered, concentrated and purified by silica gel 
column chromatography to get compound 11 (0.113 g, 0.206 mmol, 53%);  
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Method II: A solution of methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 (70 mg, 0.15 mmol) and reagent 7 (30 
mg, 0.23 mmol, 1.5 eq) in DCM (10.4 ml, 0.05 M) was stirred over activated MS3Å for 30 minutes before N-
iodosuccinimide (40 mg, 1.85 mmol, 1.2 eq) was added. The mixture was cooled to -20 oC followed by the 
addition of trimethylsilyltrifluoromethanesulfonate (10% in DCM, 55 µl, 30 µmol, 0.2 eq). The mixture was 
stirred for 2 hours. The reaction mixture was quenched with triethylamine (5 eq), filtered, diluted with DCM and 
washed with Na2S2O3 (aq). The aqueous layer was extracted with DCM thrice, the combined organic layers were 
dried over MgSO4, filtered, concentrated and purified by silica gel column chromatography to get 11 (59 mg, 0.11 
mmol, 72%). 
TLC (50% EtOAc in PE): Rf = 0.6; []D22: +59.0º  (c = 0.4`, DCM); IR (neat, cm-1): 689, 699, 738, 954, 1016, 
1089, 1118, 1281, 1378; 1H NMR (400 MHz, CDCl3) = 2.15-2.27 (m, 2H, NCCH2CH2OCH2O-), 3.39 (s, 3H, 
OMe), 3.50 (mH-2 and NCCH2CH2OCH2O-), 3.60 (m, 3H, H-4 and 2xH-6), 3.71 (m, 1H, H-5), 3.87 (t, 1H, J = 
9.2 Hz, H-3), 4.62 (m, 6H, H-1, NC(CH2)OCHHO- and 4xCHH Bn), 4.77 (m, 2H, NC(CH2)OCHHO- and CHH 
Bn), 5.01 (d, 1H, J = 11.2 Hz, CHH Bn), 7.23-7.33 (m, 15H, H arom); 13C NMR (100 MHz, CDCl3) = 18.4 
(NCCH2CH2OCH2O-), 55.2 (CH3 OMe), 63.1 (NCCH2CH2OCH2O-), 68.7 (C-6), 69.7 (C-5), 73.1 (CH2 Bn), 73.3 
(CH2 Bn), 75.4 (CH2 Bn), 75.5 (C-4),  79.9 (C-2), 81.1 (C-3), 96.5 (NC(CH2)OCH2O-), 97.8 (C-1), 117.6 (CN), 
127.5-129.8 (CH arom), 137.8 (Cq Bn), 138.3 (Cq Bn); HRMS [M+Na]
+ calcd for C32H37NO7Na 570.24622 was 
found 570.24579. 
 
Methyl 2,3,4-tri-O-benzyl--D-glucopyranoside (9) (Cleavage of Msem from 11): 
Method I: To a solution of 11 (42 mg, 77 μmol) in DMF (0.8 ml, 0.1 M) was added DBU 
(0.067 M in DMF, 120 μl, 7.7 μmol, 0.1 eq) and the reaction mixture was stirred for 6 
hours. The reaction mixture was neutralized with NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 
and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by silica gel column 
chromatography to afford methyl 2,3,6-tri-O-benzyl--D-glucopyranoside 9 (33 mg, 71 μmol, 93%). 
Method II: To a solution of 11 (52 mg, 95 μmol) in THF (1.0 ml, 0.1 M) was added TBAF (0.1 M in DMF, 100 μl, 
9.5 μmol, 0.1 eq) and the reaction mixture was stirred for 1 hours. The reaction mixture was neutralized with 
NH4Cl (aq), diluted with EtOAc, washed with NH4Cl (aq), NaHCO3 and brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography to afford methyl 2,3,6-tri-O-
benzyl--D-glucopyranoside 9 (42 mg, 91 μmol, 96%). 
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